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Part I
1

Abstract
The integrity of the genome is continuously jeopardized by endogenous re-
active byproducts of cellular metabolism and genotoxic insults by environ-
mental agents, as well as by the DNA transactions (replication, transcrip-
tion and recombination) required for cell survival and proliferation. Failure
of the mechanisms deputed to the maintenance of genome integrity leads
to genome instability, which is a hallmark of cancer and a driving force
of tumorigenesis. To fully understand the mechanisms leading to genome
instability and the cellular pathways counteracting them, three basic tasks
must be achieved: i) identify all the genes implicated in the control of
genome integrity; ii) unravel their biological role; iii) define the mechanis-
tic molecular details of the processes in which they are implicated. This
thesis describes work performed in the budding yeast Saccharomyces cere-
visiae to explore the genome stability landscape at all these three levels.
This model system is extremely useful for two main reasons: a) its high
genetic tractability allows the application of genome-wide genetic screen-
ings; b) the large conservation of the genome integrity pathways allows to
extend the findings obtained in yeast to other eukaryotic organisms.
We performed a genome-wide screen, based on the overexpression of the
DDC2 DNA damage checkpoint gene in the yeast deletion collection, to
identify genome stability genes on the basis of spontaneous accumulation of
endogenous DNA damage in the corresponding mutant strains. Our screen
identified several genes implicated in the control of genome integrity, high-
lighting, in particular, a key role for pathways protecting against oxidative
stress. We present here the preliminary characterization of a new genome
integrity gene, VID22.
We also investigated the mechanisms counteracting a newly discovered
3
Abstract
source of genome instability, namely ribonucleotides (rNTPs) incorporated
in genomic DNA during replication. We uncovered a role for RNase H
enzymes, template switch pathways and Pol z translesion polymerase in
protecting from misincorporated rNTPs. Given that mutations in any
of the three human RNase H2 subunits were proven to cause Aicardi-
Goutiéres Syndrome, these results might contribute to shed light on the
complex and largely unknown pathogenetic mechanism of this rare genetic
disease.
Finally, we studied the molecular details underlying the role of Rad9
mediator protein in DNA damage checkpoint activation, exploring the dy-
namics of Rad9 dimerization, chromatin binding, CDK-dependent phos-
phorylation and checkpoint activation in G1 and M phases of the cell cycle;
in particular, we characterized an M-phase specific pathway for checkpoint
activation which is relies on Rad9-Dpb11 interaction.
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1 Introduction: DNA damage and genome
integrity maintenance
The integrity of the DNA molecules, which are the depositary of the ge-
netic information in all living organisms, is continuously challenged by the
action of multiple endogenous and exogenous agents. First of all, as a
consequence of its intrinsic instability in an aqueous environment, DNA
molecules can undergo spontaneous hydrolysis, which can result in depuri-
nation and subsequent formation of abasic sites, or deamination, yielding
miscoding bases (Lindahl, 1993).
Second, DNA can be severely damaged by multiple byproducts of the
normal cellular metabolism. Reactive oxigen and nitrogen species cause
single-strand DNA breaks, formation of abasic sites and base oxidation,
the most common oxidized lesion being 8-oxo-guanine (8-oxo-G). Reac-
tive carbonil species (RCS) originating mainly during lipid peroxidation
yield mispairing DNA exocyclic adducts, DNA strand breaks and DNA
cross-links. Moreover, DNA alkylation by endogenous alkylating agents
may result in abasic sites, replication-blocking lesions, or point mutations
during replication, while estrogen and cholesterol metabolites can form
depurinating DNA adducts or free radicals which cause oxidative dam-
age (De Bont and van Larebeke, 2004). Among endogenous sources of
DNA damage, also DNA replication errors should be included, resulting
in dNTPs misincorporation or in accidental rNTPs incorporation in DNA
(see Section Causes of genome instability).
Third, chemical or physical environmental agents can cause hazardous
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alterations in DNA structure, above all ionizing radiation (IR) and ultra-
violet (UV) component of sunlight. UV light causes bulky lesions on DNA
(mainly cyclobutane pyrimidine dimers (CPDs) and 6-4 pyrimidine-pyrimi-
done photoproducts (6-4PPs)) which induce a distortion of the DNA helix,
which represent an obstacle for replication and transcription. Moreover,
near-UV light causes covalent modifications in DNA similar to those pro-
duced by oxidative damage. Instead, lesions generated by IR (X and g
rays) are mainly double-strand breaks (DSBs) and single-strand breaks
(SSBs) (Lindahl and Wood, 1999). Among environmental sources of DNA
damage it has to be mentioned cigarette smoke, which causes aromatic
DNA adducts and oxidative damage (Phillips et al., 1988; Kiyosawa et al.,
1990). Also chemotherapeutic agents can cause DNA lesions: alkylat-
ing agents such as methyl methanesulfonate (MMS) and temozolomide
alkylate DNA, while crosslinking agents such as mitomycin C (MMC), cis-
platin, psoralen, and nitrogen mustard introduce covalent links between the
two DNA strands (interstrand crosslinks, ICLs), which block transcription
and replication, or between bases of the same DNA strand (intrastrand
crosslinks) (Schärer, 2005). Furthermore, topoisomerase inhibitors such
as camptothecin (CPT) and etoposide, induce the formation of SSBs or
DSBs by blocking topoisomerase I or II in a topoisomerase-DNA covalent
complex (Pommier et al., 2010).
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Figure 1: The main sources of DNA damage and the most common le-
sions they create.
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DNA lesions are extremely harmful because they can be either muta-
genic (alteration of the genetic information) or cytotoxic (impairment of
cell viability). The extent of DNA damage occurring in living organisms is
surprisingly high, since it was estimated that each cell experiences about
105DNA lesions per day (Lindahl, 1993). Therefore, a serious task posed
to all cells is to maintain the integrity of the genome despite all the at-
tacks to which it is continuously subject, in order to ensure cell survival
and preserve the genetic information encoded in the DNA molecules, thus
allowing the faithful transmission of the genome across generations.
2 Genomic instability and its consequences
The failure of a cell to maintain the integrity of its genetic material leads
to a condition known as genomic instability, characterized by the acceler-
ated accumulation of a wide spectrum of genetic alterations, ranging from
point mutations to gross chromosomal rearrangements. Different classes
of genomic instability have been described: i) instability leading to muta-
tions (including base substitutions, micro-insertions and micro-deletions);
ii) mini- and micro-satellite instability (MIN) (leading to expansion or con-
traction of repetitive DNA sequences); iii) gross chromosomal rearrange-
ments (GCRs), which encompass several aberrations in chromosome struc-
ture like translocations, duplications, inversions or deletions; iv) chromo-
somal instability (CIN), defined as a persistently high rate of loss and gain
of whole chromosomes, which results in alterations in the number of chro-
mosomes (a state known as aneuploidy) (Aguilera and Gómez-González,
2008).
Genomic instability is present in almost all human cancers and it is con-
sidered one of the major hallmarks of cancer (Negrini et al., 2010; Hanahan
and Weinberg, 2011). Not only, but due to the huge number of mutations
required for tumor development, genomic instability was proposed as a key
driving force in tumorigenesis (Loeb, 1991).
Cancer is a multistep process, characterized by the gradual accumula-
tion of genetic alterations. Fig. 2 depicts an overview of the process of
7
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tumor development modeled as a darwinian evolution according to the
so-called “mutator hypothesis”, in which subsequent rounds of mutation
and selection drive cancer progression (Loeb, 2011). The mutator hypoth-
esis moves from the consideration that the observed spontaneous mutation
rate in somatic human cells (∼ 2 × 10−7 mutations/cell division) cannot
account for the several genetic changes necessary for cancer development
(Renan, 1993). This model proposes that at the beginning of cancero-
genesis, due to endogenous or environmental DNA damage, a “mutator
mutation” occurs in a gene responsible for genome integrity maintenance,
resulting in an overall increase of the mutation rate. This enhanced mu-
tagenesis will favor the occurrence of “driver mutations” in oncogenes or
tumor suppressor genes (Beckman and Loeb, 2006), which provide a pro-
liferative advantage and will thus be selected within the precancerous cell
population, according to changes in the microenvironment. To a certain
extent, this is expected to be a positive feedback mechanisms, since in a
genetically unstable cell new mutations may occur which further increase
genomic instability. Subsequent multiple rounds of selection and mutation
will direct the evolution of the tumor up to a malignant cancer. Together
with driver and mutator mutations, tumor cells will also acquire a number
of “passenger mutations”, that do not confer any growth advantage, and
account for the heterogeneity within the tumor, which may be responsible
for resistance to chemoterapeutic agents (Bielas et al., 2006).
Figure 2: Model of tumor progression according to the mutator hypothesis
(from Loeb, 2011).
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The main argument against this model is that mutations in genome sta-
bility genes (also called “caretaker genes”) are usually recessive. Therefore,
two independent mutations inactivating both alleles are needed to get an
unstable genome, and the occurrence of this event before the onset of ge-
nomic instability is expected to have a very low probability (Bodmer et al.,
2008). In accordance with these considerations, high-throughput studies
on cancer cell lines in many cases failed to detect mutations in known
caretaker genes or to identify novel putative caretaker genes frequently
mutated in tumors (Wang et al., 2004; Sjöblom et al., 2006; Wood et al.,
2007; Jones et al., 2008; Parsons et al., 2008; Cancer Genome Atlas Re-
search Network, 2008; Ding et al., 2008). Therefore, an alternative model
was proposed, the so-called “oncogene-induced DNA damage model for
cancer development”, which still partially relies on genomic instability, but
places oncogene-driven replication stress at the first stage of tumorigenesis
(Halazonetis et al., 2008). This model comes from the observation that
both precancerous and cancerous lesions exhibit a persistent DNA damage
response indicating the presence of DSBs (Bartkova et al., 2005; Gorgoulis
et al., 2005). The authors propose that the activation of a oncogene which
deregulates entry into the cell cycle is the key initial step of cancer de-
velopment. Activated oncogenes can induce a state of replication stress,
causing frequent replication fork collapse which, in turn, leads to DSBs es-
pecially at particular chromosomal loci known as fragile sites (see Section
Causes of genome instability for details). The genomic instability thus gen-
erated can subsequently lead to the loss of growth restrictions (typically by
checkpoints, apoptosis and senescence), which marks the transition from
precancerous to cancerous lesions (Fig. 3).
These two apparently conflicting models can be reconciled in a global
overview of carcinogenesis which takes into account the differences between
hereditary and sporadic cancers, as shown in Fig. 4 (Negrini et al., 2010).
The mutator hypothesis, which places genomic instability as the earliest
step of tumorigenesis, can explain very effectively the genesis of hereditary
cancers: here, a germline mutation in one of the genome stability genes is
already present in all the patient’s cells, and therefore a single mutation
9
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Figure 3: The oncogene-induced DNA damage model for cancer develop-
ment (from Halazonetis et al., 2008).
is required to inactivate the other allele, resulting in genomic instability.
And indeed, caretaker genes (mainly DNA repair or mitotic checkpoint
genes) were often found mutated in hereditary cancers (Fishel et al., 1993;
Leach et al., 1993; Al-Tassan et al., 2002; Cleaver, 2005; Ripperger et al.,
2009). Instead, the oncogene-induced DNA replication stress model is best
suitable to explain the mechanisms leading to sporadic cancer, not lastly
due to the fact that activated oncogenes are generally dominant (Lee and
Muller, 2010). In this view, deregulation of a growth-regulating gene leads
to replication stress and DNA damage, which cause genomic instability
and subsequently all the other cancer hallmarks. In fact, the results of
high-throughput sequencing studies of human sporadic cancers are in ac-
cordance with the oncogene-induced DNA replication stress model, since
the most frequently mutated or deregulated genes were found to be classical
oncogenes or tumor suppressors (Sjöblom et al., 2006; Wood et al., 2007;
Jones et al., 2008; Parsons et al., 2008; Cancer Genome Atlas Research
Network, 2008; Ding et al., 2008). It is worth noting that, despite differing
in the initial event placed at the basis of carcinogenesis, both models rely
upon genomic instability as a key factor for tumor development.
10
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Figure 4: The role of genomic instability in the genesis of hereditary and
sporadic cancers (modified from Negrini et al., 2010).
3 Causes of genome instability
Despite the need to maintain the integrity of the genetic material in or-
der to guarantee the stability of the genetic information, DNA is anything
but an inactive storage molecule. Instead, normal cellular metabolism
entails complex DNA transactions in order to transcribe, duplicate and
repair the genetic material. Therefore, apart from endogenous or environ-
mental sources of DNA damage, a very serious threat to genome integrity
comes from the DNA metabolism itself: indeed, the two main cellular pro-
cesses involving DNA, namely transcription and replication, are potential
sources of chromosome breakage. In accordance with the oncogene-induced
DNA damage model for cancer development, replication stress and subse-
quent replication errors or replication failures appear to be the main origins
of genome instability (Gorgoulis et al., 2005; Kunkel, 2004; Aguilera and
Gómez-González, 2008; Halazonetis et al., 2008). Fragile sites and highly
transcribed regions are often responsible for the impairment of replication
(Durkin and Glover, 2007; Aguilera and García-Muse, 2012). Repetitive
sequences, DNA secondary structures, telomere disfunction and chromo-
some segregation failures are additional factors contributing to the onset of
genomic instability (Aguilera and Gómez-González, 2008; Bochman et al.,
2012; Frias et al., 2012; Holland and Cleveland, 2012).
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A comprehensive overview of the mechanisms leading to the different
outcomes of genomic instability is presented in Fig. 5.
3.1 The replication fork at the center of genome
instability
During replication, DNA is most vulnerable, and its integrity is jeopar-
dised by a series of events which may perturb replication fork progression.
Accordingly, replication failures emerged as one of the main sources of ge-
nomic instability, due to the generation of both ssDNA gaps and DSBs by
multiple mechanisms (Aguilera and Gómez-González, 2008).
Replication of a nicked template inevitably results in the generation of
a DSB (Cortés-Ledesma and Aguilera, 2006).
When a replication forks encounters an obstacle on the leading strand
which prevents its progression (such obstacle may be a DNA adduct, a
protein, a DNA secondary structure or the transcription machinery), un-
coupling between replicative helicases and polymerases occurs and large
ssDNA stretches are generated: this situation is defined as “replication
fork stalling” (Carr et al., 2011). If the replisome remains associated with
the stalled fork, resumption of DNA synthesis can occur after the removal
of the obstacle. Conversely, if the stalled fork is not properly stabilized or
the obstacle cannot be removed, the replisome can disassemble, resulting
in “replication fork collapse”, with the subsequent generation of ssDNA
gaps and DSBs (Lopes et al., 2001; Sogo et al., 2002). Moreover, in case of
replication fork stalling or uncoupling between leading-strand and lagging-
strand synthesis (Pagès and Fuchs, 2003), the fork can reverse forming a
Holliday junction structure known as “chicken foot” (Postow et al., 2001;
Sogo et al., 2002): this structure can revert back to a normal fork, but it
can also be cleaved resulting in a DSB (Jaktaji and Lloyd, 2003; Heller and
Marians, 2006), or it can be processed by nucleases to generate a strech of
ssDNA (Cotta-Ramusino et al., 2005).
Alternatively the replication fork can encounter a lesion on the template
strand which prevents DNA synthesis without impairing fork progression.
12
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Figure 5: An overview of the mechanisms leading to genomic instability.
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If the lesion is on the lagging strand, a ssDNA gap is left between two
neighboring Okazaki fragments; if the lesion is on the leading strand DNA,
synthesis can resume past the obstacle, leaving a ssDNA gap behind.
DSBs are a potential source of several GCRs (Fig. 6), according to the
different ways in which they are processed and repaired (for details on
the repair pathways see Section DNA repair pathways). Direct repair by
non-homologous end joining (NHEJ) may lead to translocations, intersti-
tial deletions, inversions or insertions; de-novo telomere addition results
in a terminal deletion, while the process known as “breakage-bridge fu-
sion” (fusion of two chromosomes resulting in a dicentric chromosome, fol-
lowed by breaking during chromosome segregation) can generate translo-
cations and gene amplification. If the DSB is processed by nucleases
(resection), the break is channeled in a recombinative pathway: classical
homologous recombination (HR) or synthesis-dependent strand annealing
(SDSA) yield reciprocal translocations, interstitial deletions, duplications
and inversions, while break-induced replication (BIR) results mainly in
non-reciprocal translocations, but also interstitial deletions and inversions;
repair by single-strand annealing (SSA), instead, causes interstitial dele-
tions (Aguilera and Gómez-González, 2008).
Also ssDNA generated at the replication fork is a potential source of
genomic instability. Indeed, experimental observations suggest that ss-
DNA itself can be recombinogenic, even without being converted to a DSB
(Fabre et al., 2002; Lettier et al., 2006): therefore, the long ssDNA stretches
generated as a consequence of a perturbed replication could be a source of
hyper-recombination.
3.2 DNA replication fidelity
The accuracy of DNA synthesis according to the Watson-Crick base pair-
ing rules is a key aspect in the transmission of an intact genetic information
(Watson and Crick, 1953). For this reason, multiple biochemical mecha-
nisms ensure the fidelity of replicative polymerases (eucaryotic Pol a, Pol
d and Pol e): selectivity for the insertion of the correct nucleotide is pro-
14
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Figure 6: Different gross chromosomal rearrangements following a
double-strand break (modified from Aguilera and Gómez-González,
2008).
vided by base-base hydrogen bonding, water exclusion from the catalitic
site, and above all a steric selection on base pair shape and size within
the active site (Kunkel, 2004). Moreover, many DNA polymerases pos-
sess intrinsic proofreading activity, based on a higher efficiency of these
enzymes in extending a matched primer compared to an unmatched one,
and on an exonuclease activity wich allows the excision of the mispaired
base (Kunkel, 2004).
Despite these fidelity-ensuring systems, errors in base incorporation may
occur during replication (McCulloch and Kunkel, 2008): it was estimated
that base substitution error rate of replicative polymerases in vivo is in
the range of 10-7 to 10-8(Schaaper, 1993; Loeb, 1991). Furthermore, inser-
tions or deletions of single bases may result from strand misalignement, a
process which is strongly favored during replication of repetitive sequences
(Streisinger et al., 1966). In addiction, to replicate past a damaged tem-
plate, cells in most cases use error-prone translesion synthesis (TLS) poly-
merases (namely Pol z, Pol h, Pol i and Pol k), which can accomodate
helix-distorting modified bases in their active site, at the expenses of fi-
delity in nucleotide incorporation (Friedberg et al., 2002) (see Section DNA
15
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damage tolerance mechanisms).
3.2.1 Ribonucleotide misincorporation in DNA
Recently, another potential source of genome instability linked to replica-
tion has been described. Replicative polymerases can incorporate at ex-
tremely high rates ribonucleotides (rNTPs) instead of deoxyribonucleotides
(dNTPs) during DNA synthesis, mainly due to the higher rNTPs levels
over dNTPs in the cell. Estimates in yeast considering the rate of discrimi-
nation against rNTPs incorporation of the different replicative polymerases
and their relative contribution to genome replication, yielded a likely incor-
poration of 104 rNTPs per nuclear genome during each round of replication
(Nick McElhinny et al., 2010b). Ribonucleoside monophosphates (rNMP)
embedded in DNA can jeopardize genome stability in multiple ways: first
of all, due to the reactive hydroxyl group at the 2’ position, RNA is 100000-
fold more prone to hydrolysis than DNA under physiological conditions (Li
and Breaker, 1999). Moreover, the presence of rNMPs alters DNA helix
parameters (Jaishree et al., 1993; DeRose et al., 2012), and this distortion
may constitute an obstacle which impedes replication fork progression: in-
deed Pols a, d and e can replicate past a single ribonucleotide with reduced
efficiency (Nick McElhinny et al., 2010b; Watt et al., 2011). Finally, it was
directly demonstrated that increased ribonucleotide incorporation in DNA
causes genomic instability, likely due to mutagenic enzimatic processing
of the RNA:DNA moiety (Nick McElhinny et al., 2010a; Kim et al., 2011;
Clark et al., 2011; Shen et al., 2012).
3.3 Fragile sites
Chromosomal fragile sites are defined as specific loci which undergo fre-
quent gaps or breaks under replication stress, and are hotspots of chro-
mosome rearrangements in tumor cells (Durkin and Glover, 2007; Lukusa
and Fryns, 2008). Fragile sites are conserved from mammals to lower
eukaryotes, including yeast, where many “replication slow zones” (RSZ),
multiple “replication fork pausing (RFP) sites” and two “fragile sites” (FS1
16
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and FS2) were identified (Cha and Kleckner, 2002; Lemoine et al., 2005;
Ivessa et al., 2003; Admire et al., 2006).
Chromosomal fragile sites have been divided in two classes with distinct
features. Rare fragile sites are observed in less than 5% of the cases and are
inherited in a mendelian fashion: they are made up of microsatellite trin-
ucleotide repeats (TNRs) or AT-rich minisatellite repeats, and are often
associated with genetic diseases caused by repeat expansion (López Cas-
tel et al., 2010; Durkin and Glover, 2007). Common fragile sites (CFSs),
instead, are present in all individuals, since they represent normal compo-
nents of chromosome structure, and generally contain AT-rich sequences,
but not nucleotide repeats (Durkin and Glover, 2007; Debatisse et al.,
2012). The mechanisms underlying fragility of these sites and the genome
instability outcomes differ for the two classes described.
3.3.1 Rare fragile sites
The instability of TNRs and AT-rich minisatellites relies upon their ability
to form unusual secondary structures (such as hairpins, stem-loops or DNA
triplexes: see Section Unusual secondary structures) during replication,
which trigger MIN: in particular, hairpin structures at the 5´ end of a
displaced Okazaki fragment during lagging strand synthesis can promote
repeat expansion (Freudenreich et al., 1998; Spiro et al., 1999); similarly,
secondary structures on the lagging strand can cause replication slippage
events, which result in repeat deletions (Aguilera and Gómez-González,
2008).
Moreover, these secondary structures can be processed by nucleases
yielding a DSB (Leach et al., 1997; Lobachev et al., 2002). Addition-
ally, these secondary structures can perturb replication fork progression,
possibly resulting in gaps or breaks (Gacy et al., 1995; Hewett et al., 1998).
3.3.2 Common fragile sites
The molecular mechanisms underlying CFSs fragility is less understood
and two main models were proposed for CFSs-dependent genomic insta-
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bility, which, despite being often presented as alternative models, may pro-
vide a comprehensive overview of the problem (Ozeri-Galai et al., 2012).
AT-rich sequences within CFSs are characterized by a high degree of
DNA torsional flexibility, which has the potential to form secondary struc-
tures capable of impairing replication fork progression (Zlotorynski et al.,
2003; Shah et al., 2010). Indeed, CFSs were described as late-replicating
regions (Le Beau et al., 1998; Hellman et al., 2000; Palakodeti et al., 2004).
Therefore, a first mechanism for CFSs instability envisions CFSs as slow-
replication genomic regions which favor uncoupling between replicative
helicases and polymerases (especially in conditions of replication stress ).
The subsequent generation of long ssDNA tracts allows secondary structure
formation in AT-rich tracts, acting as replication fork barriers, ultimately
resulting in fork stalling and/or collapse and DSBs generation (Durkin and
Glover, 2007; Lukusa and Fryns, 2008).
Recent observations highlighted another feature of CFSs, that is the
paucity in replication initiation. Due to the absence or low efficiency of
replication origins, CFSs are often replicated from forks originating from
flanking regions, resulting in incomplete replication leading to chromosome
breakage under replication stress (Lemoine et al., 2008; Palumbo et al.,
2010; Letessier et al., 2011; El Achkar et al., 2005). Interestingly, the
density of initiation events is epigenetically determined, which accounts
for cell-type differences observed in CFSs fragility (Letessier et al., 2011).
Moreover, a correlation was found between the level of transcription of
very large genes at CFSs and the instability of the corresponding site
(Helmrich et al., 2011); this mechanism likely relies on the interference
between transcription and replication (see Section Transcription-associated
genomic instability).
Thus, both sequence features and origin efficiency can account for CFSs
instability. Importantly, the mechanism of CFSs fragility is in line with the
oncogene-induced DNA replication stress model for cancer development de-
scribed in Section Genomic instability and its consequences (Halazonetis
et al., 2008). During the early stages of cancer development, oncogene
activation induces replication stress, which results in chromosome break-
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age, deletions and rearrangements particularly at CFSs, which precede and
likely drive instability in other genomic regions (Tsantoulis et al., 2008).
The model is further reinforced by the finding that some CFSs lie within
tumor suppressor genes, suggesting a mechanisms for inactivation of re-
cessive tumor suppressor genes during tumor development (Bignell et al.,
2010).
3.4 Unusual secondary structures
The DNA structure described by Watson and Crick is the canonical right-
handed double helical structure called B-form DNA (Watson and Crick,
1953). Since then, non-B-form secondary structures have been found to
occur at specific DNA sequences (Fig. 7). Hairpins can form at inverted
repeats or trinucleotide repeats (TNRs), on single-stranded DNA (Nag
and Petes, 1991); similarly, inverted repeats longer than 6 nucleotides can
adopt a cruciform structure, which is made up of two hairpin-loop arms and
a 4-way junction, resembling a Holliday junction (Palecek, 1991). Three-
stranded triplex DNA structures are formed when a single-stranded DNA
region binds in the major groove of purine-rich double-stranded B-DNA,
leaving its complementary strand unpaired (Htun and Dahlberg, 1988).
Repetitive G-rich sequences can form G-quartets, in which 4 guanines are
arranged in a planar square, and multiple stacks of G-quartets yield a G-
quadruplex (G4) DNA structure, which is usually stabilized by monovalent
cations (Bochman et al., 2012).
These non-canonical secondary structures are hotspots for genomic in-
stability: hairpin formation is involved in TNRs instability (López Castel
et al., 2010); triplex DNA structures are intrinsically mutagenic, likely be-
cause they cause DSBs that result in translocations (Wang and Vasquez,
2004); cruciform structures formed at palindrome sequences are impli-
cated in DSB-induced translocations (Kurahashi et al., 2006; Inagaki et al.,
2009); G-quadruplexes stabilization induces DNA damage, and some re-
arrangement breakpoints have been mapped at sequences prone to G-
quadruplex formation (Bacolla et al., 2004; Lopes et al., 2011; Rodriguez
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Figure 7: The most common non-canonical DNA secondary structures
(from Saini et al., 2013).
et al., 2012).
The main mechanism through which all these unusual secondary struc-
tures jeopardize genomic stability relies on the observation that they can
impair replication fork progression, inducing DSBs and ssDNA gaps (Krasil-
nikova and Mirkin, 2004; Mirkin and Mirkin, 2007; Voineagu et al., 2008;
Lopes et al., 2011). Interestingly, non-canonical secondary structures-
induced genomic instability was detected in non-proliferating cells, sug-
gesting alternative mechanisms to replication fork impairment. DNA re-
pair processes expose ssDNA tracts, favoring the formation of non-B-form
secondary structures, which might interfere with the repair process itself,
resulting in GCRs. Moreover unusual secondary structures may be recog-
nized as helix-distorting lesions, and cleavage by the repair machinery may
occur, yielding deletions and GCRs. The ssDNA which is exposed after
triplex DNA formation may itself be a recombinogenic intermediate. In
addition, non-canonical secondary structures seem to be more susceptible
to DNA damage, likely because they impair nucleosome positioning (Wang
and Vasquez, 2009).
Importantly, telomeric regions are particularly prone to secondary struc-
ture formation, which is one of the causes of telomere instability (see Sec-
tion Telomeres and genome instability).
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3.5 Transcription-associated genomic instability
In recent years, increasing amount of evidence unraveled unexpected con-
nections between transcription and genomic instability (Aguilera, 2002):
indeed, high rates of transcription at a genomic locus correlate with in-
creased mutations, a phenomenon known as “transcription-associated mu-
tation” (TAM) (Datta and Jinks-Robertson, 1995; Beletskii and Bhagwat,
1996). Parallely, highly transcribed regions show a greater recombination
frequency, a phenomenon referred to as “transcription-associated recombi-
nation” (TAR) (Thomas and Rothstein, 1989; Nickoloff, 1992). Both out-
comes are likely related to interferences between transcription and replica-
tion, as well as to the generation of ssDNA (Aguilera and Gómez-González,
2008).
As a consequence of local negative supercoiling during transcription,
DNA-strand opening and ssDNA generation occurs behind an elongating
RNA polymerase. Given that ssDNA is less stable and more susceptible
to mutagenic damage from endogenous or environmental sources than ds-
DNA (Lindahl, 1993; Aguilera, 2002), this is a potential mechanism for
TAM, but likely not the only one, since it cannot explain the observation
that the non-transcribed strand (NTS) is more prone to mutations than
the transcribed strand (TS) (Skandalis et al., 1994; Beletskii and Bhagwat,
1996). A further explanation involves the formation of R-loops (Fig. 8), a
three-strand nucleic acid structure formed by annealing of the transcribed
RNA on its template, resulting in an RNA:DNA hybrid plus a displaced
DNA strand (ssDNA) (Aguilera and García-Muse, 2012). This structure
accounts for the preferential mutagenesis of the NTS, as the displaced
NTS is single-stranded, while the TS forms the RNA:DNA hybrid. More-
over, since persistent RNA:DNA hybrids can induce replication (Kogoma,
1997), it was proposed (Aguilera and García-Muse, 2012) that R-loops
might trigger unscheduled DNA synthesis, which is expected to be highly
mutagenic, in agreement with the finding that break-induced replication
(BIR) is extremely inaccurate (Deem et al., 2011).
Instead, collisions between the replication fork and the transcription
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Figure 8: R-loop structure (from Saini et al., 2013).
machinery cause replication fork impairment, DSBs and TAR (Prado and
Aguilera, 2005; Gottipati et al., 2008; Azvolinsky et al., 2009). The pos-
sible mechanisms for the induction of TAR and transcription-associated
GCRs relies upon the ability of R-loops to cause replication fork blockage
in multiple ways: i) unrepaired damage on the displaced strand might im-
pede DNA polymerase progression; ii) replication fork progression could
be impaired by the RNA:DNA hybrid itself, or by a RNA polymerase
blocked by the R-loop; iii) R-loop formation could allow the occurrence of
secondary structures on the displaced NTS, resulting in a barrier to DNA
polymerase; iv) torsional stress generated in front of a R-loop could cause
replication fork reversal, thus generating a highly recombinogenic “chicken
foot” structure. In all the indicated cases, the final outcome would be
replication fork stalling and/or collapse, with generation of DSBs or ss-
DNA gaps capable of triggering hyper-recombination and GCRs (Aguilera
and García-Muse, 2012). Furthermore, it was suggested that the attempt
to bypass a R-loop occurring between direct repeats through a template-
switch mechanism, inevitably results in the deletion of the intervening
region (Gómez-González et al., 2009).
3.6 Telomeres and genome instability
The ends of linear eukaryotic chromosomes, called telomeres, are made up
of long tracts of repeated sequences (referred to as TG repeats), extending
from few hundreds bp in yeast to several Kb in humans, and terminating
in a 3’ single-stranded overhang (also known as “G-tail”) (Blackburn et al.,
2006).
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Figure 9: Schematic representation of a human telomere (from Palm and
de Lange, 2008).
These structures pose multiple problems for genome integrity. First
of all, if not properly protected, they can be mis-recognized as DSBs
(discussed further). Moreover, the semi-conservative mode of replication
brings about a loss of single-stranded DNA on the lagging strand at the
chromosome end (a situation known as “end-replication problem”) (Wat-
son, 1972), which, together with resection of the 5’ end to generate the 3’
single-stranded overhang (Lingner et al., 1995), results in loss of telomeric
sequences at each round of replication (telomere erosion). To overcome
these threatens to genome integrity, multiple mechanisms exist to ensure
proper telomere maintenance: on the one hand, a nucleoprotein struc-
ture protects the telomere from unscheduled reactions and masks it from
recognition by the DNA damage response (a phenomenon defined “telom-
ere capping”); on the other hand, a specific complex named telomerase
adds short TG-rich repeats to chromosome ends, restoring proper length
(Blackburn et al., 2006).
Telomere erosion actually occurs in somatic cells due to insufficient ex-
pression of telomerase (Harley et al., 1990). When a telomere shortens
below a certain threshold, it looses its protective cap, it is recognized as
a DSB, and accordingly repaired through the non-homologous end joining
(NHEJ) pathway (see Section DNA repair pathways) (Smogorzewska et al.,
2002; Dimitrova et al., 2008); the same effect is obtained after telomere un-
capping linked to defects in telomere-capping proteins (van Steensel et al.,
1998). Typically, repair of an uncapped telomere results in telomere fusion,
either with the sister chromatid, or with another uncapped chromosome
end; alternatively, chromosome fusion may occur between the uncapped
telomere and a DSB end, producing a translocation.
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Figure 10: Mechanism of breakage-
fusion-bridge (BFB) cycles (modi-
fied from Lo et al., 2002).
These events may start a series of
chromosomal aberrations through
a mechanisms named breakage-
fusion-bridge (BFB) (McClintock,
1941; Mieczkowski et al., 2003;
Capper et al., 2007). Briefly, telom-
ere fusion yields a dicentric chro-
mosome, which forms a character-
istic bridge between the two pools
of separating chromosomes during
anaphase; centromeres pulling in
opposite directions results in chro-
mosome breakage, leaving two un-
capped chromosome ends which
can undergo another telomere fu-
sion event. In this way, multiple
BFB cycles may occur, which not
only give rise to increasing GCRs, but also result in gene amplification,
a phenomenon frequently observed in cancer cell lines (O’Hagan et al.,
2002).
In addition to progressive telomere erosion, also sporadic telomere dele-
tions occur, in which large tracts of telomeric repeats are lost in a sin-
gle deletion event (Lustig, 2003). These events are due to the repetitive
nature of telomeric sequences, and may result from unequal sister chro-
matin exchange or replication slippage (Baird et al., 1995). Moreover,
repetitive telomeric sequences are particularly sensitive to oxidative lesions
(von Zglinicki, 2002) and are prone to formation of secondary structures
(Parkinson et al., 2002); both events lead to replication fork stalling, with
subsequent DSBs and telomeric deletion events (Lansdorp, 2005). Fur-
thermore, it was demonstrated that mammalian telomeric regions resem-
ble fragile sites, which are prone to breakage upon replication stress, again
resulting in telomere loss and GCRs (Sfeir et al., 2009). As in the case of
telomere shortening, sporadic telomere deletions may as well trigger BFB
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cycles (Lo et al., 2002).
Telomere instability is considered an important factor in tumor develop-
ment, based on the observation that mouse models lacking telomerase show
telomere loss, genomic instability and increased cancer incidence (Blasco
et al., 1997; Rudolph et al., 1999; O’Hagan et al., 2002). The paradoxi-
cal observation that most human cancer cell lines display telomerase ac-
tivation (Shay and Wright, 2005), led to a model for cancer progression
envisaging a transient period of telomere loss (Fig. 11). Unprotected chro-
mosome ends resulting from progressive telomeric shortening or sporadic
telomere deletions (the latter likely occurring at telomeric fragile sites af-
ter oncogene-induces replication stress), are usually recognized as DSBs
and trigger cell senescence (d’Adda di Fagagna et al., 2003). Following
cell cycle checkpoints inactivation, escape from senescence occurs, and a
phase named “crisis” starts, characterized by massive genomic rearrange-
ments leading to cell death. Occasionally, some cells acquire the ability to
maintain their telomeres (usually by telomerase activation), thus surviving
crisis and being endowed with indefinite lifespan: these cells now display
a malignant phenotype (Counter et al., 1992; Chin et al., 1999; Artandi
et al., 2000). It is worth noting that telomere-driven genomic instability
may still occur in these cells, although to a lower extent, due to sporadic
telomere deletions (Muraki et al., 2012).
Figure 11: Role of telomere loss in genome instability and cancer (from
Muraki et al., 2012).
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3.7 Chromosome segregation and genome instability
At each division, the cell not only must faithfully replicate its genetic
material, but also have to successfully distribute one copy of each chro-
mosome into each daughter cell. Therefore, another critical step for the
onset of genomic instability is chromosome partitioning during mitosis. A
specific surveillance pathway called mitotic checkpoint or spindle assembly
checkpoint is entrusted with ensuring accurate chromosome segregation
(see Section Mitotic checkpoint). Failure of this pathway paves the way to
chromosomal instability (CIN) (Michel et al., 2001; Iwanaga et al., 2007).
A part from mitotic checkpoint impairment, multiple mechanisms may
be responsible for chromosome mis-segregation (Fig. 12). Cohesion de-
fects are thought to be an important cause of CIN; indeed, mutations in
genes involved in regulation of sister chromatin cohesion were identified
in human cancers (Barber et al., 2008; Solomon et al., 2011), and altered
expression of these or other genes controlling sister cromatid cohesion re-
sults in CIN (Jallepalli et al., 2001; Zhang et al., 2008; Iwaizumi et al.,
2009), likely because incorrect chromatin packaging at the centrosome
causes defects in chromosome orientation, and/or untimely chromatid dis-
junction leads to chromosome partitioning prior to establishment of proper
spindle-chromosome attachment (Thompson et al., 2010). Moreover, al-
tered kinetochore-microtubule attachment dynamics may be detrimental
for faithful chromosome partitioning in mitosis. Association and dissocia-
tion of spindle microtubules from kinetochore allows correction of merotelic
attachments, in which a single kinetochore attaches to microtubules arising
from both spindle poles (Thompson and Compton, 2008). Destabilization
of kinetochore-microtubule attachments prevents chromosome segregation
(Liu et al., 2009), while hyper-stabilization of kinetochore-microtubule at-
tachments impairs release of uncorrectly attached microtubules, reducing
the efficiency of merotelic attachment correction, which results in increased
kinetochore mal-orientations and chromosome mis-segregation (Bakhoum
et al., 2009b,a). In addition, centrosome amplification may occur due to
centriole overduplication, centrosome fragmentation or loss fo centriole co-
26
Causes of genome instability
Figure 12: Mechanisms for chromosomal instability (from McGranahan
et al., 2012).
27
State of the art
hesion (Holland and Cleveland, 2009), yielding a cell with more than two
centrosomes. This is also the outcome of tetraploidization as a consequence
of cell fusion or cell divison failures (Ganem et al., 2009). The presence of
extra-centrosomes induce the transient formation of multipolar spindles,
resulting in a high rate of merotelic attachments leading to chromosome
mis-segregation (Silkworth et al., 2009; Ganem et al., 2009).
Aneuploidy and CIN have been proposed to have a major role in tu-
morigenesis, based on the observation that solid tumours are aneuploid
(Mitelman et al., 2012). Indeed, it was shown that, when combined with
loss of p53 or other genes that restrict proliferation of aneuploid cells,
CIN has a strong tumor-promoting effect (Chi et al., 2009; Li et al., 2010;
Sotillo et al., 2010). Multiple mechanisms could account for this tumori-
genic effect: i) loss of a chromosome may uncover a recessive mutation in
a tumour suppressor gene on the homologous chromosome(Cavenee et al.,
1983); ii) aneuploidy creates imbalances in the levels of proteins required
for DNA replication, repair or mitosis, therefore increasing the mutation
rate (Duesberg et al., 2006); iii) aneuploidy was proven to be a source of
genomic instability in yeast (Sheltzer et al., 2011), and chromosome mis-
segregation was found to cause DSBs and GCRs in human cells (Janssen
et al., 2011); iv) recently, it was also shown that lagging anaphase chromo-
somes due to segregation errors are incapsulated in micronucei, where they
undergo extensive fragmentation and random rejoining (‘chromothripsis’),
resulting in rearrangements (Stephens et al., 2011; Liu et al., 2011; Crasta
et al., 2012). Importantly, due to gain or loss of whole chromosomes, CIN
provides a huge phenotypic diversity, which may be the basis for tumor
adaptation to microenvironment changes, when large adaptive responses
are likely needed (Pavelka et al., 2010; Chen et al., 2012; Holland and
Cleveland, 2012).
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4 Mechanisms preserving genome integrity
4.1 Helicases, topoisomerases and nucleases meet at the
fork
Given that the main challenge to genome stability derives from problems
during replication (Kolodner et al., 2002; Aguilera and Gómez-González,
2008), it is not surprising that a plethora of proteins endowed with different
biochemical activities are required to promote replication fork integrity
(summarized in Fig. 13).
Figure 13: Helicase, nuclease and topoisomerase activities promote repli-
cation fork progression (from Chagin et al., 2010).
DNA duplex unwinding by replicative helicases creates torsional stress
which needs to be relieved by specific topoisomerase activities: they do so
by cutting one DNA strand (topoisomerase I) or both strands (topoiso-
merase II), thereby allowing the uncut strand to pass through the break
before resealing it (Vos et al., 2011). Positive supercoiling produced in
front of a traveling replication fork, at converging replication forks, or at
head-on encounters between transcription and replication can be removed
by either Top1 or Top2 topoisomerases. Conversely, cruciform structures
(precatenanes) formed behind the replication fork or at sites of convergent
replication forks are processed only by Top2 (Bermejo et al., 2007; Branzei
and Foiani, 2010).
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Several activities ensure proper replication fork progression under per-
turbed conditions or at difficult-to-replicate regions. X-shaped DNA struc-
tures resembling Holliday junctions accumulate during a perturbed repli-
cation; these likely represent recombination structures resulting from repli-
cation fork regression or recombination-mediated bypass of replication fork
stalling (Liberi et al., 2005). Their processing involves the activity of Sgs1-
Top3-Rmi1 complex (BLM-TOPOIIIa-RMI1 in human), which employs
the concerted action of RecQ helicase BLM/Sgs1 and type IA topoiso-
merase TOPOIIIa/Top3. Alternatively, these structures can be cleaved by
a resolvase complex made up of Mus81-Mms4 in yeast and MUS81-EME1
in human (Fabre et al., 2002; Ashton and Hickson, 2010; Hickson and
Mankouri, 2011). Another helicase named Srs2, instead, directly inhibits
the formation of these recombinative structures by disrupting Rad51 nucle-
oprotein filaments, thus preventing unwanted recombination events during
replication. (Fabre et al., 2002; Pfander et al., 2005).
Other Holliday junction resolvase activities were recently detected (Svend-
sen and Harper, 2010), namely Slx1-Slx4 complex and GEN1/Yen1 nu-
clease. The Slx1-Slx4 complex is required – redundantly with Sgs1-Top3-
Rmi1 complex – for resolution of stalled forks at the rDNA locus, a difficult-
to-replicate region because of its highly repetitive nature (Kaliraman and
Brill, 2002; Fricke and Brill, 2003). It is still unclear whether the role
of the Slx1-Slx4 resolvase is required for replication of other genomic re-
gions (Svendsen and Harper, 2010). Yen1/GEN1 nuclease, despite being
involved in recombination, does not seem to be implicated in processing
recombination-associated X-structures (Ip et al., 2008; Ashton et al., 2011);
it was suggested that Yen1 is required in meiosis (Svendsen and Harper,
2010).
Beyond replisome-associated helicases responsible for the unwinding of
the DNA duplex, Pif1 family helicases assist the replication fork by un-
winding DNA secondary structures or displacing protein complexes which
might impair fork progression (Bochman et al., 2010). Pif1 is involved in
replication through G-quadruplex forming DNA regions, in inhibition of
de-novo telomere addition through displacement of telomerase, in Okazaki
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fragment maturation and in mtDNA replication (Paeschke et al., 2011;
Boulé et al., 2005; Boulé and Zakian, 2007; Cheng et al., 2007); Rrm3
activity instead is implicated in disrupting non-nucleosomal protein-DNA
complexes, which might constitute replication fork pausing sites, located
at telomeres, rDNA locus, tRNA genes, centromeres, inactive replication
origins, and transcriptional silencers (Ivessa et al., 2000, 2002, 2003). In
mammalian cells only one Pif1 helicase was identified, which appears to
perform the same functions as yeast Pif1 (Zhang et al., 2006b; Futami
et al., 2007; George et al., 2009).
Anothey key point for genome integrity maintenance at the replication
fork is the proper removal of Okazaki fragments. This task is achieved
through the concerted actions of helicases and nucleases (Zheng and Shen,
2011). RNA primers on the lagging strand can be displaced by Pold,
or Pif1 helicase, thus generating a 5’ flap: if the flap is shorter than 10
nt, it can be cleaved by flap-endonuclease Fen1/Rad27 (and to a lesser
extent by Exo1). Conversely, longer flaps are first processed by Dna2
– which possesses ssDNA exonuclease activity – and finally cleaved by
Fen1/Rad27. Importantly, Dna2 helicase activity is required for cleavage
of secondary structure-forming flaps (Kang et al., 2010). If the RNA primer
is not displaced, it can become a substrate of RNase H, an activity which
specifically cleaves DNA:RNA hybrids (Cerritelli and Crouch, 2009).
Finally, the replication checkpoint (especially in its components Tof1
and Mrc1, which are associated with the replisome) promotes replication
fork stabilization (Sogo et al., 2002; Katou et al., 2003; Hodgson et al.,
2007) (see Section DNA damage checkpoints).
4.2 Overview of the DNA damage response
To neutralize the serious threaten to genome integrity coming from replica-
tion errors, endogenous genotoxic byproducts of cellular metabolism and
environmental DNA damage, the cell has evolved a complex network of
interlinked systems, collectively defined as DNA damage response (DDR):
these mechanisms detect the DNA damage, signal its presence and carry
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out the repair of the lesion (Fig. 14).
The DNA repair systems and the DNA damage checkpoint pathways
are central for the cellular DDR. Due to the wide diversity of DNA le-
sions, several specialized repair pathways exist, capable of coping with the
various injuries affecting the DNA molecules: some of these mechanisms
are error-free, while others remove the damage at the cost of introducing
mutations. DNA damage checkpoints are surveillance mechanisms which
monitor the status of the genetic material throughout the cell cycle and,
in the presence of DNA lesions or replication stress, temporarily halt cell
cycle progression in order to provide enough time to repair the damage
and faithfully complete replication. Moreover, they stimulate the repair
processes both at transcriptional and post-transcriptional levels; in higher
eukaryotes, in case the damage cannot be removed, they channel the cell
into the apoptotic pathway (Hoeijmakers, 2001; Jackson and Bartek, 2009).
These two branches of the DDR are tightly connected and share many com-
ponents; processing of physically different lesions by repair mechanisms
triggers checkpoint activation, which in turn modulates the repair process,
by recruiting repair factors and stimulating their activity (Lazzaro et al.,
2009; Novarina et al., 2011; Sertic et al., 2012).
The importance of the DDR in the maintenance of genome integrity is
highlighted by the observation that defects in either DNA repair pathways
or DNA damage checkpoints cause sensitivity to DNA-damaging agents
and genomic instability, and inherited mutations in many DDR compo-
nents are associated with cancer-predisposing syndromes (Hoeijmakers,
2001; Kennedy and D’Andrea, 2006; Kerzendorfer and O’Driscoll, 2009;
Jackson and Bartek, 2009).
4.3 DNA repair pathways
DNA repair mechanisms are conventionally grouped into classes on the
basis of the kind of lesion detected and the strategy carried out to re-
move it. In few cases, the chemical base alteration can be corrected by
Direct Damage Reversal systems. Excision repair mechanisms include
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Figure 14: Overview of the DNA damage response (from Jackson and
Bartek, 2009).
Base Excision Repair (BER), Nucleotide Excision Repair (NER) and Mis-
match Repair (MMR): in all these three processes one or more nucleotides
at the lesion site are eliminated forming a gap, which is filled and lig-
ated. DSBs are instead repaired by Double Strand Break Repair (DSBR)
mechanisms, namely Non-Homologous End Joining (NHEJ) and homolo-
gous recombination-based systems, which can be further divided in Ho-
mologous Recombination (HR), Synthesis-Dependent Strand Annealing
(SDSA), Break-Induced Replication (BIR) and Single-Strand Annealing
(SSA). Finally, DNA damage tolerance mechanisms exist, which allow the
provisional lesion bypass in order to complete replication: these mecha-
nisms include Translesion Synthesis (TLS), Post Replication Recombina-
tional Repair (PRRR) and Replication Fork Regression (also called “tem-
plate switch”).
In the following brief description of the major DNA repair pathways
both the human and S. cerevisiae names of each factor will be usually
provided.
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4.3.1 Direct damage reversal
Photoreactivation. Photoreactivation removes UV-induced lesion through
a light-dependent mechanism: the enzyme CPD photolyase (present in
many organisms from yeast to vertebrates, but absent in mammals) detects
and repairs pyrimidine dimers, while the enzyme 6-4 photolyase (identi-
fied in vertebrates but not in yeast) is employed in the removal of 6-4PPs.
CPD photolyase binds the DNA lesion, flips the pyrimidine dimer out of
the phosphodiester backbone and breaks the chemical bound between the
two nucleotides in a light-dependent electron transfer reaction (Thoma,
1999).
Demethylation. To repair some DNA lesions caused by methylation events,
namely O6-methylguanine (O6-meG) and O4-methylthymine (O4-meT),
the enzyme O6-methylguanine-DNA-methyltransferase is capable of trans-
ferring the mutagenic methyl group from DNA to a cysteine residue in its
active site (Sedgwick, 2004). Due to irreversible inactivation of the pro-
tein after the transfer reaction – and the subsequent requirement of a new
enzyme molecule for each lesion repaired – this system seems particulary
suitable for removal of infrequent but very harmful lesions, as is the case
of O6-meG (Lindahl and Wood, 1999).
4.3.2 Base excision repair
Base Excision Repair (BER) is the main system devoted to the correction
of base alterations as a consequence of cellular metabolism (oxidative dam-
age, methylation, deamination, hydroxylation). Several specialized glyco-
sylases, each capable of recognizing a specific subset of modifications, are
employed for the removal of damaged bases: when the glycosylase encoun-
ters a lesion, the modified nucleoside is flipped out from the DNA duplex in
a cavity of the enzyme, where cleavage of the glycosidic bond between the
base and deoxyribose occurs, resulting in an abasic site. Subsequently, an
apurinic/apyrimidinic (AP) endonuclease cleaves the phosphodiester back-
bone and repair synthesis occurs. In short-patch BER, DNA pol b fills the
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one-nucleotide gap and removes the 5’-terminal baseless sugar residue via
its lyase activity, after which the nick is sealed by a ligase activity. In long-
patch BER (which involves Pol d e Pol e) re-synthesis of 2-10 nucleotides
occurs, followed by removal of the displaced flap by the flap-endonuclease
FEN1/Rad27, and subsequnt nick sealing by DNA ligase (Hoeijmakers,
2001; Memisoglu and Samson, 2000).
4.3.3 Nucleotide excision repair
Nucleotide Excision Repair (NER) is a repair mechanism which recognizes
a broad spectrum of helix-distorting DNA lesions, as UV-induced damage
(CPDs and 6-4PPs), intrastrand and interstrand crosslinks (ICLs), and
several chemical adducts. NER is divided in two sub-pathways, which
differ in the lesion recognition mechanism, while the downstream steps are
in common: Transcription-Coupled Repair (TC-NER), detects and repairs
lesions on actively transcribed DNA, while Global Genome Repair (GG-
NER) deals with non-transcribed regions and with the non-transcribed
strand of transcribed genes (Thoma, 1999). It seems that lesion recognition
by NER requires both DNA helix distortion and covalent base modification,
while lesions producing only one of the two effects are not repaired with
this system (Lindahl and Wood, 1999).
In GG-NER the lesion is recognized by XPC-hHR238B/Rad4-Rad23
complex; also human DDB and yeast Rad7-Rad16 participate in the lesion
recognition step. Subsequently, XPA/Rad14, RPA complex and TFIIH
transcription factor are recruited: helicases XPB/Rad25 and XPD/Rad3
of TFIIH unwind the DNA duplex in opposite directions; RPA stabilizes
the ssDNA at the non-damaged strand, while XPA/Rad14 is involved in
verification of the damage site. In a next step, XPG/Rad2 and XPF-
ERCC1/Rad1-Rad10 nucleases are recruited, which cleave the 3’ and 5’
end of the open repair bubble respectively, releasing a fragment of about
30 nucleotides containing the lesion. Lastly, repair synthesis fills the gap
and DNA ligase seals the nick (Thoma, 1999; Lindahl and Wood, 1999).
In TC-NER, the RNA polymerase itself is responsible for signaling the
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presence of a lesion, as the helix distortion blocks polymerase progression.
At this point, CSB/Rad26 and CSA/Rad28 displace RNA polymerase and
recruit the other NER factors: hereafter the repair is identical to GG-NER
(Hoeijmakers, 2001; Prakash and Prakash, 2000).
4.3.4 Mismatch repair
To correct mutations due to replication errors, the Mismatch Repair (MMR)
system is specialized in repairing nucleotide mispaired by replicative poly-
merases and insertion/deletion loops (IDLs) caused by slippage during
replication of repetitive sequences (Hoeijmakers, 2001). MutSa complex
(Msh2/Msh6) triggers repair of base-base mismatches and IDLs of one or
two nucleotides, while MutSb (Msh2/Msh3) is specialized in recognition
of longer IDLs. MutSa e MutSb recruit heterodimeric complexes MutLa
(Mlh1/Pms2) and MutLb (Mlh1/Pms1). It seems that MutLa, based on
its ability to translocate along DNA after mismatch recognition, has a key
role in the discrimination of the damaged (neo-synthesized) strand, likely
due to the presence of a nick: in the lagging strand the nick is provided by
removal of Okazaki fragments, while it is still unclear how nicks are gen-
erated on the leading strand (Jiricny, 2006). Different mechanisms were
proposed for mismatch excision and resynthesis, depending on whether the
nick is upstream or downstream the lesion, based on the presence of PCNA
and RFC complexes respectively at the 3’ and 5’ends of the nick. If the
nick is upstream the mismatch, MutS/MutLa complex translocating along
DNA in a 3’-5’ direction comes across RFC, displaces it and loads Exo1,
which degrades the damaged strand thanks to its 5’-3’ exonuxlease activity.
If the nick is downstream the mismatch, MutS/MutLa complex moving in
3’-5’ direction encounters PCNA; MutLa endonuclease activity, activated
in a PCNA- and RFC- dependent manner, performs an incision upstream
the lesion, which allows Exo1 loading and degradation of the damaged
strand. In both cases the ssDNA gap generated by lesion removal is cov-
ered by RPA, DNA polymerase d fills the gap and the remaining nick is
sealed by DNA ligase (Jiricny, 2006; Li, 2008).
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4.3.5 Double-strand break repair
The cell possesses two main mechanisms to repair double-strand breaks
(DSBs): in Non-Homologous End Joining (NHEJ) the broken ends are
juxtaposed and sealed, while in homologous recombination-based mecha-
nisms the lesion is repaired using the genetic information on the homolog
chromosome or the sister chromatid (Fig. 16). The repair pathway choice
is influenced by several factors, including cell cycle phase, ploidy (in yeast),
number of DSBs and features of DSB ends (Longhese et al., 2006). At the
molecular level, this choice is regulated mainly by controlling nucleolytic
processing of the lesion (resection). Immediately after DSB occurrence,
several protein complexes are recruited at the lesion site to protect its
ends (preventing unscheduled degradation and subsequent loss of genetic
information), keep the ends in close proximity (limiting the possibility of
chromosome rearrangements) and signal the presence of the damage to
the checkpoint pathways (Fig. 15). At this stage, a key role is played by
MRN/MRX and Ku complexes. MRN/MRX complex is made up of human
Mre11-Rad50-Nbs1 or yeast Mre11-Rad50-Xrs2 proteins: this complex has
a peculiar structure, with a globular head which binds a DSB end, and two
protruding tails, which interact with the tails of the MRX/MRX complex
at the other side of the break, thus ensuring a temporary tethering of the
chromosome ends until effective repair occurs (Shin et al., 2004). Ku com-
plex, composed by Ku70 and Ku80 proteins, has a toroid shape capable
of hosting the DNA duplex (Hefferin and Tomkinson, 2005): it binds the
DSB ends preventing their degradation, and recruits NHEJ factors; when
Ku complex is inhibited (mainly by CDK activity in G2 phase), resection
of the 5’ strand occurs at the DSB ends, channeling lesion repair into one
of the homologous recombination-based pathways (Clerici et al., 2008).
Non-homologous end joining. In NHEJ, after MRN/MRX and Ku com-
plexes bind to DSB ends, DNA Ligase IV-XRCC4/Dnl4-Lif1 complex is
recruited. In most of the DSBs caused by genotoxic agents, the broken
chromosome ends are not compatible and require preliminary processing
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Figure 15: Complexes formed at DSBs (modified from Longhese et al.,
2006).
through nucleolytic degradation and/or polymerization; this task in hu-
man cells is performed mainly by Artemis exonuclease, while in yeast it
involves flap-endonuclease Rad27, the 3’-5’ exonuclease activity of MRX
complex, and DNA polymerase Pol4. It’s worth noting that NHEJ is a mu-
tagenic repair system, due to frequent loss of few nucleotides during DSB
ends processing. Finally, DNA Ligase IV/Dnl4 can complete the repair by
sealing the two chromosome ends (Hefferin and Tomkinson, 2005).
Homologous recombination. The key step shared by all recombination-
based repair mechanisms is the exonucleolytic processing (resection) at the
5’ strand of the DSB ends, with the subsequent formation of ssDNA tails
at the 3’ strand (Krogh and Symington, 2004). Multiple nucleases are
involved in resection, namely Mre11, CtIP/Sae2 and Exo1, together with
the BLM/Sgs1 helicase (Harrison and Haber, 2006; Ciccia and Elledge,
2010). The assembly of a nucleoproteic filament which is recombination-
proficient is called pre-synapis: ssDNA tracts generated by resection are
immediately covered by the RPA complex, which protects it from degra-
dation and removes secondary structures which might interfere with the
following recombination steps; then Rad51 replaces RPA on the nucleo-
proteic filament, an event favored by Rad52, while Rad55 e Rad57 are
involved in nucleoproteic filament stabilization (Krogh and Symington,
2004). The synapsis step consists in the identification of the homolog
donor sequence (strand invasion) and its annealing with the nucleopro-
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teic filament (strand exchange), a process promoted by Rad54. Rad54 is
also involved in the post-synapsis step, when it displaces Rad51 from the
DNA heteroduplex, allowing the access of DNA polymerase. The subse-
quent DNA synthesis using the 3’ end of the broken strand as a primer
creates a structure known as D-loop (Li and Heyer, 2008). From this
point on, the homologous recombination sub-pathways diverge according
to what happens in the following step (Fig. 16). In classical HR, second end
capture, DNA synthesis and ligation yield an intermediate known as dou-
ble Holliday Junction (HJ) (Li and Heyer, 2008). This intermediate can
be processed by MUS81-EME1/Mus81-Mms4 or GEN1/Yen1 resolvases
(resolution), yielding crossover products, or by the concerted action of
BLM/Sgs1 helicase and TopoIIIa/Top3 topoisomerase (dissolution), yield-
ing non-crossover products (Symington and Holloman, 2008).
Synthesis-dependent strand annealing. If, during the post-synapsis pha-
se, after the synthesis of a DNA stretch the invading strand dissociates
form the donor sequence before second-end capture, Synthesis-Dependent
Strand Annealing (SDSA) occurs: the D-loop is dissolved (likely by a heli-
case activity) and the neo-synthesized strand anneals back to the other re-
sected ssDNA DSB end; repair synthesis is completed by DNA polymerase
and DNA ligase (Li and Heyer, 2008). SDSA always yields non-crossover
products (Fig. 16).
Break-induced replication. Sometimes it is possible that only one DSB
end is capable of strand invasion on the homologue chromosome, resulting
in an unidirectional replication fork which copies the donor sequence until
the end of the chromosome, or until it encounters another replication fork:
this mechanism is called Break-Induced Replication (BIR) (Fig. 16). In this
case, the second DSB end is never captured, and the genetic information
on that chromosome region is lost, resulting in loss of heterozigosity (LOH)
(Longhese et al., 2006).
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Figure 16: Mechanisms of DSB repair. A) NHEJ; B) BIR, classical HR
and SDSA; C) SSA (modified from Longhese et al., 2006 and Longhese
et al., 2008).
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Single-strand annealing. When the DSB occurs between two direct re-
peats, repair by Single-Strand Annealing (SSA) may occur: when resection
reaches the homologue sequences flanking the DSB, complementary ssDNA
regions are exposed, which may anneal, leaving ssDNA flaps subsequently
removed by nucleases; resulting nicks or gaps are filled by repair synthesis
and ligation (Fig. 16). It is worth noting that this process entails the dele-
tion of one of the repeats and all the region between them: this feature
places SSA among mutagenic repair systems (Longhese et al., 2006).
4.4 DNA damage tolerance mechanisms
In some cases (for instance in the presence of an excessive number of DNA
lesions, when they are poorly accessible, or when damage occurs during S-
phase) the repair mechanisms might not be able to remove some lesions. If
the lesions are capable of blocking the replication fork, the cell is exposed to
a risk of fork collapse, or it might even be unable to conclude the cell cycle.
To face this dangerous situation, DNA damage tolerance mechanisms exist,
which allow replication past a lesion without removing it. Of course this
task is fulfilled at the price of transmitting potential mutations to the next
generations (Andersen et al., 2008). Replication of a damaged template
may represent and extreme attempt of the cell to survive, in the hope to
repair the lesion during the next cell cycle.
4.4.1 Translesion synthesis
A first DNA damage tolerance system, called Translesion Synthesis (TLS),
is based on the employment of alternative DNA polymerases, capable
of replicating – generally with low fidelity – past a damaged template
(Fig. 17). A common feature of translesion polymerases is a looser ac-
tive site conformation, capable of accommodating bulky adducts and mis-
matched base pairs (Friedberg, 2005). S. cerevisiae possesses three transle-
sion polymerases, namely Pol h, Pol z e Rev1, while mammalian cells be-
yond these also use Pol i and Pol k. Pol h can correctly insert two A
nucleotides in front of a thymine dimer, while it displays low fidelity with
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Figure 17: DNA damage tolerance mechanisms (modified from Andersen
et al., 2008).
other lesions (Andersen et al., 2008). Pol z is made by a catalytic subunit
and a regulatory one (Rev3 and Rev7), and has a low replication fidelity,
to such an extent that it is considered the main polymerase responsible
for mutagenic lesion bypass events (Gan et al., 2008). Rev1 is capable of
inserting cytosines in front of an abasic site and, with lower efficiency, in
front of a G or and A; moreover, it is thought to play a structural role in
TLS, acting as a scaffold for the interaction between the other translesion
polymerases and PCNA (Andersen et al., 2008). Pol i has a very low pro-
cessivity (it can insert bases opposite some lesions, but not extend synthesis
past the damage) and is very error prone, in that preferentially inserts G
opposite a template T (Lehmann et al., 2007). Pol k is specialized in by-
passing N2-adducted dG lesions, but is prone to small insertions/deletions
(Waters et al., 2009).
The PCNA complex is a key regulator of DNA damage tolerance path-
way choice: damage- and Rad6-Rad18- dependent mono-ubiquitylation of
PCNA-K164 promotes TLS, while poly-ubiquitylation of PCNA on the
same residue by Mms2-Ubc13-Rad5 complex channels the lesion into a
non-mutagenic lesion bypass mechanisms (see below) (Andersen et al.,
2008). Two models, which are not mutually exclusive, have been proposed
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for TLS-mediated lesion bypass. According to the “polymerase switch”
model, many polymerases are associated to the replication fork, through
interaction with PCNA; when the fork is blocked at a lesion, PCNA mono-
ubiquitylation promotes the loading of a translesion polymerase capable of
replicating past the lesion; then a second translesion polymerase extends
the replicated strand (to avoid profreading activity by canonical replica-
tive polymerases), and finally normal synthesis is resumed. According to
the “gap-filling” model, when the replication fork is halted by a lesion,
synthesis restarts downstream of the blocking lesion, leaving ssDNA gaps
behind, which are later filled by translesion polymerases (Waters et al.,
2009).
4.4.2 Post-replication recombinational repair
Post-Replication Recombinational Repair (PRRR) represents, together with
Replication Fork Regression, a strategy to avoid replicating the damaged
template in the immediate proximity of the lesion: both systems are there-
fore error-free mechanisms.
In PRRR, when the replication forks stalls at a lesion, repriming occurs
about 1Kb downstream, allowing normal synthesis by replicative poly-
merases; the gap is repaired through homologous recombination-based
lesion bypass, triggered by sister chromatid invasion: error-free synthe-
sis takes place using the other newly-synthesized strand as a template
(Fig. 17), followed by Holliday junction resolution. (Friedberg, 2005; An-
dersen et al., 2008).
4.4.3 Replication fork regression
Alternatively, the arrested fork may undergo a structural rearrangement,
defined Replication Fork Regression, in which the template DNA partially
reanneals, while the two newly-synthesized strands anneal together, re-
sulting in a short double-stranded DNA stretch protruding in the opposite
direction (Sogo et al., 2002): this transient structure at a reversed fork is
defined “chicken foot” (Fig. 17). In this way the replicative polymerase can
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use as a template the other newly-synthesized strand, which was already
extended past the lesion, due to leading and lagging strand uncoupling.
Reversal of the “chicken foot” structure restores a normal replication fork,
which can carry on replication downstream of the lesion (Friedberg, 2005).
4.5 DNA damage checkpoints
At the molecular level, DNA damage checkpoints can be considered as
highly conserved signal transduction cascades, mainly based on phospho-
rylation events, which convey the signal from damage sensors to several
DDR effectors. The DNA damage checkpoint cascade is conventionally
described by dividing the factors involved in: DNA damage sensors, which
activate the signal transduction process; adapters and mediators, in charge
of signal amplification; transducers and effectors, which phosphorylate a
series of target proteins involved in the cellular response to damage (Melo
and Toczyski, 2002).
Figure 18: A schematic overview of the DNA damage checkpoint cascade
(from Novarina et al., 2011).
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For the sake of simplicity, the checkpoint cascade in yeast will be de-
scribed, hinting at human proteins when necessary (Fig. 18).
4.5.1 Checkpoint activation: signals and sensors
Due to the huge plethora of different DNA lesions to which the cell needs to
respond, the current model predicts that lesion processing by DNA repair
mechanisms yields a common DNA intermediate, capable of activating
the checkpoint response, because it is recognized by the apical checkpoint
factors. Several evidences suggest that this common intermediate consists
of ssDNA covered by the RPA complex (Zou and Elledge, 2003). Indeed,
ssDNA tracts are generated during the incision step in NER (Giannattasio
et al., 2004) and during resection at DSBs (Sugawara and Haber, 1992)
and uncapped telomeres (Garvik et al., 1995); moreover, replication fork
stalling displays a significant amount of ssDNA (Branzei and Foiani, 2005).
Following DNA damage, two sensor complexes are independently re-
cruited on DNA, namely the Mec1-Ddc2 and the Rad17/Mec3/Ddc1 com-
plex: their simultaneous presence at the damage site is needed for check-
point activation (Melo et al., 2001). ATR/Mec1 and ATM/Tel1 are the
apical checkpoint kinases; in human cells, they are equally important, with
ATR mainly responding to ss-DNA exposing lesions, while ATM being di-
rectly activated by DSBs; in yeast the main kinase is Mec1, while Tel1 is
redundant (Ritchie et al., 1999) and carries out only a marginal role in re-
sponse to blunt (unprocessed) DSB ends (Usui et al., 2001), being instead
involved in telomere length maintenance (Ritchie and Petes, 2000). Mec1
and its partner Ddc2 form a complex independently from the presence of
DNA damage, and the role of Ddc2 seems to recruit Mec1 to the dam-
age site for its activation, thus avoiding unscheduled checkpoint activation
(Melo et al., 2001). The Rad17/Mec3/Ddc1 complex (9-1-1 in human) is
named “PCNA-like”, due to sequence and structure similarity to PCNA;
this ring-shaped complex is loaded at the 5’ ssDNA-dsDNA junctions by
its “clamp loader” RFC-like complex (made up of Rad24 and Rfc2-5) (Ma-
jka et al., 2006a). Colocalization of Mec1-Ddc2 and PCNA-like complexes
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is a critical step for checkpoint cascade activation (Bonilla et al., 2008).
In yeast, the Ddc1 subunit of PCNA-like complex directly activates Mec1
(Majka et al., 2006b); moreover, it recruits the Mec1 activator Dpb11,
which further stimulates Mec1 activity (Puddu et al., 2008; Mordes et al.,
2008b); in human cells only the latter mode of ATR activation is conserved,
through the action of TopBP1 protein (Mordes et al., 2008a; Navadgi-Patil
and Burgers, 2009).
Once activated, Mec1 phosphorylates a series of substrates, among which
Ddc2, Ddc1, Mec3, Rad24, Rpa1, Rpa2, Rad53 and Rad9. Due to its ex-
clusive dependency from Mec1, Ddc2 phosphorylation is usually considered
a biochemical marker of the apical kinase activation (Paciotti et al., 2000).
4.5.2 The signal transduction cascade: adapters and mediators
Once checkpoint is activated, the signal must be transduced down to the
effectors of the cellular response to damage. A key role in this step is
carried out by Rad53 and Chk1 (CHK2 and CHK1 respectively in human),
two serine/theronine kinases characterized by a FHA (forkhead-associated)
domain, required for interaction with checkpoint adapters. While Rad53
is absolutely required for checkpoint activation in every cell cycle phase,
Chk1 seems to be involved mainly in G2/M phase, where the checkpoint
cascade splits into two parallel branches controlled by Rad53 and Chk1,
both under Mec1 regulation (Sanchez et al., 1999).
Activation of transducer checkpoint kinases requires the presence of
adaptor proteins, among which in S. cerevisiae the most importan is un-
doubtedly Rad9. This protein, has a modular structure, characterized by
conserved domains – as Tudor domain or tandem BRCT motifs – which
allow its interaction with a variety of cellular factors to perform its me-
diator role (Toh and Lowndes, 2003). Rad9 undergoes a CDK-dependent
phosphorylation in S and G2 phases, while it is phosphorylated by Mec1
(or alternatively Tel1) in response to DNA damage (Emili, 1998; Vialard
et al., 1998). It appears that a partial Rad9 phosphorylation by Mec1 is
required for the adaptor’s localization in the lesion proximity (at least in
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case of DSBs), while its complete phosphorylation allows Rad53 activation
(Schwartz et al., 2002; Naiki et al., 2004): hyper-phosphorylated Rad9
can interact with the transducer kinase because Rad53 FHA domain binds
a cluster of SQ/TQ motifs (SCD domain) phosphorylated by Mec1 (Sun
et al., 1998; Schwartz et al., 2002).
Two models were proposed for Rad53 activation, both supported by
experimental observations. According to the “solid-state catalist model”
after phosphorylation Rad9 dimerizes/oligomerizes through its BRCT do-
mains, thus creating a scaffold for Rad53: in this complex, Rad9 might
act as a solid-state catalist, increasing the local Rad53 concentration,
thus facilitating its in-trans autophosphorylation and subsequent activa-
tion (Soulier and Lowndes, 1999; Gilbert et al., 2001). The “adaptor-
based model” suggests that Rad9’s main role is to mediate recruitment
of Rad53 inactive form at the lesion, where Mec1-directed phosphoryla-
tion converts it in a catalytically active kinase (Sweeney et al., 2005). As
a matter of fact, the two models are not mutually exclusive. Indeed it
is possible to envision a likely scenario in which Rad9 performs both the
role of an adapter for Rad53-Mec1 interaction and that of a scaffold pro-
tein for Rad53 full activation. After its full phosphorylation by Mec1,
Rad9 dimerizes/oligomerizes and recruits Rad53, whose auto-kinase activ-
ity is triggered by Mec1-dependent phosphorylation. Two or more Rad53
molecules, located in close proximity thanks to interaction with the Rad9
dimer/oligomer, can now autophosphorylate in-trans, resulting in full ki-
nase activation and its release from the adapter (Pellicioli and Foiani, 2005;
Sweeney et al., 2005). Once released, active Rad53 can phosphorylate all
its downstream targets. Since Rad53 phosphorylation level correlates with
its kinase activity, damage-dependent Rad53 phosphorylation is generally
used as a marker of the signal transduction cascade activation (Pellicioli
et al., 1999). Also Chk1 activation by Mec1 involves Rad9, requiring in
particular its N-terminal domain named CAD (Chk1-activating domain)
(Blankley and Lydall, 2004).
In S-phase Rad9 is dispensable for checkpoint activation after replicative
stress, and it can be replaced by Mrc1 (human Claspin): Mec1-dependent
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Mrc1 phosphorylation allows Rad53 activation (Alcasabas et al., 2001).
It’s worth noting that in vertebrates Rad9 ortholog was not univo-
cally identified, although three BRCT proteins, namely BRCA1, 53BP1
e MDC1, independently and sometimes redundantly carry out Rad9’s
adapter functions in human cells (Peng and Chen, 2003; Minter-Dykhouse
et al., 2008; Wilson and Stern, 2008).
In recent years the importance of post-translational histone modifica-
tions for checkpoint activation was uncovered (described more in details in
section Chromatin dynamics in the DNA damage response): in particular,
some modified histone residues allow recruitment and retention of check-
point adapters at the damage sites. In S. cerevisiae, Rad9 recruitment onto
chromatin is mediated by interaction of its Tudor domain with methylated
lysine 79 of histone H3 (H3-K79me), and of its tandem BRCT motifs with
phosphorylated S129 of histone H2A: the current model suggests that the
initial Rad9/H3-K79me interaction allows its localization at the damage
site and its Mec1-dependent phosphorylation (Giannattasio et al., 2005;
Wysocki et al., 2005); subsequently, the adapter can bind phosphorylated
H2A and activate downstream checkpoint factors (Hammet et al., 2007).
Interestingly, while in G1-phase disruption of the interaction between Rad9
Tudor domain and H3-K79me entails complete abolition of signal trans-
duction, in G2/M phase checkpoint activation in these conditions is only
partially defective (Giannattasio et al., 2005). Indeed, it was suggested
that in this cell cycle phase an alternative pathway of Rad9 recruitment
exists, mediated by Dpb11 protein, which bridges the checkpoint adapter
and the PCNA-like compex (Du et al., 2006; Puddu et al., 2008).
4.5.3 The cellular response: transducers and effectors
Rad53 and Chk1 kinases transduce the checkpoint signal by phosphory-
lating a series of effectors which regulate the cellular response to DNA
damage. In yeast three checkpoint pahways were identified, which elicit
different responses according to the cell cycle phase in which the cell experi-
ences DNA damage (Nyberg et al., 2002): G1 checkpoint prevents replica-
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tion of a damaged DNA (Siede et al., 1994); intra-S checkpoint slows down
S-phase progression, stabilizes the replication fork and promotes alterna-
tive replication systems (Paulovich and Hartwell, 1995); G2/M checkpoint
halts the cell cycle at the metaphase-to-anaphase transition, preventing
the segregation of damaged chromosomes (Weinert, 1998).
G1 checkpoint. G1 DNA damage checkpoint slows down the cell’s entry
into S-phase: beyond inhibiting DNA replication, it delays – in a dose-
dependent manner – spindle pole body duplication, bud emergence and
CDK1 activation (Fitz Gerald et al., 2002). This slowdown is due to Rad53
dependent phosphorylation of Swi6 transcription factor, resulting in inacti-
vation of the Swi6/Swi4 complex responsible for the transcription of CLN1
and CLN2 : the repression of G1 cyclin genes causes a delay at the G1/S
transition (Sidorova and Breeden, 1997).
S-phase checkpoint. The intra-S checkpoint responds to DNA damage
experienced in S-phase, while the replication checkpoint is activated by
aberrant replication forks: these two sub-pathways share many features,
and can be collectively described under the name of S-phase checkpoint
(Nyberg et al., 2002).
Replication fork stalling (due to dNTPs depletion or to DNA lesions)
activates the S-phase checkpoint thanks to proteins associated to the fork
itself, among which Sgs1 helicase, Pol2 subunit of DNA polymerase, Dpb11
and Drc1 proteins, and RFC subunits 2,3,4 and 5 (Nyberg et al., 2002);
Rad53 activation in S-phase is mediated by two redundant sub-pathways,
one dependent on Rad9, the other on Mrc1 and Tof1 (Alcasabas et al.,
2001; Foss, 2001; Katou et al., 2003). Beyond stabilizing the replication
fork, S-phase checkpoint blocks firing of late replication origins and also
uncontrolled firing of latent origins; moreover, it inhibits recombination
activities at the fork. Lastly, after the cause of fork arrest is removed, it
allows resumption of replication (Branzei and Foiani, 2006).
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G2/M checkpoint. In G2/M phase, checkpoint cascade elicits the cel-
lular response to DNA damage through two parallel pathways under the
control of Chk1 and Rad53 kinases. On the one hand, Chk1 phospho-
rylates Pds1, preventing its degradation, which is required for mitotic
exit: Pds1 stabilization prevents chromosome segregation, promoting ar-
rest at the metaphase-to-anaphase transition (Sanchez et al., 1999). On
the other hand, Rad53 promotes Pds1 stabilization by preventing its inter-
action with Cdc20 and its subsequent ubiquitylation by the APC/CCdc20
complex (Agarwal et al., 2003). Moreover, Rad53 inhibits mitotic exit
also through an inhibitory phosphorylation on Cdc5, therefore preventing
APC/CCdh1 activation and the subsequent degradation of mitotic cyclins:
this contributes to the maintenance of a high CDK activity (Sanchez et al.,
1999).
4.5.4 Checkpoint switch-off
Cell survival to DNA damage requires not only timely checkpoint acti-
vation, but also proper shutdown of the signal transduction, which en-
sures resumption of cell cycle progression. Checkpoint switch-off may oc-
cur through two genetically controlled mechanisms, namely recovery and
adaptation (Clémenson and Marsolier-Kergoat, 2009).
After successful lesion repair, the recovery mechanism stimulates check-
point switch-off and re-entry into cell cycle: apart from the disappearance
of the most upstream activating signal (the DNA damage), a key step
in this process is Rad53 inactivation through dephosphorylation by Ptc2
and Ptc3 phosphatases (Leroy et al., 2003; O’Neill et al., 2007); however,
the signaling cascade is inactivated at multiple levels, both downstream,
through dephosphorylation and removal of checkpoint proteins from the
damage site (Vaze et al., 2002), and upstream, as suggested by the pro-
longed cell cycle arrest and Rad53 phosphorylation induced by Ddc2 or
Tel1 overexpression (Clerici et al., 2001).
In case the damage cannot be repaired, the adaptation mechanism allows
resumption of cell cycle progression despite the persistence of unrepaired
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DNA lesions, as long as this does not compromise cell survival. While
in unicellular organisms like S. cerevisiae adaptation clearly represent an
extreme attempt to survive, which relies on repair systems active in an-
other cell cycle phase, the significance of this mechanism in multicellular
organisms is less obvious, and is a source of genomic instability (Syljuåsen,
2007). Also in adaptation a key step is Rad53 dephosphorylation by Ptc2,
Ptc3 and Pph3 phosphatases (Heideker et al., 2007); a major player in
adaptation is Cdc5, which prevents/counteracts phosphorylation of many
checkpoint factors, including Ddc2, Rad9 and Rad53 (Pellicioli et al., 2001;
Donnianni et al., 2010); control of ssDNA generation is also required (Lee
et al., 1998); also several recombination and chromatin remodeling pro-
teins are involved, which regulate checkpoint factor association to the DNA
damage site (Lee et al., 2001; Vaze et al., 2002; Lee et al., 2003).
4.6 Chromatin dynamics in the DNA damage response
Since in the eukaryotic nucleus the genetic material is packed into a higher
order chromatin structure (Kornberg, 1977; Li and Reinberg, 2011), the
elevated level of compaction might interfere with recruitment of the en-
zymes involved in DNA metabolism, damage repair and checkpoint signal-
ing. As a matter of fact, chromatin is a highly dynamic structure, and
in recent years multiple connections between chromatin structure and the
DDR emerged, to such an extent that chromatin might be considered as an
integral player in the DDR, acting as a dynamic platform for signaling and
repair factors, which regulates the initiation, propagation and inactivation
of the DDR (Soria et al., 2012). Besides being controlled by chromatin
remodeling activities, chromatin dynamics rely on post-translational his-
tone modifications and incorporation of histone variants, which create a
so-called “histone code” for the fine-tuning of DDR (Lydall and Whitehall,
2005; Lazzaro et al., 2007; Downs et al., 2007a).
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4.6.1 ATP-dependent chromatin remodeling
ATP-dependent chromatin remodeling activities are accomplished by mul-
tisubunit complexes, which employ the energy derived from ATP hydrolysis
to alter histone-DNA contacts, modify the torsional degree of nucleosomal
DNA, reposition nucleosomes on DNA, partially or completely remove the
histone octamer from DNA, increase or decrease DNA accessibility to sev-
eral proteins. Examples of key chromatin remodeling complexes involved
in DDR are RSC complex, SWI/SNF complex and INO80 complex (Flaus
et al., 2006; Downs et al., 2007a).
4.6.2 Post-translational histone modifications
Histones ar rich in lysine, arginine, serine and threonine residues, which
are usually located at the external surface of the histone octamer; these
residues undergo extensive post-translational modifications, such as phos-
phorylation, methylation, acetylation, ribosylation, deimination, ubiqui-
tylation and sumoylation. Differences in electrostatic properties between
the modified versus non-modified form of these residues may significantly
alter histone-DNA interaction, or contacts between histones of neighbour-
ing nucleosomes; moreover, after the identification and characterization of
protein domains specialized in recognition and binding of specific modified
histone residues, a picture emerged in which the different post-translational
histone modifications allow recruitment of several factors onto chromatin
(Costelloe et al., 2006; Kouzarides, 2007).
H2A phosphorylation. One of the earliest events occurring after DNA
damage, is Mec1- and Tel1- dependent phosphorylation of the C-terminal
H2A tail on serine 129 (Downs et al., 2000; Marti et al., 2006; Moore
et al., 2007), a modification conserved also in human (S139 of histone vari-
ant H2AX) and in Schizosaccharomyces pombe (S128 and S129) (Rogakou
et al., 1998; Nakamura et al., 2004). This modification, named g-H2A(X),
spreads for several Kb on chromatin adjacent to the lesion (Lowndes and
Toh, 2005), and is involved in both DNA damage repair (Downs et al.,
52
Mechanisms preserving genome integrity
2000) and checkpoint signaling (Celeste et al., 2003; Nakamura et al.,
2004). The role of g-H2A(X) in repair resides mainly in cohesins recruit-
ment at DSBs, providing the sister chromatid cohesion required for re-
combinational repair (Unal et al., 2004). Conversely, it appears that the
function of g-H2A(X) in checkpoint consists in checkpoint signaling main-
tenance by stabilizing protein association to chromatin in foci, rather than
directly participating in checkpoint activation through their recruitment
(Celeste et al., 2003). Accordingly, it was recently found that, while ini-
tial Rad9 recruitment onto chromatin requires methylation of H3-K79 (see
above), stable Rad9 accumulation at the damage site depends on H2A
phosphorylation (Javaheri et al., 2006). In line with the proposed role
for g-H2A(X) in checkpoint signaling maintenance, H2A dephosphoryla-
tion by Pph3 phosphatase in yeast is needed for terminating the signaling
cascade (Keogh et al., 2006). Moreover, g-H2A(X) allows recruitment of
many chromatin remodeling factors, through interaction between phospho-
S129 and Arp4, a subunit shared by INO80 and SWR1 complex and by
acetyltransferase NuA4 (Shen et al., 2003).
H2B ubiquitylation and H3 methylation. In recent years two histone
modifications were detected which are indispensable for checkpoint signal
transduction down to the effector kinases. Rad6/Bre1 complex is respon-
sible for histone H2B ubiquitylation on lysine 123; this modification is
a prerequisite for the subsequent H3 methylation on lysines 4 and 79 by
methyltransferases Set1 and Dot1 respectively (Hwang et al., 2003; Krogan
et al., 2002; van Leeuwen et al., 2002). H3-K79me, in particular, turned out
to be necessary for damage-dependent phosphorylation of Rad9 and sub-
sequent Rad53 activation: several works emphasized that the role of this
modification lies in its ability to interact with Rad9 Tudor domain, thus
recruiting the adapter protein onto chromatin and allowing its phospho-
rylation by Mec1 (Giannattasio et al., 2005; Wysocki et al., 2005; Grenon
et al., 2007). It should be mentioned, though, that, while in G1-phase H3-
K79 methylation is strictly required for checkpoint activation, in G2/M-
phase a redundant pathway for Rad9 recruitment exists, dependent on
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Dpb11 (Puddu et al., 2008). The same happens in S. pombe, where Crb2
(Rad9 ortholog) recruitment in G2/M-phase is mediated by Cut5 (Dpb11
ortholog) (Du et al., 2006). The importance of this histone mark is un-
derlined by its conservation throughout evolution: indeed, human Rad9
ortholog 53BP1 binds H3-K79me, which mediates its recruitment at DSBs
(Huyen et al., 2004); in S. pombe, instead, Crb2 is recruited onto chro-
matin my means of interaction between its Tudor domain with H4-K20
methylated by Set9 (Sanders et al., 2004; Du et al., 2006). Interestingly,
this modification, absent in S. cerevisiae, is instead detectable in human,
where it seems to contribute to 53BP1 recruitment (Botuyan et al., 2006).
It is worth noting that – both in yeast and human – H3-K79 is con-
stitutively methylated, and no variation in its methylation levels is ob-
served after genotoxic treatment (Feng et al., 2002; van Leeuwen et al.,
2002; Huyen et al., 2004). Several hypotheses were therefore proposed to
explain the involvement of this histone modification in checkpoint acti-
vation: it is possible that Rad9 interacts constitutively with H3-K79me,
and is therefore immediately available for its Mec1-dependent phospho-
rylation; alternatively, Rad9 might be weakly bound to H3-K79me, and
its damage-dependent oligomerization could allow its accumulation at the
damage site. Another interpretation suggests that DNA damage causes
a specific H2B ubiquitylation, therefore inducing a local increase in H3-
K79me levels, which in turn is responsible for an increased Rad9 molecules
concentration at the lesion. However, the most accredited interpretation
suggests that, due to high chromatin compaction, constitutively methy-
lated H3-K79 is buried inside the nucleosome, and a damage-dependent
change in chromatin structure might expose the modified residue, making
it accessible for its interacting proteins (Giannattasio et al., 2005; Huyen
et al., 2004; Lazzaro et al., 2008). This chromatin structural alteration
could result from ATP-dependent chromatin remodeling activities, or en-
sue just as a result of DSB-induced chromatin relaxation (Bakkenist and
Kastan, 2003); in at least one case, remodeling-indendent Rad9 recruit-
ment onto chromatin was observed, suggesting a direct role for DNA dam-
age in disrupting nucleosome packaging (Javaheri et al., 2006). In any case,
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the possibility remains open that H3-K79me exposure results from a chro-
matin structure change caused by other post-translational modifications of
histone residues.
H3 and H4 acetylation. Several histone residues undergo acetylation,
which, beyond mediating protein recruitment, results in chromatin relax-
ation; indeed, lysine acetylation at the N-terminal tails of histones H3
and H4 removes the positive charge on the side chain, thus destabilizing
higher order chromatin structure (Downey and Durocher, 2006). In par-
ticular, H3K56 acetylation by Rtt109, and H4 acetylation by Esa1, Hat1
and Gcn5 acetyltransferases (HAT) were found important for the cellular
response to DNA damage (Masumoto et al., 2005; Bird et al., 2002; Qin
and Parthun, 2006; Tamburini and Tyler, 2005). Conversely, several works
highlighted the involvement of histone deacetylases (HDAC) in DDR, likely
required for the restoration of chromatin state during termination of repair
processes and checkpoint signaling (Downs et al., 2007b).
4.6.3 Incorporation of histone variants
A third mechanism through which chromatin structure can be modulated
is the substitution of one or more histones at the nucleosome core with
histone variants. To date, known histone variants concern mainly histones
H2A and H3; some of them are conserved from yeast to human, while others
are typical of vertebrates. Incorporation of histone variants can modify the
properties of nucleosome surface (defined by the exposed residues), or alter
nucleosome or higher order chromatin structure stability: the function
of these changes range from transcriptional regulation, to definition of
functional chromatin domains, to gene silencing, to DDR (Kamakaka and
Biggins, 2005).
Among the histone variants involved in DDR, H2AZ is particularly rele-
vant. SWR complex promotes replacement of a g-H2AX/H2B dimer with
a H2AZ/H2B dimer, thus promoting DSB resection, while the INO80 com-
plex stimulates H2AZ replacement by H2A; these dynamics are thought to
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participate in restoring chromatin state at a pre-damage condition (Kaloc-
say et al., 2009; Papamichos-Chronakis et al., 2011).
4.7 Mitotic checkpoint
To ensure proper chromosome partitioning during mitosis, eukaryotic cells
rely on sister chromatid cohesion, mediated by cohesins: these proteins
form a multimeric ring-like structures which helds sister chromatids to-
gether from the end of DNA replication until the metaphase-to-anaphase
transition, when they align at the center of the cell, ready for segrega-
tion. At this stage, cohesin cleavage by separase triggers anaphase and
sister chromosome separation. Untimely loss of sister chromatid cohesion
– detrimental for proper chromosome segregation and therefore for genome
stability (see Section Chromosome segregation and genome instability) – is
prevented by the mitotic checkpoint (also called spindle-assembly check-
point – SAC), a feedback mechanisms which inhibits anaphase until all the
chromosomes are stably attached to the spindle, an event which guarantees
accurate segregation (Musacchio and Salmon, 2007; Lara-Gonzalez et al.,
2012).
Briefly, mitotic checkpoint senses the presence of an unattached kineto-
chore through the binding of Mad1-Mad2 dimers (De Antoni et al., 2005);
this event triggers the formation of the so-called “mitotic checkpoint com-
plex” (MCC), made up of Mad2, BubR1/Mad3, Bub3, and Cdc20 (Sudakin
et al., 2001; Morrow et al., 2005). Cdc20 is the APC/C co-activator re-
quired for degradative ubiquitylation of securin (the separase inhibitor)
and B-type cyclins (CDK1 activators in mitosis): impairment of securin
degradation maintains separase in its inactive state, thereby preventing
cohesin cleavage; meanwhile inhibition of B-type cyclins degradation pro-
longs CDK1 activation, delaying mitotic exit until all chromosomes are cor-
rectly oriented and proper microtubule-kinetochore attachment has been
established (Musacchio and Salmon, 2007). When all kinetochores are
stably bound to spindle microtubules, the mitotic checkpoint is satisfied:
Mad1-Mad2 and the other SAC proteins are displaced from the kinetochore
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and APC/CCdc20 inhibition is relieved, thereby allowing securin and B-type
cyclins degradation and subsequent progression into anaphase (Musacchio
and Salmon, 2007; Musacchio, 2011).
5 Saccharomyces cerevisiae as tool for
investigating genome stability maintenance
5.1 S. cerevisiae as a model organism
S. cerevisiae (budding yeast) is a unicellular fungus belonging to Ascomy-
cota class; its features (above all its lab tractability and the ease of its
genetic manipulation) earned it a prominent position among model sys-
tems for the study eukaryotic cellular and molecular biology (Botstein and
Fink, 1988). This non-pathogenic organism has a very short cell cycle (dou-
bling time of ∼120’), and can propagate in the haploid state (useful for
the study of recessive mutations) or in the diploid state (suitable for stud-
ies on dominant mutations and for complementation tests). S. cerevisiae
has a small genome (∼13 Mb, split into 16 linear chromosomes), which
was the first eukaryotic genome fully sequenced (Goffeau et al., 1996); it
can be easily transformed with exogenous DNA, and its homologous re-
combination mechanisms can be exploited to integrate the transforming
DNA fragment in a precise position within the genome. The ease of tar-
geted deletion of a specific genetic locus allowed the creation of a nearly
complete set of deletions of each budding yeast open reading frame (ORF)
(Giaever et al., 2002), which – combined with the so-called ‘awesome power
of yeast genetics’ (Forsburg, 2001) – paved the way for highly informative
genome-wide scale experiments (Botstein and Fink, 2011).
In the last 10 years the most successful approach to search for functional
interactors of a given gene product has been based on the concept of “syn-
thetic lethality”. This phenotype occurs when mutations in two different
genes, each not lethal by itself, display a lethal phenotype when combined.
Only in yeast this method can be applied on a genomic scale and it is
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called “synthetic gene array” (SGA). Starting with a library of marked
yeast deletion mutants and using robots to manipulate simultaneously the
thousands of strains of the library, it is possible to cross a strain carry-
ing a mutation in a query gene to all the viable deletion mutants in the
library; subsequent recovery of haploid double-mutant progeny by means
of haploid-specific selectable markers results in combining individually the
deletions of all yeast genes with our favorite mutant strain (Baryshnikova
et al., 2010): this approach yielded a highly informative genetic landscape
of a eukaryotic cell (Costanzo et al., 2010).
The success of S. cerevisiae as a model organisms resides, on the one
hand, on the high degree of evolutionary conservation of cellular pathways
and molecular mechanisms from yeast to higher eukaryotes; and, on the
other hand, in the lower complexity of these processes in yeast. Therefore
it is reasonable to study these mechanisms in a simpler experimental sys-
tem, like yeast, and later extend the acquired knowledge to increasingly
complex organisms, up to human. In this respect, it is worth noting that of
the nearly 5800 protein-coding S. cerevisiae genes, nearly 1000 (i.e., 17%)
are members of orthologous gene families associated with human disease
(Dolinski and Botstein, 2007; Heinicke et al., 2007).
5.2 Study of genome instability in S. cerevisiae
Historically, S. cerevisiae has been successfully employed as a heterologous
host to study the functions of human DNA repair proteins and genome sta-
bility factors (Aggarwal and Brosh, 2012). Moreover, multiple assays are
available in yeast to detect different forms of genomic instability, from point
mutations (Foster, 2006) and instability of repeated sequences (Kelly et al.,
2007; Razidlo and Lahue, 2008) to spontaneous recombination (Spell and
Jinks-Robertson, 2004), chromosomal rearrangements (Motegi and Myung,
2007) and chromosome loss (Hieter et al., 1985; Spencer et al., 1990).
One of the main aims in the study of genomic instability is the system-
atic characterization of chromosomal rearrangements. In recent years, the
development of assays which permit the identification and characterization
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of a wide spectrum of genomic rearrangements (Chen and Kolodner, 1999;
Schmidt et al., 2006; Cheng et al., 2012) allowed the in-depth analysis of
pathways contributing to genome instability in yeast. Remarkably, these
studies showed that chromosomal rearrangements observed in S. cerevisiae
display similar frequencies and features to those detected in human cancers
(Kolodner et al., 2002; Putnam et al., 2005). This observation, combined
with the high degree of conservation of DNA damage checkpoints and
DNA repair pathways, makes budding yeast an excellent system to study
genomic instability. Moreover, the discovery that the genetic background
influences dramatically the class of rearrangements generated imply that
the characterization of the different classes of CGRs observed in human
tumors may shed new light on the mechanisms leading to their formation,
as well as on the presence of genetic defects in different kinds of cancer.
These observations also suggest that the evolving genotype of cancer cells
during tumor proliferation determines, at least partially, which genes are
readily misregulated by genomic instability and therefore likely control
carcinogenesis (Putnam et al., 2005).
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Aim of the project
The maintenance of genome integrity is a key task for all living organ-
isms, ensuring survival at the cell and organism level, and transmission of
an intact genetic material to the progeny. Genome integrity can be jeop-
ardized by a huge number of factors, which need to be counteracted by
an intricate network of mechanisms deputed to maintain genome stability.
The full knowledge of these mechanisms is still far from being achieved,
and further investigation is required at multiple levels. The first basic task
is to identify all the genes and pathways involved in controlling genome
integrity. Moreover, also for the genes already known to be implicated in
these controls, a deeper characterization is needed to define the mecha-
nism(s) through which they contribute to preserve the genome. Finally,
even when a genome integrity pathway has been identified, in most cases
the mechanistic molecular details still wait to be clarified.
The work described in this thesis explores the genome stability landscape
at all these three levels.
1 Screening the yeast deletion collection for new genome
stability genes
To identify new non essential genes involved in genome integrity mainte-
nance, a screen was designed, set up and performed in S. cerevisiae. The
screen is based on the effect of overexpressing the DDC2 DNA damage
checkpoint gene in the yeast deletion mutant collection, which could al-
low the identification of mutant of strains experiencing spontaneous DNA
damage.
The preliminary characterization of a new candidate genome integrity
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gene is presented in this thesis.
2 Investigating the role of RNase H in genome integrity
maintenance
Following the recent evidence of massive ribonucleotides (rNTPs) incorpo-
ration in genomic DNA, which was shown to promote genomic instability
(Nick McElhinny et al., 2010b,a), we decided to investigate the mechanistic
consequences of this rNTPs incorporation, and the biological role of yeast
RNases H, whose activities in rNTPs removal from RNA:DNA moieties
are essential to preserve genome integrity.
3 Characterization of the dynamics of Rad9 dimerization
and chromatin binding for checkpoint activation
S. cerevisiae Rad9 is a key DNA damage checkpoint mediator, involved in
the activation of the yeast checkpoint kinase Rad53 (human CHK2). Mul-
tiple mechanistic requirements for Rad9-mediated checkpoint activation
have been described, namely two histone modifications promoting Rad9
recruitment onto chromatin (Giannattasio et al., 2005; Javaheri et al.,
2006; Toh et al., 2006; Hammet et al., 2007; Nnakwe et al., 2009), and
BRCT domain-mediated Rad9 dimerization and possibly oligomerization
(Soulier and Lowndes, 1999; Usui et al., 2009). Nonetheless, the crosstalks
between these molecular determinants and their functional significance are
poorly understood.
We investigated the dynamics of Rad9 dimerization, chromatin binding,
CDK-dependent phosphorylation and checkpoint activation in G1 and M
phases of the cell cycle, exploring in particular an alternative M-phase
specific branch for checkpoint activation which is dependent on Dpb11
(Puddu et al., 2008).
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1 Identification of new genes and pathways
important for genome stability
Yeast strains deprived of key genome stability factors often undergo spon-
taneous accumulation of endogenous DNA damage. This phenotype is in-
directly detectable as a constitutive partial phosphorylation of the Rad53
checkpoint kinase, indicative of a chronically alerted DNA damage check-
point response (examples can be seen in Zhang et al., 2006a; Driscoll et al.,
2007; Duro et al., 2008; and Supplementary Figure 1). We designed a
strategy to select these phenotypes, in order to screen the yeast deletion
collection for genome integrity genes, based on accumulation of endogenous
DNA damage.
1.1 DDC2 overexpression allows the identification of
genes controlling genome integrity
The rationale of our screening relies upon the overexpression of the DDC2
gene, encoding the binding partner and activator of the DNA damage
checkpoint apical kinase Mec1 (see Section DNA damage checkpoints).
High levels of Ddc2 cause hyperactivation of the checkpoint response after
DNA damage, resulting in prolonged cell cycle arrest and cell death, while
no effect is visible on undamaged cells (Clerici et al., 2001). We verified
that DDC2 overexpression increases sensitivity to low doses of DNA dam-
aging agents, and we speculated that it might also sensitize yeast cells to
endogenous DNA damage. This hypothesis was confirmed by the severe
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growth impairment caused by DDC2 overexpression in some yeast strains
deleted for genes coding for known players in genome integrity maintenance
(Novarina et al., in preparation, Fig. S1). We exploited the Synthetic Ge-
netic Array (SGA) automated approach (Baryshnikova et al., 2010, and
Section S. cerevisiae as a model organism), to overexpress DDC2 under a
galactose-inducible promoter on a multicopy plasmid in the yeast haploid
deletion collection, and we scored for those mutants whose fitness was re-
duced on galactose medium compared to the control experiment with the
empty vector.
Our screen identified genes involved in several cellular pathways (No-
varina et al., in preparation, Fig. 1), consistent with multiple mecha-
nisms impacting on genome stability. Beside some already known DNA
damage response genes, we found several genes involved in safeguarding
cells against oxidative stress (i. e. oxidative stress response, peroxisome
function and mitochondrial metabolism), many of which were not identi-
fied in previous screens. Additional genes identified belong to pathways
already implicated in genome integrity maintenance, namely chromatin
remodeling, modulation of transcription, cell cycle control, regulation of
cytoskeleton dynamics, proteasome assembly and function and autophagy.
Other pathways were more unexpected, such as protein sorting (mainly
vesicular trafficking to vacuole or Golgi), ribosome biogenesis, aminoacid
biosynthesis or cell wall integrity and composition. Importantly, about
20% of the ORFs identified in the screen are still uncharacterized, leaving
the way open for future studies. Unespectedly, our screen also identified
some strains which show increased fitness after DDC2 overexpression, but
this class of genes needs further investigation.
1.2 VID22 is a new genome stability gene in S.
cerevisiae
Among the genes identified, we focused on VID22, which was not previ-
ously implicated in genome stability, being annotated as “Glycosylated in-
tegral membrane protein localized to the plasma membrane” which “plays
64
Identification of new genome stability genes
a role in fructose-1,6-bisphosphatase (FBPase) degradation; involved in
FBPase transport from the cytosol to Vid (vacuole import and degrada-
tion) vesicles” (Saccharomyces Genome Database). A direct involvement
of VID22 in genome integrity maintenance is suggested by the follow-
ing experimental observations (Novarina et al., in preparation, Fig. 2-3-
S2-S3): i) Vid22 localizes in the nucleus; ii) a vid22D strain displays a
persistent partial Rad53 phosphorylation and increased levels of gH2A in
unperturbed conditions, indicative of chronic accumulation of DNA dam-
age; iii) a vid22D strain shows a higher spontaneous mutation rate at
the CAN1 locus and a greater recombination rate at the rDNA locus; iv)
deletion of VID22 displays negative genetic interactions with many genes
involved in resolution of recombination intermediates arising during repli-
cation (Costanzo et al., 2010); v) vid22D cells are sensitive to genotoxic
treatment.
Vid22 was found in a complex with its paralog Env11 (encoded by
YGR071C ) and with the transcription factor and telomere silencing reg-
ulator Tbf1 (Krogan et al., 2006). Strikingly, an env11D mutant was
not found sensitive to any genotoxic agent examined, and did not display
hallmarks of genomic instability, suggesting that VID22 controls genome
integrity at least partially independently from its role in the Vid22-Env11-
Tbf1 complex. However, we could not similarly test a tbf1D mutant, since
Tbf1 is an essential gene.
Bioinformatic analysis of the Vid22 protein sequence revealed two con-
served domains, an N-terminal BED-finger domain and a central RNase
H fold (Fig. 19). The BED-finger domain is a modified zinc finger with
DNA-binding ability found in transcription factors, proteins associated
with chromatin insulators, and transposases (Aravind, 2000). The RNase
H fold is a structural characteristic of the catalytic core of enzymes be-
longing to the retroviral integrase superfamily, such as RNases H, Holliday
junction resolvases, nucleases, retroviral integrases, reverse transcriptases
and transposases. Despite low sequence similarity, the structure of the
RNase H fold is remarkably conserved: it consists of a five-stranded b-
sheet, with two key catalytic Asp residues located in the middle of the
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first b-strand and at the end of the fourth strand respectively (Nowotny,
2009). However, these catalytic residues do not seem to be conserved in
Vid22, as suggested by the secondary structure-based alignment between
the RNase H fold of Vid22 and the highly similar RNase H fold of the Her-
mes transposase through the Phyre2 server (Kelley and Sternberg, 2009)
(Supplementary Figure 2): thus, it seems unlikely that the RNase H fold
of Vid22 is catalytically active.
Figure 19: Schematic representation of Vid22 conserved domains.
FACS analysis of cell cycle progression in vid22D cells revealed a delay
in S-phase, and a discrete subpopulation of cells is arrested at the G1/S
transition as unbudded cells (Novarina et al., in preparation, Fig. 4). We
propose that these phenotypes can be explained by the analysis of the
transcriptional profiling we carried out on the vid22D mutant strain: in
fact, we found that in the absence of VID22, several genes involved in
the control of G1/S transition and S-phase progression are downregulated.
These genes include: a) CLN1 and CLN2, coding for G1 cyclins respon-
sible for expression of the G1/S regulon through a positive-feedback loop
(Skotheim et al., 2008); b) CLB6, coding for an S-phase cyclin involved
in the firing of replication origins and in the initiation of DNA synthe-
sis (Schwob and Nasmyth, 1993); c) CDC6 and CDC45, whose products
are required for replication initiation (Enserink and Kolodner, 2010). The
experimental evidences linking deregulation of G1/S transition and repli-
cation origin firing with genomic instability (Dershowitz and Newlon, 1993;
Spruck et al., 1999; Bielinsky, 2003; Enders and Maude, 2006) suggest a
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model to describe the transcriptional effects of VID22 deletion on genome
integrity: reduced expression of genes encoding for cyclins and other key
replication initiation factors causes a stochastic cellular arrest at the G1/S
transition in a minority of cells, while the rest of the population proceeds
through S phase with insufficient origin firing, leading to genomic instabil-
ity (Novarina et al., in preparation, Fig. 5).
To explore a possible evolutionary conservation of VID22, alignment-
based homology search was performed, but no significant similarity was
found in higher eukaryotes. Conversely, analysis of proteins which share
the same combination of BED-finger domain and RNase H fold yielded
interesting results. Our attention was drawn by Drosophila DREF and its
human ortholog ZBED1/hDREF, since both are implicated in the control
of G1/S transition. DREF transcription factor regulates transcription of
several genes involved in DNA replication and cell proliferation, such as
the genes coding for PCNA, Orc2, Orc5, DNA primase, DNA polymerase
a, RFC140, E2F and cyclin A (Yamaguchi et al., 1995; Matsukage et al.,
2008). Similarly, ZBED1 targets the promoters of genes involved in DNA
replication, DNA repair and cell cycle regulation. Importantly, ZBED1
silencing results in inhibition of G1/S progression, reminiscent of what we
observed in vid22D cells (Ohshima et al., 2003). These findings suggest
that the role of VID22 in the control of genome integrity is likely to be
conserved in higher eukaryotes.
2 RNase H and DNA damage tolerance
mechanisms protect cells from
ribonucleotides incorporated in DNA
Eukaryotic cells possess two RNase H activities, namely RNase H1 and
RNase H2, exhibiting partially overlapping substrate specificity: while
both are capable of cleaving a stretch of at least four rNMPs in an RNA:DNA
hybrid, only RNase H2 can incise 5’ to a single rNMP incorporated within
a DNA molecule (Cerritelli and Crouch, 2009). Mammalian RNase H1 is
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essential for mitochondrial DNA replication (Cerritelli et al., 2003), but
this function is not conserved in budding yeast. RNase H2, which repre-
sents the major RNase H activity in eukaryotic cells, has been implicated
in several cellular processes involving RNA:DNA hybrids, from Okazaki
fragment processing to removal of R-loops (Qiu et al., 1999; Huertas and
Aguilera, 2003). RNase H2 is a trimeric complex, made up of one cat-
alytic and two non-catalytic subunits, encoded respectively by RNH201,
RNH202 and RNH203 genes in S. cerevisiae; all the three subunits are
required for RNase H2 activity (Jeong et al., 2004).
It was recently shown that ribonucleotides (rNTPs) are incorporated
in DNA at high levels by replicative polymerases (Nick McElhinny et al.,
2010b), and this incorporation constitutes a threat for genome integrity
(Nick McElhinny et al., 2010a). This discovery prompted us to investigate,
in collaboration with the Kunkel lab, the role of yeast RNases H and
possibly other pathways in the preservation of genome integrity.
We found that the absence of both RNase H activities causes chronic
checkpoint activation in untreated yeast cells, suggesting a persistent repli-
cation stress. Moreover, simultaneous knock down of RNase H1 and RNase
H2 is synthetically lethal with a Pole variant (encoded by pol2-M644G)
which incorporates rNTPs at extremely high levels , indicating that both
RNase H activities are crucial for the repair of rNTPs incorporated during
replication (Lazzaro et al., 2012, Fig. 1-S1). This observation reveals a
previously undetected role for RNase H1 in removal of rNTPs from the
chromosomes.
Unrepaired rNMPs in genomic DNA will impact on cell-cycle progres-
sion since, at the next round of DNA replication, a RNA-containing DNA
template must be duplicated. Given that replicative DNA polymerases are
incapable of replicating past a template ribonucleotide (Watt et al., 2011),
we assume that when the replisome encounters rNMPs in the template
strand, endogenous replication stress is generated. Low levels of replica-
tion stress-inducing agents (HU or MMS) are known to be toxic for cells
with replication problems. And indeed, rnh1D rnh201D cells are highly
sensitive to very low doses of HU or MMS: cells arrest in G2-M after the
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bulk of genome replication has been completed, accumulate hyperphos-
phorylated Rad53, and exhibit massive cell lethality. Similar results were
observed with the pol2-M644G rnh201D double mutant, confirming that
increased rNTPs incorporation sensitizes yeast cells to replication stress
(Lazzaro et al., 2012, Fig. 1-S1). We excluded that these phenotypes are
due to defects in Okazaki fragment processing or R-loops removal (Lazzaro
et al., 2012, Fig. S2).
Since rnh1D rnh201D cells are viable, we investigated the additional
cellular pathways involved in the removal or tolerance of rNTPs in the
genome. Our genetic analysis excludes a contribution of NER in cor-
recting rNMPs, while a minor involvement of BER in repairing rNMP-
containing chromosomes cannot be completely ruled out. We then explored
a possible role of DNA damage tolerance mechanisms in the replication of
rNMPs-containing chromosomes. Loss of only the template switch path-
way (Post-replication recombinational repair or Replication fork regres-
sion) or only translesion DNA synthesis (TLS) has no detectable effect
on rnh1D rnh201D cells. Conversely, simultaneous inactivation of both
template switch and TLS had a striking effect in cells lacking RNAse
H activities: these cells exhibit severe growth defect, G2-M arrest, cell
lethality, extreme sensitivity to low HU doses, and a dramatic increase
in PCNA ubiquitylation, indicative of constitutively active DNA damage
tolerance pathways (Lazzaro et al., 2012, Fig. 2-5-S3). Further genetic
and biochemical analyses to identify which translesion polymerases were
implicated in rNMPs bypass showed that cells can use Pol z to replicate
rNMPs-containing templates and that Rev1 likely plays a non-catalytic
role to promote Pol z activity (Lazzaro et al., 2012, Fig. 3-4).
Altogether, these findings indicate that: i) high levels of unrepaired rN-
MPs in the chromosomes hinder DNA synthesis blocking replication forks,
leading to replication stress; ii) RNases H1 and H2 are crucial to process
misincorporated rNTPs; iii) template switch mechanisms and Pol z are
critical to allow replication of endogenous, unrepaired rNMPs (Lazzaro
et al., 2012, Fig. 6). Interestingly, the mechanistic details of single rNTPs
removal from DNA were investigated in vitro in a following paper by the
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Burgers group: they coined the definition of Ribonucleotide Excision Re-
pair (RER), and showed that this newly characterized repair pathway relies
on RNase H2 for incision, Fen1 or Exo1 for flap removal, Pol e or Pol d
together with PCNA and RFC complexes for repair synthesis, and DNA
ligase I for nick sealing (Sparks et al., 2012).
The role of RNases H in the preservation of genome integrity through
rNTPs removal is conserved also in mammals (Reijns et al., 2012). This
may have important implications for human health. The observation that
cells depleted for RNases H are sensitive to low levels of replication stress
may have consequences for cancer chemotherapy. In fact, many cancer
cells are characterized by endogenous replication stress and may be thus
sensitized to inhibitors of RNase H activity, which could selectively kill
cells experiencing replication stress. Furthermore, mutations in any of the
three subunits of human RNase H2 cause a rare genetic syndrome named
Aicardi-Goutières Syndrome (AGS), an auto-inflammatory disorder mim-
icking a congenital viral infection that may arise from nucleic acid byprod-
ucts generated during DNA replication (Aicardi and Goutières, 1984; Crow
et al., 2006; Crow and Rehwinkel, 2009). Our work may contribute to a
better understanding of the mechanisms underlying the disease. In par-
ticular, the reported synthetic interactions between RNase H activities,
replication stress, template switch and TLS, could facilitate the identifica-
tion of modifier genes that may influence the penetrance of AGS-causing
mutations in human RNase H2.
To gain further insights into the function(s) of RNAses H in eukary-
otic cells, we performed a genome-wide screen to identify synthetic ge-
netic interactions with the simultaneous loss of RNase H1 and RNase H2
in budding yeast. In fact, even though a global genetic interaction map
in S. cerevisiae has been already published (Costanzo et al., 2010), the
data obtained from digenic interactions are not always informative, due
to functional redundancy in pathways of crucial importance for the cell.
This is the case of RNase H1 and RNase H2, where indeed only simultane-
ous ablation of both activities makes cells sensitive to genotoxic treatment
(Lazzaro et al., 2012). In collaboration with the Brown’s and Boone’s
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labs in Toronto, we performed three SGA screens with a double mutant
rnh1D rnh201D query: one was done in unperturbed conditions, while the
others were performed in the presence of 10 and 25 mM HU respectively
(Supplementary Figure 3). The overall results of the screens appear very
promising for four main reasons: a) the large majority of the ∼50 identified
interactors fall in categories that are related to likely functions of RNases H
in the cell (replication/recombination/repair 62%; chromatin 10%; meio-
sis/mitosis 10%; mitochondria 2%; transcription 2%; uncharacterized 2%;
others 12%); b) some genes were identified in all conditions, while others
were specifically found in the presence of HU; c) most of the identified genes
worsen the HU sensitivity of RNases H mutants, but some of them appear
to ameliorate the phenotype; d) among the interactors identified we often
found genes coding for subunits of the same protein complex making the
likelihood of interaction more evident. The identified genes represent pu-
tative candidates for the yet unidentified AGS mutations found in human
patients or may code for genes linked to the “compensatory mechanisms”
observed in some AGS patients.
3 Dynamics of Rad9 dimerization and
chromatin binding for checkpoint activation
S. cerevisiae Rad9 is a conserved key mediator protein of the DNA damage
checkpoint cascade (see Section DNA damage checkpoints). As an adapter
protein, it has a modular structure made of different functional domains
which allow interactions with multiple partners (Fig. 20). An N-terminal
Chk1 activation domain (CAD) is required for activating the Chk1 check-
point kinase after DNA damage, likely through direct Rad9-Chk1 inter-
action (Blankley and Lydall, 2004; Qu et al., 2012). The [S/T]Q clus-
ter domain (SCD), which is heavily phosphorylated in a Mec1-dependent
manner after DNA damage, is bound by Rad53 FHA domain and medi-
ates Rad53 activation (Schwartz et al., 2002). Tudor and BRCA1 carboxyl
terminus (BRCT) domains, instead, have been reported to mediate Rad9
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recruitment onto chromatin, via interaction with post-translationally mod-
ified histone residues. Constitutive Rad9 docking onto chromatin is medi-
ated by interaction between its Tudor domain and H3-K79 methylated by
Dot1, while the tandem BRCT motifs, which represent a single functional
phospho-protein binding domain (Yu et al., 2003), allow Rad9 damage-
dependent interaction with g-H2A. Importantly, H3-K79 methylation is
needed for subsequent Rad9 binding to g-H2A, and both Rad9-histone
contacts are a pre-requisite for checkpoint activation in G1-phase, and for
repair in G2/M-phase, where they are instead dispensable for checkpoint
activation (Giannattasio et al., 2005; Wysocki et al., 2005; Toh et al., 2006;
Javaheri et al., 2006; Grenon et al., 2007; Hammet et al., 2007). Finally,
BRCT domain mediates Rad9 dimerization (through a BRCT-BRCT inter-
action) and oligomerization (through BRCT-SCD interactions), required
for a robust and sustained checkpoint activation (Soulier and Lowndes,
1999; Du et al., 2004; Usui et al., 2009). Despite this wealth of mechanis-
tic details, the crosstalks between these molecular determinants and their
functional significance remain to be elucidated.
Figure 20: Schematic representation of Rad9 domains and phosphorylat-
able sites.
To gain further insights into the mechanisms underlying Rad9 function in
response to DNA damage, we decided to explore the interplay between the
dynamics of Rad9 multimerization and chromatin binding for checkpoint
activation in G1 and M phases of the cell cycle (Granata et al., 2010).
To dissect the contribution of the different functions of Rad9 BRCT
motifs, these were substituted with heterologous domains which provide a
constitutive or conditional dimerization function. This analysis revealed
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that BRCT-mediated Rad9 dimerization is required for Rad9 chromatin
binding in G1 phase, both in untreated conditions and after genotoxic
treatment: importantly, this interaction occurs via H3-K79me (Granata
et al., 2010, Fig. 1-2). We suggest that, given the symmetrical structure
of the histone octamer within the nucleosome core, dimerization might
facilitate the correct orientation and positioning of two Rad9 molecules on
the nucleosome, allowing productive interactions with modified histones
(Granata et al., 2010, Fig. 9). This dynamics is conserved also in S.
pombe, as suggested by structural modeling of a Crb2 (Rad9 ortholog)
dimer on the nucleosome (Kilkenny et al., 2008), and in human, where
53BP1 self-interaction is mediated by a dimerization region outside the
BRCT motifs (Ward et al., 2006; Zgheib et al., 2009).
Conversely, heterologous domain-driven dimerization could not restore
Rad9 chromatin binding in M-phase, suggesting that some cell cycle-depen-
dent phosphorylation of Rad9 may impair the chromatin association of this
artificial Rad9 dimer, or that another function of the BRCT motifs is re-
quired for Rad9-chromatin interaction in mitosis. Strikingly, despite unde-
tectable chromatin binding, Rad9 forced dimerization allowed a full check-
point activation after DNA damage in M phase-arrested cells (Granata
et al., 2010, Fig. 2-3). These findings suggest that in mitosis Rad9 dock-
ing onto chromatin may be uncoupled from its mediator function in check-
point activation, and indeed it was proposed that in this cell cycle phase
the chromatin-bound Rad9 population might be involved in repair of DNA
damage (Toh et al., 2006; Grenon et al., 2007).
Previous work from our lab demonstrated that H3-K79me and g-H2A
are partially dispensable for checkpoint activation in M-phase, and identi-
fied an histone-independent branch which triggers the checkpoint cascade,
hinging on Dpb11 (Puddu et al., 2008). In the light of our latest results,
we hypothesized that when Rad9 cannot bind to chromatin via histone
marks, Dpb11 may act as a platform for Rad9 recruitment, thus allowing
efficient Rad53 activation. Moreover, given that this alternative pathway
is observed specifically in M-phase, we speculated that this proposed Rad9-
Dpb11 interaction could be cell-cycle regulated. We explored the molecu-
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lar determinants of the Dpb11-dependent pathway through protein-protein
interaction experiments and epistasis analysis. Through yeast two hybrid
experiments we detected and M-phase specific interaction between Rad9
and Dpb11, which is severely reduced by deletion of Rad9 N-terminal re-
gion (NT) or by CDK1 inhibition (Granata et al., 2010, Fig. 4-6). At
the same time we found that checkpoint activation in the absence of the
histone-dependent pathway depends on an intact Dpb11, on Rad9 NT, and
on CDK1 activity (Granata et al., 2010, Fig. 4-5). Rad9 has been shown to
be a CDK1 substrate (Ubersax et al., 2003), and Rad9 N-terminal region
contains 9 consensus sites for CDK-dependent phosphorylation (Fig. 20),
which were mutagenized and tested, individually or in different combi-
nations: only mutation of S11, which was found phosphorylated in vivo
(Smolka et al., 2005), significantly affected cell cycle-dependent Rad9 phos-
phorylation. We then showed that the Dpb11-dependent branch for check-
point activation needs Rad9-S11 phosphorylation; we also detected a di-
rect Rad9-Dpb11 interaction in vivo by co-immunoprecipitation, which
is dependent on DNA damage and Rad9-S11 phosphorylation (Granata
et al., 2010, Fig. 5-S2). Finally, we explored the dynamics of Rad9
chromatin binding and checkpoint activation in the histone-dependent and
the Dpb11-dependent pathways, and we found that the Dpb11-dependent
pathway in M phase triggers Rad53 activation independently from Rad9
chromatin binding (Granata et al., 2010, Fig. 7).
Our working model for Rad9 dynamics predicts that checkpoint acti-
vation in G1 phase entirely relies upon Rad9 binding to histone marks:
a Rad9 dimer is constitutively bound to chromatin via Tudor-H3-K79me
interaction; after DNA damage, activated Rad9 may change its conforma-
tion, interacting also with g-H2A. In M-phase an alternative way for Rad9
recruitment at DNA lesions involves its interaction with Dpb11. This
factor is brought near the Mec1-Ddc2 complex via its interaction with
the 9-1-1 clamp, and it binds the phosphorylated N-terminal portion of
Rad9; Mec1 can thus hyper-phosphorylate Rad9, leading to Rad53 re-
cruitment and full checkpoint activation, while the histone bound Rad9
sub-population likely mediates DNA lesion repair (Granata et al., 2010,
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Fig. 9). This mechanisms are conserved in S. pombe, where the histone-
dependent branch is governed by BRCT-directed Crb2 dimerization, Tu-
dor domain binding to H4-K20me and BRCT domain binding to g-H2A,
while a histone-independent pathway relies upon Crb2 interaction with
Dpb11 ortholog Cut5 (Du et al., 2006). Similar dynamics are observed for
human Rad9 orthologs, albeit with some differences: BRCT-independent
dimerization is required for 53BP1 docking onto H3-K79me (Huyen et al.,
2004; Ward et al., 2006; Zgheib et al., 2009); moreover, a direct interac-
tion between 53BP1 and TopBP1 (Dpb11 ortholog) appears to mediate
recruitment of the latter to DSB sites in G1 (Cescutti et al., 2010); an-
other Rad9 ortholog, MDC1, directly interacts with TopBP1 to promote
its recruitment at stalled replication forks (Wang et al., 2011).
More recently the Diﬄey group re-investigated the molecular require-
ments for Rad9-Dpb11 interaction (Pfander and Diﬄey, 2011). Through
in-vitro pulldown experiments with protein fragments they mapped S462
and T474 as the key Rad9 residues phosphorylated by CDK1, which seem
necessary and sufficient for Rad9-Dpb11 interaction and histone-indepen-
dent checkpoint activation; surprisingly, peptides containing phospho-S11
were unable to interact with Dpb11. These discrepancies are likely due
to differences between in vivo an in vitro experiments: in vitro analysis
allows a more direct exploration of some mechanistic details, at the ex-
penses of a loss of key physiological determinants, such as full length pro-
tein folding and cellular environment. We believe that phospho-S11 may
control additional Rad9-Dpb11 contacts needed for stabilization of Rad9-
Dpb11 interaction. Alternatively, S11 phosphorylation by CDK1 may be a
pre-requisite for S462 and T474 phosphorylation, possibly influencing the
folding of the Rad9 protein.
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Conclusions and future
perspectives
A deep understanding of the mechanisms through which eukaryotic cells
maintain the integrity of their genome is of capital importance, since failure
of these pathways leads to genome instability, a driving force in tumorige-
nesis. The contribution of the work described in this thesis can be sum-
marized as follows: i) we identified several novel genes possibly implicated
in the control of genome stability; ii) we characterized the role of VID22
in preserving the integrity of the genome; iii) we uncovered a new role for
RNases H, template switch pathways and Pol z translesion polymerase in
protecting the genome from misincorporated rNTPs; iv) we defined the
mechanistic details of Rad9 in mediating checkpoint activation.
Each of these results raises new questions and paves the way for fur-
ther investigations. Among the genes identified by the DDC2 overexpres-
sion screen, we are particularly interested in unraveling the biological and
molecular functions of the uncharacterized ORFs and we will explore the
contribution of genes regulating peroxisome biology in the preservation of
genome integrity. Moreover, additional experiments are required to test the
model we proposed to explain the genome instability phenotype observed
in the absence of VID22 : in particular DNA combing experiments will
allow direct assessment of origin firing efficiency, while aberrant recom-
bination structures arising during replication could be detected through
two-dimensional gel electrophoresis. Another issue worth investigating is
whether Vid22 has also a direct role in the stabilization of replication forks
or in the resolution of X-shaped molecules: techniques such as ChIP (chro-
matin immunoprecipitation) or iPOND (isolation of proteins on nascent
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DNA) could reveal a possible Vid22 localization at the replication fork.
The unexpected interplay between cellular pathways protecting yeast
cells from rNTPs incorporated in the genome, needs to be validated also
in human cells: we are presently silencing the human counterparts of the
genes identified in yeast. The analysis of the expression profile of these
genes in lymphoblastoid cell lines derived from AGS patients will help to
better understand the mechanisms regulating RNasesH production and
their functional interactions with the cellular DNA damage response. Fur-
ther investigation of the genetic interactors identified in yeast (and possi-
bly in human cells) is required: the characterization of the corresponding
gene products will help to clarify the function(s) of RNAsesH in the cell,
and possibly to shed some light on the pathogenic mechanisms of Aicardi-
Goutières Syndrome.
A paper form our lab demonstrated that the Rad9 mediator is not only
responsible for transducting the checkpoint signal to the effector kinases
Rad53 an Chk1, but it is also involved in the control of the DSBs processing
(resection). In fact, binding of Rad9 to H3-K79me through its Tudor do-
main is required to inhibit resection, thus preventing excessive nucleolytic
processing and ssDNA generation, which may promote genomic instability
(Lazzaro et al., 2008). Our observation was later extended to human cells
(Bunting et al., 2010). It will be interesting to combine domain-swapping
experiments and analysis of point mutations selectively abrogating single
Rad9 interactions/functions to examine the dynamics of Rad9 dimeriza-
tion, chromatin binding and CDK-dependent phosphorylation in the con-
trol of resection at DSBs.
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Introduction
The DNA damage checkpoint coordinates cell cycle progres-
sion, DNA repair, replication, recombination, apoptosis and
senescence in response to genotoxic stress. Defects in this
surveillance mechanism lead to increased genomic instability,
cancer susceptibility, ageing and several human pathologies [1,2].
The checkpoint is organized as a signal transduction cascade,
whose players have been conserved throughout evolution [3,4].
When DNA is damaged, cells are able to sense and process the
lesions generating a series of phosphorylation events, which are
then amplified and propagated to specific targets [3,4]. Critical
checkpoint factors are phosphorylated in response to DNA
damage and their order of functions in the cascade has been
mainly inferred by monitoring their phosphorylation state [5]. The
apical kinases in the pathway are members of a family of
phosphatidylinositol 39 kinase-like kinases (PIKKs), which includes
Mec1 and Tel1 from budding yeast, as well as mammalian ATM,
ATR and DNA-PK [6]. In the yeast Saccharomyces cerevisiae the first
biochemical event in response to checkpoint activation is the
Mec1-dependent phosphorylation of its interacting subunit Ddc2
[7–9]. Other critical Mec1 targets are histone H2A, the 9-1-1
complex and the Rad9 mediator which is necessary for the
recruitment and activation of the main effector kinase Rad53
[10–16]. Rad53 phosphorylation is a key step in the signal
transduction cascade and it is generally used as a marker to
monitor full checkpoint activation [17].
In a pioneering study, RAD9 was the first DNA damage
checkpoint gene identified in yeast and it is required for proper
DNA damage response in all cell cycle phases and in response to a
variety of genotoxins [18–20]. Rad9 is a large protein of 148 kDa
containing a tandem repeat of the BRCT (BRCA1 C-terminus)
motif, which is required for Rad9 oligomerization and function
[21–23]. Until recently the biochemical role of the RAD9 gene
product remained obscure. Gilbert et al., were the first to purify
Rad9 complexes from undamaged and UV-treated cells; structural
characterization of such complexes led to the proposal that Rad9
recruits and catalyzes the activation of Rad53, by acting as a
scaffold protein bringing Rad53 molecules in close proximity, thus
facilitating the Rad53 autophosphorylation reaction [14].
The Rad9 protein contains several potential target sites for
CDK1/Cdc28 kinase and PIKK-directed phosphorylation [24].
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Rad9 is phosphorylated in an unperturbed cell cycle and it is
hyper-phosphorylated in a Mec1- and/or Tel1-dependent manner
after genotoxic treatments [12,13]. This hyper-phosphorylation is
a pre-requisite for Rad9-Rad53 association, which is mediated by
the two forkhead associated (FHA) Rad53 domains and specific
Rad9 amino acid residues that are modified in the hyper-
phosphorylated Rad9 form [12,13,15,16,25–27]. Recent data
confirmed that the Rad9 BRCT domains mediate Rad9
oligomerization, and these interactions are also modulated by
Mec1/Tel1-dependent phosphorylation of a SQ/TQ cluster
domain (SCD) in Rad9. Rad9 oligomerization is required to
maintain checkpoint signaling through a feedback loop involving
Rad53-dependent phosphorylation of the Rad9 BRCT domains,
which attenuates BRCT-SCD interactions [27].
Despite the fundamental nature of the cellular response to DNA
damage, Rad9 and its Schizosaccharomyces pombe and metazoan
orthologs Crb2 and 53BP1 show a modest level of amino acid
sequence conservation. Dimerization mediated by the BRCT
domains has been shown to be essential for the biological function
of both Rad9 and Crb2 [21,28], however, 53BP1 oligomerization
occurs in a BRCT-independent manner [29,30]. Recent structural
analysis showed that an equivalent surface is conserved to a certain
degree also in 53BP1 and it provides the binding site for p53. It
was thus suggested that a functional requirement for dimerization
of a checkpoint mediator may have been conserved in the
evolution, but in metazoan organisms it may be delivered via a
second protein rather than through homotypic interactions [31].
In the last few years it became evident that chromatin
remodelling activities and post-translational modifications of
chromatin components, including histones, influence DNA
damage checkpoint signalling and repair in all eukaryotic cells
(see [32] for a recent review). Moreover, it has been recently
suggested that Rad9 may also be chromatin-bound in the absence
of DNA damage [22]. This dynamic interaction with chromatin
appears to require the Tudor domain of Rad9 and methylated
lysine 79 of histone H3 (H3-K79me). Furthermore, this interaction
modulates Rad9 functions after DNA damage [22,23,33–35].
However, the Crb2 and 53BP1 orthologues of Rad9 both
recognize H4 methylated at lysine 20 (H4-K20me), although
human 53BP1 may also be recruited to chromatin through
interactions with H3-K79me [34,36–39].
For the Rad9/Crb2/53BP1 mediator proteins, efficient recruit-
ment seems to require additional molecular interactions. Rad9 and
Crb2 interact via their BRCT domains with H2A phosphorylated at
serine 129 (cH2A) at sites of DNA damage [22,31,37,40–42]. 53BP1
binding to DSBs is facilitated by phosphorylation of serine 139 of the
histone variant H2AX (cH2AX) [29,43–45]. It has been reported
that various oligomerization domains in 53BP1 facilitate its
recruitment to damaged DNA sites [30]. Moreover, 53BP1
recruitment to chromatin is facilitated by ubiquitination of H2A
and H2AX by RNF8 through a yet unidentified mechanism [46–48].
Recently, it has been shown that Dpb11 in S. cerevisiae and its S.
pombe and metazoan orthologs, termed Rad4/Cut5 and TopBP1,
respectively, are required for full PIKK-dependent checkpoint
activation in response to DNA damage [49,50]. Moreover it has
been suggested that Dpb11 orthologs may modulate checkpoint
activation through interaction with mediator/adaptor proteins
[37,51]. To explore the functional role and the relationship
between the BRCT domains and Rad9 ability to bind chromatin,
we have analyzed both Rad9 chromatin recruitment and
checkpoint activation in cells engineered to express various forms
of Rad9 harboring mutated BRCT domains, including point
mutations, deletion and substitutions with heterologous dimeriza-
tion domains. We found that the requirements for Rad9 binding to
chromatin are different in G1 or in M phase cells and in damaging
versus unperturbed conditions. Moreover, we tested the require-
ments for Rad9 chromatin binding in yeast mutants defective in
either the histone-dependent and/or histone-independent path-
ways essential for full checkpoint activation in M phase.
Importantly, we found that CDK1-dependent Rad9 phosphory-
lation on Ser11 modulates the Dpb11-dependent branch in the M
phase of the cell cycle in a chromatin-independent manner.
Results
Rad9 BRCT domains are required for its binding to
chromatin in unperturbed and DNA damaging
conditions
The Rad9 checkpoint mediator protein contains a tandem
repeat of the BRCT motif at its C-terminus. Previous experiments
have shown that the BRCT domains are critical for the activation
of the DNA damage checkpoint and two-hybrid and GST pull-
down analysis indicated that the BRCT domains modulate Rad9-
Rad9 interactions [21]. More recently, it has been shown that
Rad9 mutations in a conserved region of the first BRCT motif
affect binding to cH2A, thus altering the G1 checkpoint signaling
in response to DSBs [22,40] and the G2/M response to uncapped
telomeres [23]. However, the mutations analyzed did not influence
Rad9 chromatin binding in unperturbed conditions [22].
The rad9-F1104L or the rad9-W1280L mutations substitute the
most highly conserved amino acid residues in the two BRCT
motifs and each mutation affects productive Rad9-Rad9 interac-
tions [21]. We tested whether such rad9 mutations impair Rad9
recruitment to chromatin both in unperturbed and DNA
damaging conditions. As expected, a proportion of wild-type
Rad9 migrated much more slowly under our gel running
conditions after UV treatment, consistent with hyper-phosphory-
lation of Rad9 (Figure 1A). A relevant fraction of Rad9 was found
associated to chromatin in the absence of DNA damage, both in
G1- and in M-arrested cells, confirming previous observations
[22]. Control experiments were routinely performed to verify the
distribution of standard protein markers in the soluble and
Author Summary
In response to DNA damage all eukaryotic cells activate a
surveillance mechanism, known as the DNA damage
checkpoint, which delays cell cycle progression and
modulates DNA repair. Yeast RAD9 was the first DNA
damage checkpoint gene identified. The genetic tools
available in this model system allow to address relevant
questions to understand the molecular mechanisms
underlying the Rad9 biological function. By chromatin-
binding and domain-swapping experiments, we found
that Rad9 is recruited into DNA both in unperturbed and in
DNA–damaging conditions, and we identified the molec-
ular determinants required for such interaction. Moreover,
the extent of chromatin-bound Rad9 is regulated during
the cell cycle and influences its role in checkpoint
activation. In fact, the checkpoint function of Rad9 in G1
cells is solely mediated by its interaction with modified
histones, while in M phase it occurs through an additional
scaffold protein, named Dpb11. Productive Rad9-Dpb11
interaction in M phase requires Rad9 phosphorylation by
CDK1, and we identified the Ser11 residue as the major
CDK1 target. The model of Rad9 action that we are
presenting can be extended to other eukaryotic organ-
isms, since Rad9 and Dpb11 have been conserved through
evolution from yeast to mammalian cells.
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chromatin fractions (Figure S1B). In various experiments we
consistently found that the ratio of hyper- to hypo-phosphorylated
Rad9 was approximately constant in both the soluble and
chromatin fractions in G1 cells. Interestingly, in M phase cells,
hyper-phosphorylated Rad9 was mostly present in the soluble
fraction, while chromatin was enriched in the hypo-phosphory-
lated form (Western blot quantitation are shown in Figure S1C).
As shown in Figure 1A, any of the two BRCT mutations abolished
Rad9 phosphorylation and recruitment to chromatin in G1- or M-
arrested cells. As expected [21], rad9-F1104L and rad9-W1280L
mutant cells were highly sensitive to UV treatments (Figure 1B).
These results indicate that BRCT domains influence not only
Rad9 binding to chromatin by modulating its interaction with
cH2A after DNA damage [22], but they also control Rad9
recruitment to chromatin in unperturbed conditions.
A heterologous dimerization domain restores Rad9
binding to chromatin in G1-arrested, but not M-arrested,
cells
To further evaluate the relevance of Rad9-Rad9 interactions in
chromatin binding, we generated a set of yeast strains in which the
C-terminal region of Rad9, containing the BRCT motifs, was
substituted with either a 13-MYC epitope or a GST tag (see
Materials and Methods). The latter has been shown to act as a
heterologous constitutive dimerization domain [28,52,53].
As shown in Figure 2A, the GST tag was capable of driving,
albeit somewhat less efficiently, Rad9 chromatin binding in G1-
arrested cells, both in the absence or presence of DNA damage.
Importantly, Rad9DBRCT::GST recruitment to chromatin still
occurs through its interaction with H3-K79me, as it was drastically
reduced in a dot1D background, lacking the specific H3-K79
histone methyl-transferase. Rad9 dimerization through the GST
tag also significantly recovered Rad9 hyper-phosphorylation after
UV irradiation and full checkpoint function (Figure 2A and data
not shown).
It must be underlined that addition of the GST tag to
Rad9DBRCT, allowing Rad9 dimerization, reconstitutes chroma-
tin binding even though Rad9DBRCT::GST lacks the BRCT
tandem repeats and is, therefore, unable to interact with cH2A [22].
These authors suggested that, after DNA damage, Rad9 shifts from
H3-K79me to phosphorylated H2A-S129, and this translocation
would be deficient in rad9DBRCT::GST cells. As a consequence of its
defective interaction with cH2A, binding of Rad9DBRCT::GST to
chromatin is probably much less stable. This hypothesis may
explain the finding that in the rad9DBRCT::GST strain the majority
of phosphorylated Rad9 after UV irradiation in G1 is found in the
soluble fraction (Figure 2A).
To further support the role of Rad9 dimerization in its chromatin
binding in G1-arrested cells solely by inducing Rad9-Rad9
interactions, we tested the possibility to direct a Rad9DBRCT
isoform to chromatin by adding to the truncated protein a FKBP
Figure 1. Rad9 chromatin binding requires an intact BRCT domains in UV–treated and in unperturbed conditions. (A) wt (K699), rad9-
F1104L (YNOV15), rad9-W1280L (YNOV31) strains were arrested in G1 with a-factor or in M with nocodazole and either mock or UV irradiated (75 J/
m2). 10 min after irradiation, samples were collected and analyzed in their total (T), soluble (S) and chromatin-enriched (Ch) fractions. Blots were
probed with anti-Rad9 antibodies and, after staining, the blots were cut to eliminate the Rad9-unrelated protein species migrating adjacent to the
hyper-phosphorylated Rad9 isoform (Figure S1A). The positions of Rad9 and its hyper-phosphorylated isoform (pRad9) are indicated. (B) The same
yeast strains analyzed in A and a rad9D strain (YMAG88) were grown overnight to log phase and serial dilutions were spotted onto YPD plates, which
were then irradiated at the indicated UV doses and incubated for 3 days.
doi:10.1371/journal.pgen.1001047.g001
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tag, which can dimerize only in the presence of the small inducing
molecule AP20187 [54]. Indeed, the presence of the FKBP tag
partially rescued Rad9 chromatin binding in G1-arrested cells, but
only in the presence of inducing AP20187 (Figure 2B). Importantly,
addition of the dimerization inducing molecule fully recovered the
UV sensitivity of rad9DBRCT cells (Figure 2C).
Contrary to our observations in G1-arrested cells, the
heterologous GST dimerization domain did not rescue Rad9
binding to chromatin in nocodazole-arrested cells, although it
restored checkpoint activation after DNA damage (Figure 2D,
Figure 3A). Rad9 missing the BRCT domains only exhibits partial
phosphorylation; this form can be distinguished from the hyper-
phosphorylated isoform due to different electrophoretic mobility
and its incapacity to activate Rad53 (see Figure 3A).
Altogether, the findings reported above indicate that dimeriza-
tion is required for Rad9 to bind H3-K79me in G1-arrested cells,
both with and without an exogenous DNA damaging agent.
However, this is not the case in M phase-arrested cells, where
GST-directed Rad9 dimerization partially recovers genotoxin-
induced Rad9 hyper-phosphorylation, but fails to rescue its
binding to chromatin. This may suggest that, at least in M phase,
Rad9 chromatin binding is not directly linked to Rad9 hyper-
phosphorylation.
GST-driven Rad9 dimerization rescues checkpoint
activation and UV–sensitivity, despite undetectable
chromatin binding
Although the addition of a heterologous dimerization domain
to truncated Rad9DBRCT was not able to allow Rad9
chromatin binding in M phase-arrested cells, it rescues Rad53
activation after UV irradiation. In fact, as shown in Figure 3A,
the phosphorylation state of the effector checkpoint kinase,
Rad53, was found to be very different after UV-irradiation of
rad9DBRCT::GST or rad9DBRCT::13MYC cells arrested with
nocodazole. The hyper-phosphorylated form of Rad53 is absent
in UV treated rad9DBRCT::13MYC cells, while it is clearly
detectable in rad9DBRCT::GST cells. Although the extent of
Figure 2. GST-driven Rad9 dimerization recovers its binding to chromatin in G1, but not in M phase. (A) wt (K699), rad9DBRCT::13MYC
(YFL696/1b), rad9DBRCT::GST (YMAG74) and rad9DBRCT::GST dot1D (YFL773/2c) cells were arrested in G1 with a-factor and either mock or UV
irradiated (75 J/m2). After 10 min, samples were collected and analyzed in their total (T), soluble (S) and chromatin-enriched (Ch) fractions. Blots were
probed with anti Rad9 antibodies as in the legend to Figure 1A. (B) wt (K699) and rad9DBRCT::FKBP (YFL901) cells were incubated for 6 h in the
presence or in the absence of the dimerization-inducing molecule AP20187, blocked in G1 with a-factor and analyzed in their total (T), soluble (S) and
chromatin-enriched (Ch) fractions. Blots were probed with anti Rad9 antibodies. (C) The same strains as in B were grown overnight to log phase and
incubated for 6 h in the presence or in the absence of the dimerization-inducing molecule AP20187. Serial dilutions were spotted onto YPD plates,
which were then irradiated at the indicated UV doses and incubated for 3 days. (D) Western blot analysis of the total, soluble and chromatin-enriched
fractions from wt (K699), rad9DBRCT::13MYC (YFL696/1b) and rad9DBRCT::GST (YMAG74) cells arrested in M phase and either mock or UV irradiated
(75 J/m2). In all panels, the positions of Rad9 and its hyper-phosphorylated isoform (pRad9) are indicated. p* marks a partially phosphorylated Rad9
species.
doi:10.1371/journal.pgen.1001047.g002
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Rad53 phosphorylation was reduced in rad9DBRCT::GST
relative to wild-type cells, the presence of the heterologous
GST dimerization domain recovers the Rad9 checkpoint
function, as confirmed by a direct checkpoint assay (data not
shown). This conclusion is also supported by the observation
that addition of the GST tag significantly rescued, although not
completely, the UV sensitivity of the rad9DBRCT::13MYC strain
(Figure 3B), and these findings are in agreement with previous
experiments in S.pombe [28].
Thus far our data indicate that dimerization of Rad9 directed
by an heterologous domain confers activation of the DNA damage
checkpoint cascade, as well as significant resistance to UV in M
phase-arrested cells, despite undetectable binding of Rad9 to
chromatin (see Figure 2D).
Checkpoint activation in M phase requires CDK1 activity
and is driven by Rad9–Dpb11 interaction
We have recently demonstrated that in the M phase of the cell
cycle, full activation of the DNA damage checkpoint in response to
various genotoxic stress is dependent upon Dpb11 [50]. Our data
suggested that Dpb11 facilitates the recruitment of Rad9
proximally to DNA lesions through a mechanism independent of
histone modifications. Indeed, as shown in Figure 4A, checkpoint
activation after UV irradiation of nocodazole-arrested cells is only
partially affected either in dot1D or in dpb11DCT cells. On the
other hand, dot1D dpb11DCT double mutant cells are dramatically
deficient in Rad53 phosphorylation since both the histone-
dependent and histone-independent pathways for checkpoint
activation are not functional. This finding can be interpreted by
hypothesizing that when Rad9 cannot bind to chromatin via
histone marks, Dpb11 may act as a platform for Rad9 recruitment
in a histone-independent manner. Moreover, because the Dpb11-
dependent pathway is particularly relevant in the G2 to M phases
of the cell cycle [50], it was tempting to hypothesize that the
proposed interaction between Rad9 and Dpb11 might be
regulated by cell cycle-dependent control mechanisms [55].
Initially, we monitored this interaction using two-hybrid analysis
performed at different cell cycle stages (see Materials and
Methods). As shown in Figure 4B, a strong Rad9-Dpb11
interaction was observed in nocodazole-arrested cells. Several
independent two-hybrid experiments showed that Rad9-Dpb11
interaction was more evident in M- rather than in G1-arrested
cells. Experiments performed with a bait and a prey already
known to interact by two-hybrid, indicate that the M/G1 ratio of
Rad9-Dpb11 interaction was significantly higher than that found
in the controls, suggesting a cell cycle-specific effect (Figure S2A).
The Rad9-Dpb11 interaction was further confirmed biochemically
(see below).
Since the interaction between Rad9 and Dpb11 appears to be
induced in M phase, we reasoned that the Dpb11-dependent
branch of the DNA damage checkpoint in M phase might be
related to the increasing level of CDK1 kinase activity as cells
move through the S, G2 and M phases of the cell cycle. To
address this issue, we took advantage of the cdc28-as1 mutant (in
which only the Cdc28 kinase is specifically sensitive to bulky ATP
analogues, such as 1NMPP1 [56]) to conditionally inactivate
CDK1 in nocodazole-treated cells. Cdc28 kinase activity was
inhibited or not with 1NMPP1 in nocodazole arrested cells and
mitotic cells were then mock- or UV irradiated to induce DNA
damage. Western blot analysis of Rad53 revealed that CDK1
inhibition abolished phosphorylation of Rad53 in the absence of
the histone-dependent pathway, while no effect was observed in
DOT1 cells (Figure 4C). A similar experiment was performed by
tethering checkpoint factors to DNA in the absence of damage
[57]. The difference between our result and that reported by
Bonilla, may be explained if, in their experimental conditions,
without the addition of genotoxic agents, checkpoint activation is
independent upon the Dpb11 branch.
Figure 3. GST-driven Rad9 dimerization allows M checkpoint function regardless of Rad9 chromatin binding. (A) wt (K699),
rad9DBRCT::13MYC (YFL696/1b), rad9DBRCT::GST (YMAG74) cells were cultured to mid-log phase, arrested in M with nocodazole, and either mock or
UV irradiated (75 J/m2); 10 min after irradiation, Rad53 phosphorylation was analyzed by SDS-PAGE and Western blotting with polyclonal Rad53
antibodies and with the F9 monoclonal antibody (Mab) recognizing only the hyper-phosphorylated active form of Rad53 to monitor checkpoint
activation. (B) The same cells analyzed in A and a rad9D control strain (YMAG88) were cultured overnight, diluted and plated on YPD plates, which
were irradiated with the indicated UV doses. Cell survival was assayed by determining the number of colonies grown on plates after 2 days; error bars
were obtained from 3 independent experiments.
doi:10.1371/journal.pgen.1001047.g003
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Altogether, our results indicate that CDK1 activity is required
for the function of the histone-independent branch necessary for
Rad53 phosphorylation in cells arrested in mitosis.
CDK1-dependent phosphorylation of serine 11 of Rad9
modulates the Dpb11-dependent branch in M phase
cells
Rad9 contains 20 potential (SP or TP) target sites for CDK-
dependent phosphorylation, 9 of which conform to the canonical
CDK phosphorylation site (S/T-P-x-K/R) (Figure S2B). We
hypothesized that Rad9 could be a relevant CDK1 target in the
histone-independent branch of the DNA damage checkpoint in M
phase cells. Initially, we tested a rad9DNT mutant strain, in which
the first 231 amino acids, including 9 S/T-P sites, of Rad9 are
missing (Materials and Methods and [58]). As shown in Figure 5A,
Rad53 phosphorylation was partially defective in both dot1D and
rad9DNT mutants and essentially abolished in a rad9DNT dot1D
double mutant strain.
All 9 potential Cdc28 phosphorylation sites in the Rad9 N-
terminal region were individually mutagenized and different
mutant combinations tested (Materials and Methods and data
not shown). rad9-S11A cells displayed a detectable defect in cell
cycle-regulated Rad9 phosphorylation (Figure S2C). Moreover,
the rad9-S11A mutation recapitulates the phenotype we observed
in rad9DNT cells, namely, severe loss of DNA damage-dependent
Rad53 phosphorylation when combined with dot1D (Figure 5B).
Consistently, the rad9-S11A mutation alone did not confer a strong
sensitivity to UV irradiation (Figure 5C), while a rad9-S11A dot1D
double mutant strain was synthetically sensitive to genotoxic
treatment. On the other hand, a rad9-S11A dpb11DCT double
mutant strain did not exhibit an increased sensitivity to UV
irradiation when compared to strains harboring the single
mutations, indicating that Dpb11 and Rad9-S11 phosphorylation
act in the same pathway (data not shown). Phosphorylation of
Rad9S11 has been reported in vivo [59]. In order to verify the
relevance of S11 phosphorylation in our experimental conditions,
we reverted the S11A mutation to Thr, another phosphorylatable
residue. Figure 5D shows that Rad9 carrying a Thr at position 11
rescues the phenotype imparted by the S11A mutation, since
checkpoint activation in the rad9-S11T dot1D strain is identical to
that found in dot1D cells.
Interestingly, Rad9-Dpb11 interaction by two-hybrid analysis
was reduced when the Rad9NT isoform, lacking the 9 potential
CDK1 phosphorylation sites, was used as a prey in a wild-type
background, or when Cdc28 activity was inhibited by 1NMPP1
addition in the cdc28-as1 strain (Figure 6A). The in vivo interaction
between Rad9 and Dpb11 was also confirmed by co-immupre-
cipitation of the endogenous proteins after genotoxic treatment. As
shown in Figure 6B, immunoprecipitation of MYC-tagged Dpb11
recovers the hyper-phosphorylated isoform of Rad9, and this
interaction is virtually lost in the rad9-S11A mutant strain
(Figure 6C). We also noticed that the Rad9-S11A mutant protein
has slighlty less gel-mobility than its wild type counterpart, as
shown in Figure 6C. This observation can be explained by either a
mild defect in Mec1/Tel1-dependent hyperphosphorylation of the
Rad9-S11A protein, due to the loss of Rad9-Dpb11 interaction, or
a direct effect of the S11A mutation which, affecting CDK1-
dependent phosphorylation of Rad9, may directly modify its
migration in SDS PAGE.
Altogether, the above findings indicate that the Ser11 CDK1-
consensus site on Rad9 is a relevant target to modulate Rad9-
Dpb11 interaction and the CDK1-dependent checkpoint response
in M phase cells.
Figure 4. A cell cycle–dependent interaction between Dpb11
and Rad9 may regulate the Dpb11-dependent pathway. (A) wt
(YMAG149/7B), dpb11DCT (YMAG145/20C), dot1D (YMAG150/4A) and
dpb11DCT dot1D (YMAG148) strains were arrested in M with nocodazole
and mock or UV irradiated (75 J/m2). 10 min after irradiation, samples
were taken and protein extracts were separated by SDS-PAGE. Blots
were analyzed with anti Rad53 antibodies. (B) EGY42 cells, containing
the pSH18-34 b-galactosidase reporter plasmid, were transformed with
the Rad9 prey plasmid pMAG11.1 (pJG4-5-RAD9) and/or with the Dpb11
bait plasmid pFP15 (pEG202-DPB11). Strains were cultured overnight in
-His, -Trp, -Ura medium plus raffinose and arrested in M phase by
nocodazole treatment. Galactose was then added to the medium to
induce bait expression. A modified version of ONPG yeast two-hybrid
assay was used to determine the b-galactosidase activity in each strain,
expressed in relative units. (C) cdc28-as1 (JAU01) and cdc28-as1 dot1D
(YNOV4) strains were arrested in M with nocodazole and, after
incubation for 2 h in the absence or in the presence of 5 mM 1NMPP1,
were either mock or UV irradiated (75 J/m2). After 10 min, samples were
collected and protein extracts were separated by SDS-PAGE. Blots were
analyzed with anti-Rad53 antibodies.
doi:10.1371/journal.pgen.1001047.g004
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The Dpb11-dependent branch in M phase modulates
checkpoint activation in a chromatin-independent
manner
To gain further insights into the mechanisms involving Rad9
and the Dpb11-dependent branch of the DNA damage checkpoint
operating in nocodazole-arrested cultures, cell extracts were
fractionated into soluble and chromatin fractions. Specifically,
we monitored Rad9 chromatin binding and Rad53 phosphoryla-
tion in strains harbouring defects in the different branches known
to regulate Rad9 checkpoint functions during M phase.
As shown in Figure 7, following DNA damage, the Dpb11 C-
terminal region carrying the BRCT domain does not appear to be
required for Rad9 binding to chromatin, as dpb11DCT cells
behave as wild type. However, as expected, Rad9 chromatin
recruitment is defective in dot1D and H2A-S129A mutant cells, as
binding of Rad9 is dependent upon H3-K79me and cH2A, via its
Tudor and BRCT domains respectively [22,34,60]. Checkpoint
activation, as determined by Rad53 phosphorylation, was
abolished in any double or triple mutant combinations carrying
the dpb11DCT mutation (Figure 7). Intriguingly, even when
detectable Rad9 binding to chromatin is abrogated (as in the
single dot1D and H2A-S129A or in the double dot1D H2A-S129A
mutant strains) Rad53 can be fully phosphorylated. Similar genetic
dependencies were found when the various single, double and
triple mutant strains were tested for checkpoint activation in
response to zeocin treatment, which is known to cause DSBs
(Figure S3 and data not shown).
Dpb11 is responsible for checkpoint activation in M
phase cells when the Rad9 BRCT domains are replaced
with a heterologous dimerization domain
We have determined (Figure 3A) that in nocodazole-arrested
cells defective checkpoint activation due to the absence of the
Rad9 BRCT domain can be partially rescued by adding the GST
Figure 5. Phosphorylation of Rad9S11 by CDK1 is required for the establishment of an effective UV response in the absence of
Dot1. (A) wt (K699), dot1D (YFL234), rad9DNT (DLY2236) and rad9DNT dot1D (YFP91) strains were arrested with nocodazole and either mock or UV
irradiated (75 J/m2). After 10 min samples were collected and protein extracts were separated by SDS-PAGE. Blots were analyzed with anti-Rad53 or
with the F9 Mab to monitor checkpoint activation. (B) wt (K699), dot1D (YFL234), rad9-S11A (YMAG162) and rad9-S11A dot1D (YMAG164) strains were
arrested in M, irradiated and Rad53 was detected by Western blotting as describe in panel A. (C) The same strains analyzed in B were cultured
overnight, diluted and plated on YPD plates, which were irradiated with the indicated UV doses. Cell survival was assayed as described in the legend
of Figure 3. (D) wt (K699), dot1D (YFL234), rad9-S11A dot1D (YMAG164) and rad9-S11T dot1D (YNOV52) strains were arrested with nocodazole and
either mock or UV irradiated (75 J/m2). After 10 min samples were collected and protein extracts were separated by SDS-PAGE. Blots were analyzed
with anti-Rad53 or with the F9 Mab to monitor checkpoint activation.
doi:10.1371/journal.pgen.1001047.g005
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dimerization domain. Moreover, we demonstrated that the M
phase-specific DNA damage checkpoint contains a pathway
based on Rad9-Dpb11 interactions and modulated via phos-
phorylation of the Ser11 residue of Rad9 by CDK1 (Figure 4,
Figure 5, and Figure 6). As a consequence, we tested whether, in
nocodazole-arrested cells, checkpoint activation supported by the
heterologous dimerization motif in the rad9DBRCT::GST mutant
strain was dependent upon Dpb11. To address this question, we
introduced the S11A point mutation in the rad9DBRCT::GST
strain (rad9-S11ADBRCT::GST). Whilst either single mutant strain
was only partially defective in Rad53 phosphorylation, in rad9-
S11ADBRCT::GST cells, checkpoint activation was severely
impaired (Figure 8A). This result indicates that in
rad9DBRCT::GST cells residual checkpoint activation depends
upon an active Dpb11 branch acting through a potential CDK1
site (S11) in the amino terminus of Rad9. As expected, rad9-
S11ADBRCT::GST cells, in which the sole Rad9 expressed
contains both the point mutation and the domain swap, are
more sensitive to UV irradiation than either single mutant
(Figure 8B).
In conclusion, our data are consistent with the hypothesis that
Rad9 plays two independent roles in checkpoint activation: the
first mediated by its dimerization and binding to modified
histones, the second, which involves its phosphorylation by
CDK1 and interaction with Dpb11 (Figure 9).
Discussion
RAD9 was the first DNA damage checkpoint gene identified in
yeast [18]; however, the precise molecular details regarding the
role of the corresponding gene product, its function and regulation
remain far from being fully understood. In budding yeast, Rad9
seems to act as an adaptor protein in the signal transduction
checkpoint cascade, mediating the transmission of the signal from
the apical PIKKs to the main primary transducer kinase, Rad53
[27,61]. Rad9 phosphorylation, mediated by Mec1, is an early
event in the signal transduction cascade and this modification in
G1 is mainly influenced by histone H3 methylation [22,33,60,62].
In M phase, Rad9 phosphorylation also requires Dpb11, whose
role as an alternative scaffold for Rad9 activation has been
unveiled only recently [50]. The dynamics of Rad9 recruitment at
various cell cycle stages and the genetic dependencies controlling
Rad9 interaction with DNA/chromatin and other proteins are
largely unknown.
Figure 6. CDK1-dependent phosphorylation of S11-Rad9 modulates Rad9-Dpb11 interaction. (A) Two-hybrid interaction between
Dpb11 and Rad9 was tested in a wt (K699) (left) or in a cdc28-as1 (JAU01) (right) genetic background with the indicated bait and prey plasmids.
Where specified 5 mM 1NMPP1 was added to the media for 1 h before bait induction and extracts preparation. (B) The Dpb11-myc (YFP38) strain was
arrested with nocodazole and either mock treated or treated with 150 mg/ml of zeocin for 30 min. Whole cell protein extract was prepared and
tagged Dpb11-MYC was immunoprecipitated either with anti-MYC antibodies or unspecific mouse IgG as described in Materials and Methods. The
presence of Rad9 in the IPs was detected by Western blot analysis of the immunoprecipitates with specific anti-Rad9 antibodies. (C)
Immunoprecipitations with anti-MYC antibodies were performed on extracts from nocodazole arrested cells, treated with 150 mg/ml of zeocin for
30 min, expressing Dpb11-MYC in a RAD9 (YFP38) or rad9S11A (YMAG281) background. The presence of Rad9 was detected by Western blot analysis
of the immunoprecipitates with specific anti-Rad9 antibodies. Lower exposure of the crude extracts lanes are shown to allow visualization of both
Rad9 and Dpb11 specific bands.
doi:10.1371/journal.pgen.1001047.g006
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Figure 7. The Dpb11-dependent pathway in M phase modulates Rad53 activation in a chromatin-independent manner. wt
(YMAG149/7B), H2A-S129A (YMAG168), dpb11DCT (YMAG145/20C), dot1D (YMAG150/4A), H2A-S129A dpb11DCT (YMAG155), H2A-S129A dot1D
(YMAG170), dpb11DCT dot1D (YMAG148) and H2A-S129A dpb11DCT dot1D (YMAG157) strains were arrested in M with nocodazole and UV irradiated
(75 J/m2). After 10 min, samples were collected and analyzed in their total (T), soluble (S) and chromatin-enriched (Ch) fractions; blots were probed
with anti-Rad9 antibodies (left panel). Protein extracts were also prepared from mock and UV treated samples and analyzed by SDS-PAGE and
Western blotting with anti-Rad53 antibodies to monitor checkpoint activation (right panel). The positions of Rad9 and its hyper-phosphorylated
isoform (pRad9) are indicated. p* marks partially phosphorylated Rad9 species.
doi:10.1371/journal.pgen.1001047.g007
Figure 8. Partial checkpoint activation after forced Rad9 dimerization in M phase acts through the Dpb11-dependent checkpoint
pathway. (A) wt (K699), rad9-S11A (YMAG162), rad9DBRCT::GST (YMAG74) and rad9-S11ADBRCT::GST (YFL1177) strains were arrested with nocodazole
and mock or UV irradiated (75 J/m2). After 10 min, samples were collected and protein extracts were separated by SDS-PAGE. Blots were analyzed
either with anti-Rad53 antibodies or with the F9 Mab to monitor checkpoint activation. (B) UV survival assay. The same strains as in A were cultured
overnight and then diluted and plated on YPD plates, which were irradiated with the indicated UV doses. Cell survival was assayed as described in the
legend to Figure 3.
doi:10.1371/journal.pgen.1001047.g008
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Here, we show that a significant proportion of Rad9 is already
chromatin-bound in unperturbed conditions throughout the cell
cycle, confirming previous suggestions [22] and supporting our
earlier model [14]. According to the current view, Rad9-
chromatin association is controlled by interaction between its
Tudor domain and H3-K79me. Constitutive, dynamic recruit-
ment of Rad9 to chromatin may facilitate the efficiency and speed
of the Rad9-dependent response to genotoxins. After DNA
damage, Rad9 binding to chromatin is further strengthened
through its BRCT domain, which is required to productively
interact with cH2A [22,23]. In this study we found that the BRCT
domain of Rad9, in addition to promoting interaction with cH2A,
has a more general function in modulating Rad9 recruitment. In
fact, the rad9-F1104L and rad9-W1280L mutations, affecting the
folding of the whole BRCT domain [21], alter binding to
chromatin also in the absence of any genotoxic treatment. The
observation that rad9-K1088M cells are defective in Rad9
chromatin recruitment only after c-irradiation may be explained
if such mutation only prevents Rad9-cH2A interaction [22].
In G1 cells, Rad9 binding to chromatin can be achieved by
substituting the BRCT repeats with a heterologous dimerization
domain; such recruitment requires the activity of Dot1 histone
methyl-transferase, indicating that BRCT-mediated dimerization
may be a pre-requisite for constitutive interaction between the
Rad9 Tudor domain and H3-K79me. Given the symmetrical
structure of the histone octamer within the nucleosome core,
dimerization might facilitate the correct orientation and position-
ing of two Rad9 molecules on the nucleosome, allowing
productive interactions with modified histones (Figure 9). Such
hypothesis is supported by structural modeling of a dimeric S.
pombe Crb2 complex on a single nucleosome, where all the
interactions with H4-K20me and cH2A are satisfied without
changing the conformation of the histone core [31].
It is worth noting that dimerization forced by replacement of the
Rad9 BRCT domains with the heterologous GST tag only restores
Rad9 binding to chromatin in G1-, and not in M-arrested cells. In
fact, in cells arrested with nocodazole, we observed that GST-
induced dimerization can rescue Rad9 hyper-phosphorylation and
DNA damage checkpoint activation, but not its stable recruitment
to chromatin. It is possible that in mitosis cell cycle-dependent
phosphorylation of Rad9 may interfere with the chromatin
association of this artificial Rad9 dimer. Alternatively, in
nocodazole-arrested cells the Rad9 BRCT motifs may play
additional roles in modulating Rad9-chromatin interactions.
Several findings indicate that the cellular response to DNA
damage, including the repair mechanisms themselves, are
regulated differently in distinct cell cycle stages. Multiple layers
of cell cycle regulation may modulate the recruitment of critical
checkpoint and repair factors to damaged DNA, as well as
facilitate their reciprocal cross-talk [63–67]. We have previously
shown that Dpb11 is essential for full DNA damage checkpoint
activation in M-arrested cells [50]. Dpb11 is held in proximity to
damaged DNA through its interaction with phosphorylated 9-1-1
complex, leading to Mec1-dependent Rad9 phosphorylation.
Taking advantage of the cdc28-as1 mutation, which allows
conditional turn off of CDK1 kinase activity, we have demon-
strated that CDK1, targeting Rad9, is required for the function of
the Dpb11-dependent branch of the checkpoint response. Indeed,
yeast cells carrying a truncated Rad9 version lacking 9 putative
Cdc28 phosphorylation sites in the N-terminal region, are
checkpoint-defective in M phase, in the absence of the histone-
dependent branch. The Ser11 residue in the Rad9 N-terminal
region is the most relevant Cdc28 target site, since a rad9-S11A
mutation recapitulates the phenotypes observed in rad9DNT cells.
By two-hybrid analysis we showed that Rad9 and Dpb11
specifically interact in M-phase arrested cells, even in the absence of
DNA damage, and this interaction is stimulated by CDK1-
dependent Rad9 phosphorylation. Co-immunoprecipitation exper-
Figure 9. Possible model of the dynamics of Rad9 chromatin
binding and its interaction with Dpb11 to modulate check-
point activation in M phase. Under untreated conditions, Rad9 is
chromatin bound through the interaction of its Tudor domain with H3-
K79me and its BRCT-mediated dimerization. After DNA damage,
activated Rad9 may change its conformation, interacting also with c-
H2A. In M-phase an alternative means of Rad9 recruitment near DNA
lesions involves its interaction with Dpb11. This factor is brought near
the Mec1-Ddc2 complex via its interaction with the 9-1-1 clamp, and it
binds the phosphorylated N-terminal portion of Rad9 leading to full
checkpoint activation.
doi:10.1371/journal.pgen.1001047.g009
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iments confirmed that Rad9-Dpb11 interaction requires phosphor-
ylation of Rad9-S11 and revealed that it depends upon genotoxic
treatment, although we cannot exclude a weak/transient interaction
in untreated conditions. This finding can be explained if activation
of Mec1 by DNA damage facilitates or controls this interaction, e.g
phosphorylating Dpb11 [50], exposing phospho-S11 or stimulating
Rad9-S11 modification by CDK1. The overexpression conditions
typical of the two hybrid system can easily explain why a weak
interaction can be detected also in the absence of DNA damage.
Interestingly, the functional interactions between Dpb11 and Rad9
in budding yeast are reminiscent of similar findings in the distantly
related S. pombe, where histone-independent checkpoint activation is
also modulated by CDK1 [37].
The Dpb11-dependent pathway does not require the histone
modifications modulating Rad9 recruitment to chromatin. We
found that a truncated C-terminal version of Dpb11 does not
affect Rad9 recruitment to chromatin, which is instead abolished
when the histone-dependent pathway is defective. Surprisingly, in
a dot1D H2A-S129A double mutant strain checkpoint activation in
M phase is virtually undistinguishable from that found in wild type
cells, although Rad9 is not stably bound to chromatin. Only when
the dpb11DCT mutation is combined with the dot1D or H2A-S129A
mutation the checkpoint response is turned off. The working
model presented in Figure 9, suggests that Dpb11 may act in M-
phase as an alternative means of Rad9 recruitment. Dpb11 is
located close to sites of DNA damage through its interaction with
the Mec1-phosphorylated 9-1-1 complex; DNA damage leads to
Mec1-dependent phosphorylation of Dpb11 [50], which interacts
with S11-phosphorylated Rad9 (Figure 9). This Dpb11-dependent
localization of Rad9 to sites of DNA damage allows rapid Rad9
hyper-phosphorylation by PIKKs, as suggested by the observation
that the interaction between Rad9 and Dpb11 is induced by
genotoxic agents and hyper-phosphorylated Rad9 is enriched in
the Dpb11-bound population. Subsequently, Rad53 recruitment
via its FHA domains leads to full activation of the checkpoint
response. Unlike Rad9 bound via histone marks, Rad9 complexed
with Dpb11 does not appear to be tightly linked to chromatin,
explaining why the Dpb11-dependent branch for checkpoint
activation seems to act in a chromatin-independent manner.
However, we cannot rule out the possibility that the Rad9-Dpb11
complex can transiently or weakly bind to chromatin.
The model suggested here is in agreement with similar findings
in the distantly related S.pombe fission yeast [37] as well as with
recent in vitro data describing Dpb11 role in checkpoint activation
[68], suggesting that the proposed mechanism can be extended to
other eukaryotic organisms.
Materials and Methods
Strains and plasmids
All of the strains used in this work are derivatives of W303
[MATa ade2-1 trp1-1 can1-100 leu2-3,12 his3-11,15 ura3 rad5-535];
only strains YFP91 and DLY2236 (provided by D. Lydall), are
RAD5+. All the strains used in this study are listed in Table S1 and
further information regarding strains and plasmids is available
upon request.
Plasmids pMAG11.1 and pFP15 are, respectively, the Rad9
prey and Dpb11 bait plasmids used for the yeast two-hybrid
analysis. They were obtained by amplifying the relevant coding
sequences from genomic DNA and by ligating the resulting
fragments into pJG4-5 and pEG202 [69], respectively.
The plasmid pMAG9, which encodes the Rad9DNT prey, was
obtained cloning the rad9DNT sequence, amplified from the yeast
strain DLY2236, into pJG4-5.
Gene deletions were obtained by PCR-mediated gene replace-
ment [70].
The YNOV15 (rad9-F1140L) and YNOV31 (rad9-W1280L)
strains were obtained from YFL871. The kanMX4 and KlURA3
CORE cassettes, amplified from pCORE [71], were integrated in
a K699 strain at position 1941 of the RAD9 gene. Subsequently,
the CORE cassette was replaced with the C-terminus of the rad9-
F1104L or rad9-W1280L alleles, amplified respectively from
pFL75.5 or pFL69.1, thus restoring the full-length RAD9 open
reading frame bearing the intended mutation. RAD9 site-specific
mutations on plasmids pFL75.5 and pFL69.1 were obtained by
PCR with mutagenic oligonucleotides on the pFL36.1 plasmid
[50]. Recombination events were selected on 5-fluoroorotic acid
plates, and the strains were verified by sequencing.
The rad9DBRCT::13MYC and the rad9DBRCT::GST mutant
alleles were obtained by introducing the 13-MYC or GST tags at
the 984 aa, using the one-step PCR method [70], thus eliminating
the whole Rad9 BRCT domain.
The cdc28-as1 mutant allele was obtained by ClaI-directed
integration of plasmid pVF6 [72] at the CDC28 locus into the
desired background. Plasmid pop-out events were selected on 5-
fluoroorotic acid plates, and the presence of the cdc28-as1 mutation
was verified by assessing sensitivity to 1NMPP1 on plate.
Strains encoding the rad9-S11A mutant allele were obtained by
MscI-directed integration of pRS306-NTRAD9cdk1 into the
desired background. The transversion TCT-GCT causing the
rad9-S11A mutation and the reversion GCT to ACT generating
the rad9-S11T allele were produced by site- directed mutagenesis
(Stratagene) of pGEMTeasyRAD9, containing a 2547 bp frag-
ment from position -445 to position +2102 within the RAD9 ORF.
The 1.8 Kb BamHI-MscI fragment from the pGEMTeasyRAD9
vector was swapped with the equivalent fragment from an existing
6.3 Kb pRS306-NTRAD9 integrative vector, containing a
BamHI-SpeI RAD9 fragment from position 2445 to position
1478 within the RAD9 ORF and the presence of the mutation
verified by sequencing. Plasmid pop-out events were selected on 5-
fluoroorotic acid plates, and the rad9-S11A mutation was
confirmed by PCR sequencing.
The dpb11DCT mutant allele was obtained by introducing a
premature stop codon at the 583 aa and the HPH cassette after the
codon with the one step PCR method previously described [73],
thus mimicking the dpb11-1 mutation [74].
Strain YFL921 was obtained by using the one-step PCR
strategy described in Longtine 1998, using pFA6-FKBP2x-13MYC-
KanMX6, as template. This plasmid was generated by cloning in
PacI-linearized pFA6-13MYC-KanMX6 the FKBP2x sequence
amplified from pC4M-FV2E (ARGENT Regulated Homodimer-
ization kit, ARIAD Pharmaceutical).
The yeast two hybrid was performed using the B42/lexA system
with strain EGY42 (MATa his3 ura3 trp1 6lexAOP-LEU2; lex- AOP-
lacZ reporter on plasmid pBH18-34) as the host strain [69].
Chromatin binding
To analyze chromatin binding of proteins, yeast extracts were
prepared from G1- or M-arrested cells following published
procedures [22].
Cell cycle blocks and DNA damage treatments
Cells were grown in YPD medium at 28uC (25uC in the
experiments with strains harboring the dpb11DCT mutation) to a
concentration of 66106 cells/ml and arrested in G1 or M with a-
factor (20 mg/ml) or nocodazole (20 mg/ml), respectively. 50 ml of
cultures were centrifuged, resuspended in 500 ml of fresh YPD and
plated on a Petri dish (14 cm diameter). Plates were quickly
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irradiated with a Stratalinker at 75 J/m2 and cells resuspended in
50 ml of YPD plus a-factor or nocodazole. A 25 ml sample was
taken 10 min after the treatment and processed for protein
extraction with trichloroacetic acid (TCA) [75]. For analysis of the
double-strand breaks (DSBs) checkpoint response, cells arrested at
the proper cell cycle phase were treated with 150 mg/ml of zeocin.
Samples were taken 45 min after treatment and processed for
protein extraction.
FKBP dimerization
To analyze FKBP-driven (FK506 binding protein) dimerization,
overnight cell cultures were diluted at a concentration of
16106 cells/ml and treated for 6 h with 1 mM AP20187
(ARGENT Regulated Homodimerization kit, ARIAD Pharma-
ceutical). UV sensitivity assays or chromatin binding analysis were
performed as described elsewhere in this section.
Inactivation of the Cdc28 kinase activity
Exponentially growing cells in a cdc28-as1 background were
harvested at a concentration of 46106 cells/ml and blocked in M
phase as described above. To selectively inhibit Cdc28 activity
[56], the ATP analogue 1NMPP1 was then added to a
concentration of 5 mM to half of the cultures; after 2 h of
incubation at 28uC, cells were either mock- or UV-irradiated and
protein extracts were prepared.
SDS-PAGE and western blotting
TCA protein extracts or chromatin binding samples were
separated by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) in 10% acrylamide gels. For the analysis of
Rad9 phosphorylation, NuPAGE Tris-acetate 3% to 8% gels were
used following the manufacturer’s instructions. Western blotting
was performed with anti-Rad9 (D. Stern), anti-Rad53 (C.
Santocanale), with anti-phosphorylated Rad53 F9 Mab antibodies
[76] anti-ORC2 (Abcam) and anti-tubulin (ML. Carbone), using
standard techniques.
UV–sensitivity assay
To assess cell survival after UV irradiation, serials dilutions of
overnight cultures were spotted onto YPD plates, which were
either irradiated with different UV doses or mock-treated. For
survival curves, yeast strains were cultured overnight to exponen-
tially growing phase. Cells were diluted and approximately 500
cells/plate were plated, and then either irradiated with various UV
doses or mock-treated. After 3 days, the total number of colonies
formed on each plate was counted.
Yeast two-hybrid analysis
Protein interaction between Rad9 and Dpb11 in the G1 and M
phase of the cell cycle was assessed by measuring b-galactosidase
activity with ortho-Nitrophenyl-b-galactoside (ONPG) assay.
Briefly, cells expressing Rad9 bait and/or Dpb11 prey were
cultured overnight in yeast synthetic media (-Ura, -His, -Trp) with
2% (w/v) raffinose to a concentration of 56106 cells/ml. Cultures
were centrifuged and cells resuspended in YP plus raffinose and
arrested in G1 or M phases, as described above. Galactose to a 2%
w/v final concentration was added to the medium to induce prey
expression. A 15 ml sample was taken after 1 h of galactose
induction, centrifuged and resuspended in 250 ml of breaking
buffer (100 mM Tris HCl at pH 8.0, Glycerol 10%; DTT 1 mM,
1 tablet of complete Roche antiproteolytic cocktail. Cells were
lysed by using a FastPrep cell disruptor; the optical density (OD) of
protein extract at 600 nm was determined using the Bio-Rad
protein assay reagent. 1 ml of Z buffer (60 mM Na2HPO4,
40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, and 50 mM b-
mercaptoethanol at pH 7.0) plus ONPG 4 mg/ml was aliquoted
in a small glass tube for each sample. 20 ml of protein extract was
added to each tube and incubated at 37uC until a yellow color
developed. The reaction was stopped by adding 400 ml of 1 M
NaCO3 and the OD at 420 nm of each sample was measured. b -
Galactosidase activity was calculated by using the formula units
= 103 OD420/(OD600 x reaction time in min).
Rad9-Dpb11-MYC immunoprecipitation
1.5 l cultures of strains YFP38 and YMAG281 expressing,
respectively, the tagged Dpb11-MYC fusion protein under the
control of the endogenous DPB11 promoter in a wild-type or
rad9S11A mutant background were grown in YPD medium at a
cell density of 16107 cells/ml. Cells were then arrested in M phase
by addition of 10 mg/ml of nocodazole and were either mock
treated or treated with 150 mg/ml of zeocin for 30 min. Cells were
washed twice with pre-cooled ddH2O and once in 26 lysis buffer
(300 mM KCl, 100 mM Hepes (pH 7.5), 20% glycerol, 8 mM b-
mercaptethanol, 2 mM EDTA, 0.1% Tween20, 0.01% NP-40).
Resuspended cells were frozen as droplets in liquid nitrogen.
Aliquots of frozen cells were manually ground in a mortar in liquid
nitrogen. One volume of 26 lysis buffer, containing a protein
inhibitor cocktail (2.8 mM leupeptin, 8 mM pepstatin A, 4 mM
PMSF, 50 mM benzamidine, 25 mM antipain, 4 mM chymostatin
in ethanol) and phosphatase inhibitors (2 mM sodium fluoride,
1.2 mM b-glycerophosphate, 0.04 mM sodium vanadate, 2 mM
EGTA, 10 mM sodium pyrophosphate), was added. Cell extract
was clarified by a low speed centrifugation followed by additional
centrifugation for 1 h at 42.000 rpm in a Beckman Sw55Ti rotor.
The clarified crude extract (Ext) was adjusted to 10 mg/ml in the
various immunoprecipitation experiments. 1 ml of Ext was pre-
cleared by incubation with 40 ml of 50% (v/v beads/16 lysis
buffer) Protein G slurry for 1 hour at 4uC on a rotating wheel. Pre-
cleared supernatants were incubated with either 20 mg of the anti-
myc Mab 9E11 or 20 mg of unspecific mouse IgG. Samples were
incubated for 2 h at 4uC on a rotating wheel and centrifuged at
14.000 rpm for 15 min at 4uC. 40 ml of 50% protein G slurry were
added to the supernatants, incubated on a rotating wheel for 2 h at
4uC and recovered by centrifugation. Immunoprecipitated
Dpb11-MYC samples were washed four times with 1 ml of lysis
buffer containing protease and phosphatase inhibitors. Beads were
finally resuspended in 40 ml of 36Laemmli buffer (IP), boiled for
5 min and released proteins separated on 6.5% (80/1 acrylamide/
bisacrylamide) SDS-PAGE gels. After blotting, Rad9 was
visualized with the NLO5 Rad9 polyclonal antibody [13] or the
9E11 Mab (Abcam).
Supporting Information
Figure S1 (A) wt (K699) cells were arrested in G1 with a-factor
and either mock or UV irradiated (75 J/m2). 10 min after
irradiation, samples were collected and analyzed in their total
(T), soluble (S) and chromatin-enriched (Ch) fractions. Blots were
probed with anti Rad9 polyclonal antibodies. After UV irradiation
the hyper-phosphorylated Rad9 isoform migrates and it is detected
on Western blots probed with anti-Rad9 antibodies near to an
aspecific protein species (mostly present in the supernatant
fraction) [50]. Such band was omitted in the Western blots shown
in Figure 1, Figure 2, and Figure 7 for clarity. The positions of
Rad9 and its hyper-phosphorylated isoform (pRad9) are indicated;
* marks the background protein species unrelated to Rad9. (B)
The Western blots in which the presence of Rad9 was analyzed in
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the total (T), soluble (S) and chromatin-enriched (Ch) fractions
were controlled for proper fractionation of control proteins, known
to remain in the soluble fraction (Tubulin) or to bind to chromatin
(Orc2). The blots in S1 Panel B show the results obtained with the
same protein samples analyzed in Figure 1A. (C) Quantitative
analysis of the percentage of hyper-phosphorylated and hypo-
phosphorylated Rad9 isoforms in the total (T), soluble (S) and
chromatin-enriched (Ch) fractions in a-factor and nocodazole
arrested wild-type cells. Quantification was obtained with a
Versadoc (Biorad) after incubation with fluorescent secondary
antibodies, and error bars were obtained from 4 independent
experiments. The percentages of hyper- and hypo- phosphorylated
isoforms were calculated respectively to the total amount of Rad9.
Found at: doi:10.1371/journal.pgen.1001047.s001 (1.16 MB TIF)
Figure S2 (A) The histograms show the M/G1 ratio increase in
b-galactosidase activity, when the interaction between Dpb11/
Rad9 or the positive controls p53 and SV40-TAg was measured
by two-hybrid analysis in nocodazole (M) or a-factor (G1) arrested
cells. Error bars were obtained from three independent two-hybrid
experiments. (B) Amino acid sequence of the Rad9 ORF; the basic
CDK1 (S/T-P) and PIKK (S/T-Q) consensus phosphorylation
sites are shown in black or gray, respectively. (C) wt (K699) and
rad9-S11A (YMAG162) strains were arrested in M with nocodazole
and samples were collected to prepare protein extracts. Rad9
phosphorylation was analyzed by SDS-PAGE and Western
blotting with anti-Rad9 antibodies.
Found at: doi:10.1371/journal.pgen.1001047.s002 (0.77 MB TIF)
Figure S3 wt (YMAG149/7B), H2A-S129A (YMAG168),
dpb11DCT (YMAG145/20C), H2A-S129A dpb11DCT
(YMAG155), dot1D (YMAG150/4A), H2A-S129A dot1D
(YMAG170), dpb11DCT dot1D (YMAG148) and H2A-S129A
dpb11DCT dot1D (YMAG157) strains were arrested in M with
nocodazole and treated with zeocin (150 mg/ml). After 45 min,
samples were collected and protein extracts were analyzed by
SDS-PAGE and Western blotting with anti Rad53 antibodies to
monitor checkpoint activation.
Found at: doi:10.1371/journal.pgen.1001047.s003 (0.76 MB TIF)
Table S1 Strains used in this study. All of the strains used in this
work are derivatives of W303 [MATa ade2-1 trp1-1 can1-100 leu2-
3,12 his3-11,15 ura3 rad5-535]; only strains YFP91 and DLY2236
(provided by D. Lydall), are RAD5+.
Found at: doi:10.1371/journal.pgen.1001047.s004 (0.06 MB
DOC)
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Table S1. Strains used in this study. 
 
Strain Relevant genotype Source 
K699 MATa ade2-1 trp1-1 leu2-3,112 his3-11 ura3 can1-100 rad5-535 K. Nasmyth 
YFL871 K699 rad9aa1-646:kanMX4:URA3 This work 
YNOV15 K699 rad9-F1104L This work 
YNOV31 K699 rad9-W1280L This work 
YMAG88 K699 rad9::HIS3 This work 
YFL696/1b K699 rad9ΔBRCT::13MYC:TRP1 This work 
YMAG74 K699 rad9ΔBRCT::GST:kanMX6 This work 
YFL773/2c K699 dot1::kanMX6 rad9ΔBRCT::GST:kanMX6 This work 
YFL921 K699 rad9ΔBRCT::2xFKBP-13MYC:kanMX6 This work 
YMAG149/7B K699 hta1_htb1::LEU2 hta2_htb2::TRP1 (pSAB6) (50) 
YMAG145/20C K699 hta1_htb1::LEU2 hta2_htb2::TRP1 dpb11ΔCT::HPH (pSAB6) This work 
YMAG150/4A K699 hta1_htb1::LEU2 hta2_htb2::TRP1 dot1::kanMX6 (pSAB6) (50) 
YMAG148 K699 hta1_htb1::LEU2 hta2_htb2::TRP1 dpb11ΔCT::HPH dot1::kanMX6 (pSAB6) This work 
EGY42 MATα his3 ura3 trp1 leu2::6LexAop-LEU2 R. Brent 
JAU01 K699 cdc28-as1 (56) 
YNOV4 K699 cdc28-as1 dot1::kanMX6 This work 
YFL234 K699 dot1::kanMX6 (33) 
DLY2236 K699 rad9::LEU2 ura3::rad9-M232:URA3 RAD5+ (58) 
YFP91 K699 rad9::LEU2 ura3::rad9-M232-URA3 dot1::kanMX6  RAD5+ This work 
YMAG162 K699 rad9-S11A This work 
YMAG164 K699 rad9-S11A dot1::kanMX6 This work 
YMAG168 K699 hta1_htb1::LEU2 hta2_htb2::TRP1 (pJD151) (50) 
YMAG170 K699 hta1_htb1::LEU2 hta2_htb2::TRP1  dot1::kanMX6 (pJD151) (50) 
YMAG155 K699 hta1_htb1::LEU2 hta2_htb2::TRP1 dpb11ΔCT::HPH (pJD151) This work 
YMAG157 K699 hta1_htb1::LEU2 hta2_htb2::TRP1 dpb11ΔCT::HPH dot1::kanMX6 (pJD151) This work 
YFL1177 K699 rad9-S11AΔBRCT::GST:kanMX6 This work 
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a  b  s  t  r  a  c  t
Cells  respond  to genotoxic  insults  by  triggering  a DNA  damage  checkpoint  surveillance  mechanism  and
by  activating  repair  pathways.  Recent  ﬁndings  indicate  that  the  two  processes  are  more  related  than
originally  thought.  Here  we  discuss  the mechanisms  involved  in  responding  to  UV-induced  lesions  in
different  phases  of the  cell  cycle  and  summarize  the  most  recent  data  in  a  model  where  Nucleotide
Excision  Repair  (NER)  and  exonucleolytic  activities  act  in  sequence  leading  to checkpoint  activation  in
non  replicating  cells.  The  critical  trigger  is likely  represented  by problematic  intermediates  that  cannot  be
completely  or  efﬁciently  repaired  by NER.  In  S  phase  cells,  on  the  other  hand,  the replicative  polymerases,
blocked  by bulky  UV  lesions,  re-initiate  DNA  synthesis  downstream  of the  lesions,  leaving  behind  a  ssDNA
tract. If these  gaps  are  not  rapidly  reﬁlled,  checkpoint  kinases  will  be  activated.
© 2011 Elsevier B.V. All rights reserved.
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1. Introduction
Cellular DNA is constantly threatened by genotoxic events aris-
ing from cellular metabolisms (e.g., free oxygen radicals, replication
errors) and induced by environmental factors (e.g., ionizing and
UV radiations, chemicals). To prevent the effect of endogenous and
exogenous mutagenic agents and to maintain genome integrity,
cells have evolved a complex response to DNA damage (DDR),
which includes repair mechanisms and regulatory circuits. A key
role in this response is played by signaling pathways that we  will
refer to as DNA damage checkpoints, surveillance mechanisms
responsible for the coordination of cell cycle progression, DNA
∗ Corresponding author. Tel.: +39 0250315034; fax: +39 0250315044.
E-mail addresses: paolo.plevani@unimi.it (P. Plevani),
marco.muzifalconi@unimi.it (M.  Muzi-Falconi).
replication, transcription with DNA repair and apoptosis. Check-
point activation temporarily halts or delays cell cycle progression,
possibly providing the cell with enough time to remove DNA
lesions before these are converted in secondary and more dan-
gerous lesions (e.g., replication through a single strand gap would
generate a double strand break). The checkpoints also actively stim-
ulate the repair processes [1–9] and, in higher eukaryotes, trigger
the apoptotic response, if damage cannot be dealt with successfully
[10–12].
2. DNA damage checkpoint
The importance of the DNA damage checkpoint in the main-
tenance of genomic stability is underlined by the existence of
many syndromes linked to mutations in checkpoint genes, causing
increased cancer proneness or other clinical symptoms, espe-
1568-7864/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.dnarep.2011.04.030
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Table  1
Checkpoint functions are evolutionarily conserved. The table shows the correspon-
dence between various checkpoint factors in different organisms. The upstream
factors are in blue, mediators are in pink and downstream effectors are in green.
cially neurological defects [13,14]; it is thus not surprising that
these pathways are extremely conserved throughout evolution
(Table 1).
The DNA damage checkpoint response consists of a signal trans-
duction cascade mainly based on phosphorylation events; the
mechanistic details of the pathway have been recently discussed
elsewhere [15,16], and will be just brieﬂy summarized here to give
a schematic picture to the reader. The ﬁrst signaling event is car-
ried out by the apical checkpoint kinases and is triggered after DNA
damage detection. Two complexes are independently recruited
at the lesion sites [17]: the human ATR/ATRIP or Saccharomyces
cerevisiae Mec1/Ddc2 complex, and the 9-1-1 checkpoint clamp
complex, composed of Rad9-Rad1-Hus1 in human or their ortho-
logue subunits Rad17-Mec3-Ddc1 in yeast. The co-localization of
these complexes is sufﬁcient to trigger at least a partial check-
point signaling even in the absence of actual DNA damage [18].
In S. cerevisiae the Mec1 apical kinase can be activated both by
the Ddc1 subunit of the checkpoint clamp and by the adaptor
protein Dpb11 which is recruited at the lesion through interac-
tion with Ddc1 [19–23].  In human cells, the 9-1-1 complex is not
able to directly activate ATR, but it is needed to recruit TopBP1
(the Dpb11 orthologue) which, in turn, stimulates ATR activity
[24]. The apical kinases phosphorylate checkpoint mediators or
adaptors, which are held close to the lesion by the interaction
with post-translationally modiﬁed histone residues and with other
checkpoint factors [25]. The mediators amplify the signaling cas-
cade providing a platform to recruit effector kinases close to the
apical kinases, and facilitating their activation. In budding yeast,
Mec1 activates both Rad53 and Chk1 [26], while in human cells
Chk2 is activated by ATM and Chk1 by ATR [27]. The prototype
of checkpoint mediators is S. cerevisiae Rad9, which, once phos-
phorylated by the apical kinase, recruits Rad53 at the damage
site allowing its phosphorylation by Mec1. Oligomerization of
Rad9 seems to be critical to provide a scaffold for Rad53 bind-
ing, leading to a local increase in Rad53 molecules and stimulating
its auto-phosphorylation; this event is responsible for full Rad53
activation [28,29]. Chk1 activation also requires Rad9, but the
mechanism through which this mediator facilitates Chk1 phospho-
rylation by Mec1 is still poorly understood [30]. In human cells,
the identity of the functional Rad9 orthologue is still debated:
multiple candidates exist – i.e., MDC1 (mediator of DNA-damage
checkpoint 1), 53BP1 (p53-binding protein 1) and BRCA1 (breast
cancer 1 early-onset) – all characterized by the presence of tan-
dem BRCT (BRCA1 C-terminal repeat) domains. Since these three
proteins are involved in checkpoint signal transduction and each
of them seems to carry out, separately and sometimes redun-
dantly, some of Rad9 functions, they may  be all considered as Rad9
orthologues [31]. Finally, effector kinases are responsible for the
phosphorylation of a great number of targets, including cell cycle
machinery factors and key proteins important for replication and
repair [32,33].
The checkpoint response can act in at least three different phases
of the cell cycle: in G1, to prevent chromosomes with problem-
atic lesions from entering S phase, in S phase to control their
replication, and in G2 (or M in some organisms) to avoid loss of
genetic information due to mitotic segregation of severely dam-
aged chromosomes. The general scheme of the checkpoint cascade
is similar in all three cases, but signiﬁcant differences can be found,
depending on the nature of the DNA lesion and on the cell cycle
phase in which the damage is detected [13,34–36].  Furthermore, in
human cells the two  apical kinases seem to be partly specialized in
the response to different classes of DNA damaging agents. In fact,
ATM (Ataxia Telangiectasia Mutated) is activated by double-strand
breaks (DSBs) caused, for example, by ionizing radiation (IR), while
ATR (ATM and Rad3-Related) is activated by ssDNA coated with the
RPA heterotrimeric complex and mainly triggers checkpoint acti-
vation after UV irradiation or replication-stress. This specialization
is possibly imputable to the different networks of physical inter-
actions that these kinases participate to, and that are responsible
for their recruitment at the sites of lesion [37–40].  The situation is
somewhat complicated by the ﬁnding that ATR can be also recruited
to DSBs and this binding depends upon ATM [41,42]. This separa-
tion of tasks is not found in budding yeast, where Mec1 (the ATR
homologue) is the main player of checkpoint activation after all
kind of DNA lesions, while Tel1 (the ATM homologue) is especially
devoted to telomere maintenance. The redundant role of Tel1 in the
DNA damage checkpoint is uncovered only in the absence of Mec1
[15,43].
In this review, we will focus our attention on UV-induced lesions
and we will discuss the reciprocal interactions between NER, post
replication repair (PRR), and the checkpoint pathway. In particular,
we will discuss how NER plays a role in the activation of the check-
point response after UV treatment, and how checkpoint kinases
contribute to modulating the actual repair events.
Given the variety of DNA lesions the cell has to deal with, it
was hypothesized that the ﬁrst responders, among checkpoint fac-
tors, had to be recruited to a common DNA intermediate, which was
later identiﬁed as long regions of ssDNA covered by RPA [44]. While
ATRIP and Ddc2 directly bind RPA-covered ssDNA [44], loading
of the 9-1-1 complex requires the activity of an RFC-like com-
plex, that places it at the junction between dsDNA and 5′ ssDNA
[45]. In the case of a single DSB, a large amount of evidence indi-
cates that recombination factors are ﬁrst recruited at the DSB, and
then the 5′ ends of the DSB are processed through the concerted
action of several proteins, including helicases and nucleases. This
action generates long ssDNA tails that, on one hand will recruit
checkpoint factors, and on the other will initiate repair through
homologous recombination mechanisms [46]. On the other hand,
extensive resection is not required when a DSB is repaired through
a Non-Homologous End Joining (NHEJ) process [47]. For a long time,
it was unclear how UV irradiation, which causes bulky lesions on
DNA (mainly cyclobutane pyrimidine dimers (CPD) and 6,4 photo-
products (6-4PP)) responsible for inducing a distortion of the DNA
helix [48], triggers the same checkpoint response in the absence of
any DSB (Fig. 1).
3. Nucleotide excision repair
UV-induced DNA lesions are mainly removed through NER that
efﬁciently identiﬁes 6-4PPs and more slowly takes care of CPDs.
The lesion recognition mechanism of NER depends upon the phys-
Published paper II
142
D. Novarina et al. / DNA Repair 10 (2011) 751– 759 753
Fig. 1. The DNA damage checkpoint cascade. The DNA damage checkpoint is triggered by a ssDNA region. The left side of the ﬁgure reports the checkpoint cascade in budding
yeast.  RPA-covered ssDNA recruits the Mec1-Ddc2 and the 9-1-1 complexes. Phosphorylated Ddc1 interacts with Dpb11 which recruits the Rad9 mediator. Rad53 and Chk1
kinases  are activated upon binding to oligomeric Rad9 and then leave chromatin to ﬁnd their own  targets. The right side of the ﬁgure summarizes the same signaling cascade
in  human cells.
ical location of the lesion, with TC-NER acting on lesions that block
transcription, and GG-NER taking care of the rest of the genome
[48].
NER has been reconstituted in vitro and the mechanism is dis-
cussed elsewhere in this issue. Brieﬂy, once the lesion has been
recognized a pre-incision complex is assembled at the damage site.
Endonucleolytic incision 5′ and 3′ to the lesion produces a short gap
containing ssDNA covered by RPA, which is then reﬁlled by DNA
polymerase activities.
How long this ssDNA tract is exposed for, before a DNA poly-
merase reﬁlls the gap is not clear, but most reports seem to agree
that the reﬁlling is extremely rapid and tightly coordinated with
the incision process [49,50] (see review by Fagbemi et al. in this
issue of DNA Repair).
Since UV lesions are bulky and block the progression of replica-
tive DNA polymerases, when the replication forks collide with
UV-induced lesions during the S phase of the cell cycle re-priming
events may  take place downstream of the lesions, leaving ssDNA
gaps behind the fork. Such structures have been detected by elec-
tron microscopy on replicating UV-damaged DNA and are likely
responsible for the rapid and sensitive response observed in UV-
irradiated S phase cells [51]. Outside of S phase and in non cycling
cells the situation is quite different. Recent analysis showed that
UV lesions themselves cannot activate the checkpoint and NER
plays a major role in triggering the checkpoint response, although
contrasting results have also been reported [52–57].
4. NER and DNA damage checkpoint
The tight relationship between NER and the checkpoint
response started to become clear when, in budding yeast, a rad14
mutant, which is defective in assembling a competent pre-incision
complex, was identiﬁed in a screen for mutations speciﬁcally inac-
tivating the DNA damage checkpoint in response to UV irradiation,
while leaving intact the DSB-induced checkpoint [55]. Furthermore,
a direct interaction between Rad14 and the 9-1-1 checkpoint com-
plex was reported, albeit its physiological signiﬁcance has not been
fully addressed. This work also showed that, in non cycling cells,
any NER mutation affecting the incision event caused a deﬁcient
checkpoint activity, demonstrating that UV lesions per se are not
sufﬁcient to trigger the apical checkpoint kinase, and that their
processing by a repair mechanism is necessary for recruiting the
Mec1/Ddc2 and the 9-1-1 complexes to damaged chromosomes
and for a prompt checkpoint response [55]. Such results are also
consistent with the ﬁnding that UV irradiation in G1  of a cycling
rad14 strain results in a strong arrest at the beginning of S phase
[58], accompanied by the accumulation of replication-dependent
ssDNA regions [51]. Altogether, it was  suggested that a NER inter-
mediate, possibly the ssDNA gapped structure generated by the
double incision event may  be responsible for recruiting and activat-
ing checkpoint factors. In cycling NER-deﬁcient cells, UV irradiation
would not cause a G1 delay or G2/M arrest and replication of
the damaged template would lead to the accumulation of ssDNA
regions resulting in Mec1 activation.
Extension of this kind of analysis to human cells derived from
XP patients conﬁrmed that lack of NER-dependent processing pre-
vented UV-induced checkpoint activity in non cycling ﬁbroblasts,
revealing that XP cells are not only deﬁcient in repairing UV lesions,
but they are also deﬁcient in the G1 and G2/M UV-induced check-
point [56,57]. Interestingly, while XPC cells, defective in GG-NER,
exhibit a checkpoint failure, cells obtained from Cockayne syn-
drome patients, which are defective in TC-NER, are instead able to
activate the checkpoint, possibly thanks to the activity of GG-NER.
Intriguingly, there seems to be a correlation between the capacity
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of these cells to properly control G1 and G2/M transitions after UV,
their genomic instability and the proneness of XP and CS patients
to develop tumors [56]. In budding yeast, the analysis of mutants
speciﬁcally defective in the TC-NER or in the GG-NER branches
of NER, revealed that activity of either one of the sub-pathways
was sufﬁcient to trigger a checkpoint response [55]. Interestingly,
although UV-induced photoproducts and DSBs are processed by
different DNA repair pathways and trigger signaling responses
controlled by distinct apical kinases (see above) they eventually
generate the same epigenetic mark involving H2A ubiquitination
[59].
The model suggesting that gapped NER intermediates are
responsible for checkpoint activation in UV-irradiated cells poses a
few problems: (a) the gaps are very short (∼30 nt); (b) repair syn-
thesis is very rapid, so the gaps are virtually absent; (c) it is not
clear what would be the advantage of activating the checkpoint
and arresting cell cycle progression, once the damage is practically
repaired.
Recent work shed light on these problems, showing that nor-
mal  NER-intermediates are not directly responsible for activating
checkpoint kinases. In order to achieve a full and prompt check-
point activity after UV irradiation in non cycling yeast cells, NER is
necessary but not sufﬁcient: in fact, the nuclease activity of Exo1
is also required [60,61]. Exo1 belongs to the Rad2 family of nucle-
ases and has multiple cellular roles (see [62] for a review). This
work shows that UV irradiation causes the accumulation, in yeast
chromosomes, of long ssDNA regions that are dependent upon
NER and Exo1 and correlate with Mec1 kinase activation. Prevent-
ing completion of repair synthesis by genetic or chemical means
strongly increases accumulation of ssDNA and checkpoint acti-
vation, in agreement with a previous report [63]. The frequency
of these large ssDNA gaps is much lower than the expected fre-
quency of UV damages, suggesting that only a minor fraction
of lesions undergo Exo1-dependent processing. Intriguingly, this
mechanism is conserved also in human cells (Sertic et al., in prepa-
ration). These results suggest that the ∼30 nt long ssDNA gaps
produced by NER can be reﬁlled by DNA polymerases or extended
by Exo1; given that polymerases reﬁll a DNA gap at a rate of about
3700 nt/min and Exo1 excises DNA at 160 nt/min, most UV lesions
are normally rapidly repaired by NER. This is consistent with the
observation that very low UV doses do not seem to activate the
G1 checkpoint [61,64,65];  if NER can rapidly and effectively deal
with a low number of lesions, there would be no point in trigger-
ing a checkpoint response. If for any reason the repair synthesis
step is perturbed, Exo1 may  have a kinetic opportunity to pro-
cess the NER gap, generating a long ssDNA region, which recruits
checkpoint factors and triggers the signaling cascade (Fig. 2). This
situation may  arise, for example, at higher UV doses, in case repair
synthesis factors become limiting or if the reﬁlling polymerase
encounters an insurmountable block. In these conditions, repair
may  not be completed and the extension of the ssDNA region
may  meet two purposes: activating the checkpoint response and
channeling the problematic lesion to a different repair pathway
(e.g., recombination) [66–68].
Interestingly, translesion DNA polymerase activities (TLS) seem
to counteract the generation of the UV-induced checkpoint signal
[61,69].  Moreover, an unexpected role for TLS polymerases in NER
was described in human cells, where DNA polymerase  was found
to be responsible for approximately 30% of the unscheduled DNA
synthesis detected in UV-irradiated cells [70,71]. The actual role of
TLS polymerases in NER is not completely understood and it will
be interesting to determine if their activity is limited to particular
regions of the genome and/or to particular conﬁgurations, such as
the presence of a lesion in the template strand that may  interfere
with the reﬁlling step of NER, as previously suggested in bacteria
[72].
5. Closely opposing lesions
The possibility that Exo1-depedent processing may  be facili-
tated by a polymerase blocking lesion in the template is intriguing.
One instance where this might happen is when two  UV lesions, one
on each DNA strand, are generated in a limited region; this con-
ﬁguration has been deﬁned “closely opposing UV lesions” [73–75].
Probability calculations would predict that the frequency of closely
opposing lesions increases with the square of the UV dose and
the chance of generating such situation in a yeast chromosome
is expected to be very low. On the other hand, UV lesion for-
mation has a strong sequence bias, and actual measurements on
irradiated DNA proved that approximately 1% of all UV-induced
lesions are conﬁgured as closely opposing lesions [76–78].  When
NER encounters two closely spaced lesions, one on each strand,
a major problem arises. NER can only process one damage at a
time because the lesion needs to be in a double-stranded conﬁg-
uration [79]. Incision and removal of the ﬁrst UV-induced dimer
leaves to the reﬁlling polymerase a gap containing a lesion in the
template strand. DNA polymerase  or , which normally take care
of repair synthesis, cannot replicate past the template lesion and
stall, strongly resembling a blocked replication fork. During S phase,
such situation would be bypassed via Post Replication Repair (PRR),
which entails TLS polymerases and/or template switching mecha-
nisms. Interestingly, it was recently shown that DNA polymerase 
directly participates to NER repair synthesis in human cells [70,71]
and that loss of TLS activity greatly potentiates the checkpoint
response to UV irradiation in yeast G1 cells [61], suggesting that
closely opposing UV lesions may  indeed be at least partly respon-
sible for checkpoint activation. These particular lesions may  also
contribute to explain the observation that both in wild-type yeast
and bacteria cells most of the UV-induced mutagenesis depends
upon a functional NER and takes place in G1 cells, while in the
absence of NER the mutagenesis is S-phase speciﬁc [80,81].  More-
over, a role for TLS in G1-irradiated cells is also supported by the
ﬁnding that G1 synchronized cultures of yeast mutants lacking TLS
polymerases are more sensitive to UV light than asynchronous cul-
tures, while this is not the case for strains that are TLS proﬁcient
[61].
6. Replicating UV damaged DNA
As mentioned above, in NER deﬁcient cells, the lack of lesion
removal coupled to the failure to activate the G1 DNA damage
checkpoint in response to UV irradiation allows a large amount
of DNA lesions to go into S phase. Here, there is no need for
lesion processing to generate the checkpoint activating structures
since ssDNA regions are generated by the stalling of replication
forks at the polymerase blocking lesions. Blocked polymerase can
leave the lesion and PCNA behind and re-initiate downstream
of the lesion via a re-priming mechanism, generating numerous
ssDNA gaps behind the forks, which are likely responsible for the
strong activation of Mec1 during S phase in UV-irradiated cells
[51,82–85]. Consistently, even at low UV doses (5 J/m2), NER deﬁ-
cient yeast cells exhibit a strong cell cycle arrest at the beginning of
S phase, due to Mec1 DNA damage checkpoint activation [58]. An
active checkpoint leads to Rev1 phosphorylation [86,87],  possibly
increasing TLS activity and progressively reducing the amount of
RPA-covered ssDNA, thus promoting the switch off of the check-
point itself.
In a wild type background, elegant time lapse experiments
showed that after an acute low dose of UVC light (5 J/m2) yeast
cells do not delay cell cycle progression until they proceed through
S phase; for this reason this response was called post-replication
checkpoint [64]. With low levels of UV-induced lesions the NER
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Fig. 2. UV-induced checkpoint response. In cells that are not replicating their genome (i.e., G1, G2 or non-cycling cells), NER removes UV lesions efﬁciently and DNA
polymerases (i.e., pol , pol , TLS polymerases) begin the reﬁlling process. If the repair reaction is impeded after the excision step, a competition between the reﬁlling
polymerases and Exo1 nuclease can take place. Problematic reﬁlling (e.g., closely opposing lesions) allows Exo1 to further process the gapped intermediate generating long
ssDNA gaps which recruit checkpoint factors and trigger the signaling. At low UV-doses G1 and G2 cells do not accumulate large ssDNA gaps since UV lesions can be efﬁciently
removed by NER. If the damages are still present when the cell enters S phase, the replicative polymerase will be blocked by the bulky lesion and will reinitiate DNA synthesis
further downstream, leaving ssDNA gaps behind the replication fork. These gaps can be reﬁlled by post replication repair and trigger a post-replication checkpoint.
mechanism is very efﬁcient and rapidly takes care of most lesions,
so that neither the G1 or the G2 checkpoints are activated. The
few lesions that are encountered by replicating polymerases in
these conditions, on the other hand, block the replication fork
and trigger a checkpoint response; this response may  be detected
in late S phase, when most replicons have completed duplica-
tion and the left-over ssDNA gaps need to be reﬁlled (Fig. 2).
An important point in this regard was made by irradiating bud-
ding yeast cells with very low (0.18 J m−2 min−1) chronic UV dose
(CLUV): the only pathway necessary and sufﬁcient to ensure cell
survival was found to be the RAD5-dependent branch of PRR [65].
Indeed, NER deﬁcient cells (rad14)  and DNA damage check-
point deﬁcient cells (mec1) are not particularly sensitive to the
CLUV treatment, contrary to the rad18 and rad5 cells, deﬁ-
cient in PRR [65], which irreversibly activate Mec1 DNA damage
checkpoint and die in the G2 phase. In fact, S phase can be com-
pleted in the absence of PRR, but the gapped replicated DNA
needs to be reﬁlled by PRR in G2 in order to warrant cell survival
[66,67].
In mammalian cells the situation is more complex, because NER
acts also in S phase, where GG-NER is enhanced [88] and is stimu-
lated by active ATR [89,90].  Indeed, ATR-deﬁcient Seckel syndrome
ﬁbroblasts exhibit attenuation of S phase speciﬁc GG-NER and a
similar effect has been detected in XPV skin ﬁbroblasts, deﬁcient in
pol  [91]. Thus, in human cells both ATR-dependent DNA damage
checkpoint and TLS inﬂuence S phase-speciﬁc GG-NER: defects in
ATR or pol  may  cause the abnormal persistence of ssDNA gaps
opposite a template lesion and this would inhibit DNA adducts
excision by GG-NER.
7.  Recruitment of checkpoint factors by NER
In the last few years evidence has emerged that the role of NER in
checkpoint activation is not limited to the generation of the ssDNA
signal but, in addition, NER proteins seem to be involved in directly
recruiting checkpoint factors to the proximity of DNA lesions.
In S. cerevisiae, a physical interaction was identiﬁed between
Rad14 and both Ddc1 and Mec3, two  subunits of the 9-1-1
checkpoint complex. Although the physiological relevance of this
interaction has not been directly investigated further, association
of Ddc1 and Ddc2 to UV-damaged chromosomes is lost in a rad14
strain, suggesting that the 9-1-1 complex may  be initially recruited
at the sites of DNA lesions by directly interacting with the key NER
factor Rad14 [55].
Additional observations indicate that this mechanism is most
likely conserved in higher eukaryotes. In human G1 cells the
recruitment of the 9-1-1 complex onto damaged DNA is dependent
on XPA and XPC proteins [92]; analogously, Cep164, a checkpoint
mediator protein in the ATR signaling pathway required for Chk1
phosphorylation after UV damage, was  shown to be recruited
to CPD sites in a NER-dependent manner, through UV-induced
physical interaction with XPA [93]. In addition, a role for NER in
the activation of ATM after cisplatin treatment was discovered.
Immunoprecipitation experiments revealed a physical interaction
between ATM and NER factors and this association is required for
ATM recruitment to DNA [94] (Fig. 3).
Combining the notion that processing of lesions by repair
machineries is a pre-requisite for checkpoint activation outside of
S phase, with the observation that checkpoint factors interact with
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Fig. 3. Crosstalks between NER and checkpoint factors. A two-way functional interaction exists between the checkpoint machinery and the NER apparatus: some examples
(discussed in the text) are shown. (A) NER factors recruit checkpoint proteins to damaged chromosomes, thus facilitating the activation of the signaling cascade. (B) DNA
damage  checkpoint factors modulate NER activity allowing for efﬁcient repair of the lesions.
repair proteins depicts a model where the repair machinery, which
is specialized for direct lesion recognition, increases the local con-
centration of checkpoint sensors on damaged chromosomal regions
facilitating a robust checkpoint response.
Interestingly, a NER-independent mechanism for activating
checkpoint kinases seems to exist in non cycling cells. If NER-
deﬁcient yeast cells are blocked in the G1 phase of the cell cycle,
UV irradiated and held in non dividing conditions indeﬁnitely,
a delayed activation of the Mec1-dependent pathway has been
reported [95,96]. Recent evidence indicates that UV-induced sig-
naling may  proceed via NER-independent mechanisms also in
non-dividing mammalian cells likely through generation of DNA
strand breaks [97].
8. NER modulation by checkpoint proteins
The interplay between NER and the DNA damage checkpoint is
even more complex; in fact, while NER is involved in checkpoint
activation, the checkpoint pathway actively stimulates NER by
modulating cellular levels, localization and activity of NER factors,
through transcriptional regulation, direct protein–protein interac-
tions and post-translational modiﬁcations (Fig. 3).
The S. cerevisiae Rad9 gene product plays a role in the repair
of both UV-damaged strands of an actively transcribed gene; this
effect on NER is likely indirect and probably occurs through up-
regulation of some NER genes (i.e., RAD2, RAD7, RAD16 and RAD23),
consistently with a previously reported Rad9-dependent stimula-
tion of NER genes transcription [98]. Rad9 does not seem to be
required for the repair of non-transcribed regions, suggesting that it
is acting only when repair is coupled to transcription [8].  Along sim-
ilar lines, Rad26, a NER factor critical for TC-NER, is a direct target
of Mec1 kinase and its phosphorylation enhances TC-NER, possibly
by stimulating its ATPase activity or by modulating its interaction
with other TC-NER proteins [99]. Notably, CSB (the human ortho-
logue of Rad26) was identiﬁed in a screen for putative ATM/ATR
substrates [33], pointing to a conservation of this regulatory mech-
anism through evolution. Other NER factors were found in the
same screening, namely XPA, XPC, RPA1 and RAD23B, but further
characterization will be required to prove the signiﬁcance of the
interaction between ATM/ATR and the NER factors identiﬁed in the
screen. Another example on the possible feedback of the check-
point on NER is the regulation of XPA by ATR. It has been found
that XPA nuclear import and its stable accumulation at nuclear foci
after UV irradiation is dependent upon ATR. ATR also seems to be
responsible for XPA phosphorylation after UV radiations, although
this modiﬁcation is not required for XPA foci formation [100–102].
Further studies will be required to ﬁrmly establish the role of ATR in
the modulation of the XPA function. Finally, an S-phase speciﬁc role
for the DNA damage checkpoint in regulating GG-NER was recently
suggested. In particular, ATR inhibition was shown to speciﬁcally
abrogate NER in S-phase, while the repair rate was unaffected in G1
and G2/M cells [89]. Another report revealed a role for the replica-
tion checkpoint mediator Claspin in regulating the DDB2 subunit of
the UV-DDB factor, which is involved in the initial steps of GG-NER
[103]. DDB2 is localized at the UV-induced DNA lesions, where its
ubiquitination and subsequent degradation seems to control XPC
recruitment and damage recognition, thus triggering the NER pro-
cess [104]. Claspin knockdown affects DDB2 recruitment at damage
sites and its subsequent ubiquitin-mediated degradation; in agree-
ment with this observation, it has been shown that Claspin and
DDB2 physically interact and their association is greatly enhanced
upon UV irradiation [103].
9. Summary and perspectives
The complex interplay between NER and DNA damage check-
points is not an isolate case in the DDR landscape, since in recent
years a large cluster of papers highlighted the reciprocal inter-
dependence of the checkpoint pathways and virtually all other
known repair systems. It seems that, as a general rule, a two-way
functional interaction exists between the checkpoint machinery
and the repair apparatus. On one side, repair factors help to
recruit checkpoint proteins at the damage sites onto DNA and, by
modifying the primary lesions to RPA-covered ssDNA, trigger the
checkpoint cascade; on the other side, once activated the check-
point pathway stimulates the repair process mainly through direct
protein–protein interactions or post-translational modiﬁcations.
One of the key factors at the interface between checkpoint and
repair is the 9-1-1 checkpoint clamp, and its involvement in such
processes has been recently discussed [25].
The checkpoint response may  be seen as a process that signals
the cell that something that should have been working properly, has
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instead some problem; the cell can thus deploy a set of measures
to attempt to solve the problems and avoid further complications.
The data obtained with low acute UV doses suggest that if the
lesions are not frequent enough to interfere with G1 or G2 pro-
cesses, the cell has no way (or need) to acknowledge their presence
and activate the checkpoint. Indeed, NER can easily keep these
lesions under control. When these damage-containing chromo-
somes are replicated, though, the DNA polymerases scanning the
genome will eventually detect them, and re-initiate DNA synthesis
further downstream leaving behind ssDNA gaps. Since the region
hosting a polymerase-blocking lesion can be almost completely
replicated by an incoming fork starting from an adjacent origin,
at low levels of lesions the gaps will accumulate and activate the
checkpoint kinases toward the end of S phase. This event has a clear
relevance since checkpoint mutants will die in this situation, and
only after checkpoint activation the gaps are reﬁlled by PRR and the
lesions are actually removed from the chromosomes [61]. It has to
be noted that a checkpoint response can be triggered in G1 cells,
even at these low UV doses, if something interferes with comple-
tion of NER. Indeed, alterations in the reﬁlling step of repair will
sensitize G1 cells more than S phase cells [58].
At higher UV doses (>20 J/m2), cells promptly respond also in
non replicating conditions, consistently with the increased prob-
ability of repair problems arising. Repair DNA synthesis, in these
situations, could be affected by the low level of dNTPs, by the for-
mation of closely opposing lesions, by limiting level of particular
factors in saturating conditions and by the higher possibility that
lesions are generated in “difﬁcult to repair” chromosomal loca-
tions. If the reﬁlling reaction is problematic, nucleases like Exo1
have a greater chance to process the NER intermediates and elicit
a checkpoint response [58].
What is surprising is what happens with chronic low UV doses
(CLUV), which are supposed to best mimic  sunlight exposure.
Experiments performed in yeast cells have suggested that in CLUV
conditions no checkpoint is activated, not even during S phase;
indeed, checkpoint deﬁcient strains do not exhibit sensitivity to
CLUV treatment [62]. Even more surprisingly, NER is not important
in these conditions, since NER-deﬁcient cells are also not sensitive
to CLUV. The possibility to extend these ﬁndings beyond yeast cells
remains to be determined, indeed they seem to contrast with the
situation observed in XP patients, who are deﬁcient in NER and
clearly hypersensitive to sunlight. In the future the actual events
happening with sunlight exposure will need to be investigated.
NER is the most versatile repair system and eliminates a wide
repertoire of DNA lesions, among which are UV-induced CPD and
6-4PP, that represent the main determinants in solar mutagenesis
and skin cancer [105,106].  The importance of the ﬁndings summa-
rized here may  thus expand further than the problems related to
exposure to UV light.
It is expected that genome-wide analysis of protein–protein
interaction networks provided by high throughput screenings will
progressively increase the number of known physical interactions
between checkpoint proteins and repair factors, thus strengthen-
ing and expanding the model describing the functional connections
between these two key genome stability pathways.
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SUMMARY
The chemical identity and integrity of the genome
is challenged by the incorporation of ribonucleo-
side triphosphates (rNTPs) in place of deoxy-
ribonucleoside triphosphates (dNTPs) during repli-
cation. Misincorporation is limited by the selectivity
of DNA replicases. We show that accumulation of
ribonucleoside monophosphates (rNMPs) in the
genome causes replication stress and has toxic
consequences, particularly in the absence of RNase
H1 and RNase H2, which remove rNMPs.We demon-
strate that postreplication repair (PRR) pathways—
MMS2-dependent template switch and Pol z-depen-
dent bypass—are crucial for tolerating the presence
of rNMPs in the chromosomes; indeed, we show that
Pol z efficiently replicates over 1–4 rNMPs.Moreover,
cells lacking RNase H accumulate mono- and polyu-
biquitylated PCNA and have a constitutively acti-
vated PRR. Our findings describe a crucial function
for RNase H1, RNase H2, template switch, and trans-
lesion DNA synthesis in overcoming rNTPs misincor-
porated during DNA replication, and may be relevant
for the pathogenesis of Aicardi-Goutie`res syndrome.
INTRODUCTION
The integrity of the eukaryotic cellular genome is preserved by
surveillance mechanisms that coordinate DNA replication,
repair, and recombination with cell-cycle progression (Muzi-
Falconi et al., 2003; Lazzaro et al., 2009). The DNA nature of
the chromosomes provides for an intrinsic stability as opposed
to the fragility of RNA, which is due to the higher reactivity of
ribose compared to deoxyribose. The incorporation of ribonucle-
otides (rNTPs) in place of deoxyribonucleotides (dNTPs) within
genomic DNA is generally avoided by the high selectivity of
DNApolymerases, largely due to a steric gate residue in the poly-
merase active site (Joyce, 1997). However, there are occasions
when rNTPs can be linked to DNA chains, such as during the
synthesis of Okazaki fragments or possibly during repair of
double strand DNA breaks in G1 (Nick McElhinny and Ramsden,
2003; Zhu and Shuman, 2008). Recent work indicates that during
normal DNA replication, DNA polymerases can also incorporate
rNTPs in place of dNTPs (Nick McElhinny et al., 2010b). rNMPs
embedded in DNA are expected to represent a problem for
cycling cells, sensitizing the DNA backbone to spontaneous
and/or enzymatic nicking. Indeed, the presence of rNMPs in
the yeast genome elevates the rate of short deletions in repeated
sequences through amechanism depending on topoisomerase I
(Nick McElhinny et al., 2010a; Clark et al., 2011; Kim et al., 2011).
Furthermore, the presence of rNMPs alters DNA helix para-
meters. For example, structural studies (Egli et al., 1993;
Jaishree et al., 1993; Ban et al., 1994a; Ban et al., 1994b; Wahl
and Sundaralingam, 2000) indicate that rNMPs in dsDNA alter
global conformation from B- to A-form, with most of the sugars
adopting C30-endo or closely related conformations. rNMPs
must be removed prior to the next cell cycle or they will pose
problems during subsequent rounds of replication; in fact, effi-
cient and accurate synthesis by replicative DNA polymerases
strongly depends on helix geometry, such that changes in sugar
pucker could render a primer terminus more difficult to extend.
Indeed, a recent study has shown that single rNMPs in DNA
templates impede DNA synthesis by the yeast replicases (Watt
et al., 2011). Altered helix geometry may be less problematic
for polymerases specialized for translesion synthesis, e.g.,
DNA polymerase z, which can efficiently extend aberrant primer
termini (Prakash et al., 2005). An important question is thus how
cells cope with replicating chromosomes containing rNMPs that
escape repair.
RNase H is a family of enzymes that cleave the RNA moiety in
RNA:DNA hybrids, allowing the reconstruction of a dsDNAmole-
cule. Eukaryotic cells possess RNase H1 and RNase H2 activi-
ties that have partially overlapping substrate specificity. While
RNase H1 requires at least a tract of four rNMPs to cleave,
RNase H2 can incise 50 to a single rNMP incorporated within
a DNA molecule (Cerritelli and Crouch, 2009). The in vivo roles
of RNase H in eukaryotic cells are still not fully understood. In
mammalian cells, RNase H1 is essential for mitochondrial DNA
replication (Cerritelli et al., 2003); such function is not conserved
in budding yeast cells. The role of the nuclear population of
RNase H1 is still not clear. RNase H2 represents the major
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RNase H activity in eukaryotic cells and is involved in several
cellular processes (Cerritelli and Crouch, 2009). Evidence indi-
cates that these enzymes can process Okazaki fragments during
replication although, at least in budding yeast, such activity is
redundant and Okazaki fragment processing can be carried
out by Rad27 and Dna2 (Rydberg and Game, 2002; Ayyagari
et al., 2003). Furthermore, removal of R-loops, which accumulate
when a transcription bubble collides with a replication fork, can
be achieved by overexpressing RNase H (Huertas and Aguilera,
2003). Mutations in any of the three subunits of human RNase
H2 are themolecular cause of a human genetic syndrome known
as Aicardi-Goutie`res syndrome (AGS) (Crow et al., 2006a). The
mechanism(s) involved in the pathogenesis of AGS is under
intense investigation but still uncertain (Crow et al., 2006b;
Yang et al., 2007; Stetson et al., 2008; Rice et al., 2009; Crow
and Rehwinkel, 2009).
Another enzyme that processes rNMPs in DNA is topoisomer-
ase I. It was recently reported that, in the absence of RNase H2,
rNTPs incorporated in DNA are targeted by topoisomerase I,
which cleaves but fails to rejoin the DNA backbone, generating
a ssDNA break (Sekiguchi and Shuman, 1997; Kim et al.,
2011). Interestingly, not all genomic rNMPs are topoisomerase
I targets (Kim et al., 2011), and cells lacking RNase H2 do
not exhibit growth defects, suggesting that cells must have
other pathways allowing them to replicate rNMP-containing
chromosomes.
In this work, we investigate the processes permitting yeast
cells to survive in the presence of elevated rNTPs incorporated
within genomic DNA. We show that both RNase H1 and RNase
H2 play a critical role in repairing rNMPs incorporated by
replicative polymerases, and in the absence of RNase H activity
residual genomic rNMPs cause replication problems in the
following cell cycle. When the replicative DNA polymerases
encounter rNMPs in the template strand, endogenous replica-
tion stress is generated, which sensitizes cells tomild treatments
with exogenous replication stress-inducing agents. In this
situation, postreplication repair mechanisms are effectively
responsible for the survival of RNase H defective cells. We
provide genetic and biochemical evidence that rNMPs-contain-
ing chromosomes can be fully replicated through the action of
template switch and DNA polymerase z, which efficiently
bypasses rNMPs in a DNA template.
Our data show unexpected mechanisms that preserve
genome integrity in normally replicating cells, extend the role of
PRR, and particularly that of Pol z, to the replication of rNMPs
in genomic DNA, and reveal a synthetic interaction between
PRR, RNase H activities, and replication stress that may have
relevant consequences for human disease, identifying a possible
family of modifier genes that may influence the penetrance of
a set of AGS mutations.
RESULTS
Unrepaired rNMPs Incorporated in Genomic DNA
during Replication Sensitize Cells to Replication
Stress-Inducing Agents
The preferential incorporation of dNTPs over that of rNTPs is at
least partially provided by a steric gate that prevents replicative
DNA polymerases from using rNTPs during the elongation step
(Joyce, 1997). Nonetheless, budding yeast DNA polymerase ε
has been demonstrated (Nick McElhinny et al., 2010b) to
incorporate large numbers of rNTPs into DNA. This effect is
exacerbated in a Pol ε variant, Pol2-M644G, where a methionine
adjacent to the steric gate residue (Y645) has been changed to
glycine (Nick McElhinny et al., 2010a). A pol2-M644G rnh201D
strain, where the mutation in Pol ε is combined with inactivation
of RNase H2, which has been implicated in processing of rNMPs
incorporated during DNA synthesis, exhibits slower progression
through S phase (NickMcElhinny et al., 2010a), coupled to phos-
phorylated Rad53 checkpoint kinase (Figure S1C), suggestive of
increased replication stress.
Low levels of replication stress-inducing agents (HU or MMS)
are known to be toxic for cells with replication problems. To test
whether the presence of rNMPs in the template strand affected
DNA replication, we plated pol2-M644G rnh201D cells on
medium containing low doses of HU or MMS, which in wild-
type cells onlymildly slowdowncell-cycle progression. Figure 1A
shows that a combination of the pol2-M644G and rnh201D
mutations, leading to accumulation of elevated levels of rNMPs
in genomic DNA, causes high sensitivity to low levels of HU
andMMS (see also Figure S5 for quantitative survival data). Inter-
estingly, loss of RNase H1 alone does not sensitize pol2-M644G
cells to HU or MMS (Figure 1A). These phenotypes can be ex-
plained by the fact that, even though the substrate specificity
of RNase H1 partially overlaps with that of RNase H2, and both
enzymes cleave DNA containing four or more consecutive
rNMPs, only RNase H2 cleaves at single rNMPs (Cerritelli and
Crouch, 2009). These observations suggest that the presence
of large amounts of single rNMPs within chromosomal DNA
generates endogenous replication stress. When both RNase
H1 and H2 enzymes are inactivated, virtually all single and
multiple rNMPs incorporated during DNA synthesis will persist
until the next round of replication. Strikingly, pol2-M644G
rnh201D is synthetic lethal with the absence of RNase H1 (Fig-
ure 1B), indicating that RNase H1 plays an important role in
repairing the rNTPs incorporated by Pol ε.
RNase H1 Cooperates with RNase H2 in the Removal
of rNMPs from the Chromosomes Preserving
Genome Integrity
The critical role of both RNase H enzymes is supported by the
fact that double mutant rnh1D rnh201D, rnh1D rnh202D, and
rnh1D rnh203D cells (RNH202 andRNH203 encode the two non-
catalytic subunits of RNase H2) are sensitive to low levels of
replication stress even in the presence of normal replicases (Fig-
ure 1C). Microscopic observation revealed that rnh1D rnh201D
cells form small and irregular microcolonies on plates containing
25 mM HU while wild-type cells generate a regular colony (Fig-
ure 1D). FACS analysis of synchronous cultures incubated with
low levels of HU or MMS shows that cells lacking RNase H arrest
in G2-M after the bulk of genome replication has been completed
(Figures 1E and S1A), and western blot analysis of Rad53 kinase
revealed that mutant cells accumulate hyperphosphorylated
Rad53 (Figures 1F and S1B). It is worth noting that cycling cells
of mutants that accumulate elevated rNMP levels in the genome
exhibit a constitutively phosphorylated Rad53, indicative of
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Figure 1. Abundant Incorporation of rNTPs into DNA Sensitizes Cells to Replication Stress and Is Lethal in Cells Lacking RNase H
(A) To test sensitivity to sublethal doses of HU or MMS, 10-fold serial dilutions of the indicated mutant strains were plated on YPD, YPD + 25 mM HU and YPD +
0.04% MMS. Pictures were taken after 3 days of incubation.
(B) Tetrads derived from a cross between rnh1D rnh201D and rnh1D pol2-M644G were dissected on YPD plates. Seven tetrads (1–7) are shown. The circles on
the figure indicate the position of the original rhn1D rnh201D pol2-M644G spores.
(C) Sensitivity to HU and MMS of the indicated strains was tested as described in (A). A checkpoint-defective mec1-1 strain was included as a positive control.
(D) Single cells were isolated on YPD plates and grown for 22 hr in the presence of 25 mM HU; colonies were visualized by microscopic analysis.
(E and F) wild-type and rnh1D rn201D cells were released in 25mMHU after a factor arrest. After 180min, cultures were analyzed by FACS, for DNA contents, and
cell extracts were tested by western blotting with anti-Rad53 antibodies.
(G) Wild-type and rnh1D rnh201D cells were plated on YPD with or without 25 mM HU in the presence of Phloxine B, which stains in red colonies containing
dead cells.
(H) Quantification of cell survival was obtained by plating G1 synchronized cells (100 cells per plate) on dishes containing 25 mM HU or mock. Colonies were
counted after 3 days of incubation. The graph is representative of three independent experiments. Error bars describe standard deviation.
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chronic replication stress (Figure S1C). These findings indicate
that low doses of HU lead rnh1D rnh201D cells to block at the
mitotic checkpoint and cause massive cell lethality, as sug-
gested by the rugged shape of the microcolonies (Figure 1D)
and further demonstrated by the fact that the small colonies
eventually growing on 25 mM HU contain a large proportion of
dead cells, which are stained by Phloxine B (Figure 1G). To esti-
mate the extent of such lethality, we plated wild-type and rnh1D
rnh201D cells in the absence or presence of 25 mM HU and
calculated the percent survival on HU. Three independent exper-
iments confirmed 40% lethality in cells lacking RNase H and
exposed to low doses of HU (Figure 1H). Quantitative survival
data for all the strains used throughout this study are shown in
Figure S5. To test whether Rad53 phosphorylation and loss of
cell viability derive from enzymatic processing of rNMP-contain-
ing DNA followed by chromosome breakage, we monitored
phosphorylation of histone H2A on S129, a marker of DNA
damage. Figure S1D shows that exposure of rnh1D rnh201D
cultures to 25 mM HU does not induce H2A phosphorylation,
suggesting that these cells do not accumulate double strand
breaks, even when challenged with HU.
The sensitivity to HU observed upon loss of RNase H is
unlikely to be due to the role of RNase H in Okazaki fragment
processing or to a possible involvement in R-loop metabolism.
Indeed, rad27 mutated cells, which accumulate unprocessed
Okazaki fragments (Ayyagari et al., 2003), are not sensitive to
replication stress (Figure S2A). Moreover, combining rnh1D
rnh201Dwith a mutation inHPR1 gene, which leads to the accu-
mulation of R-loops (Huertas and Aguilera, 2003), does not
increase sensitivity to 25 mM HU and actually seems to mildly
suppress the rnh1D rnh201D phenotype at this low dose, even
though the mechanism is not known (Figure S2B). These find-
ings strongly support the notion that RNase H activity is
important to keeping genomic DNA free from rNMPs incorpo-
rated by DNA polymerases during replication and that sensitivity
to replication stress-inducing drugs is a valid assay to track this
process.
Survival of Cells with rNMPs-Containing Chromosomes
Requires Translesion DNA Synthesis and Template
Switch PRR Pathways
The survival of cells lacking RNase H activities indicates that
yeast must have additional mechanisms to cope with the incor-
poration of rNTPs into the genome.
We investigated whether nucleotide excision repair (NER) or
base excision repair (BER) play a role in the removal of rNMPs
from the chromosomes. Abolishing NER (rad14D) or deleting
APN1, which is responsible for R97% of AP endonuclease
and 30-diesterase activities required for BER (Popoff et al.,
1990), does not sensitize rnh1D rhn201D cells to replication
stress-inducing agents (Figure 2A). This result is consistent
with data showing that rNMPs-containing DNA cannot be pro-
cessed by NER and BER nucleases (Rydberg and Game,
2002). The observation that deletion of APN2 in a rnh1D
rnh201D apn1D causes an increase in sensitivity to 25 mM HU
can be explained by the fact that simultaneous deletion of
APN1 and APN2 causes an accumulation of elevated levels of
endogenous lesions, increasing cellular stress (Leroy et al.,
2001). We cannot exclude, though, that a secondary BER
pathway may be able to process a minority of rNMPs.
Given that rNMPs in DNA templates impede DNA synthesis by
the yeast replicases Pols ε and d (Watt et al., 2011), lethality
may result from failure to complete DNA replication. We thus
investigated whether postreplication repair (PRR) mechanisms
may allow full genome replication in rnh1D rnh201D cells.
When DNA polymerases encounter replication-blocking lesions,
PCNA is monoubiquitylated by Rad6-Rad18 triggering transle-
sion DNA synthesis (TLS), while polyubiquitylation, carried out
by Mms2-Ubc13-Rad5, promotes template switch (Ulrich,
2011).
We checked by spot assay whether deleting either branch of
PRR would affect DNA replication in cells that do not remove
rNMPs from genomic DNA, and cell lethality was quantitated
as in Figure 1. Loss of only the template switch pathway
(mms2D) or only translesion DNA synthesis (TLSD: correspond-
ing to deletions of REV1, REV3, REV7, and RAD30 genes
encoding all TLS polymerases in budding yeast) does not
sensitize cells lacking RNase H to HU. On the other hand,
concomitant elimination of TLS and template switch results in
almost no growth of rnh1D rhn201D cells in 25 mM HU, due to
cell lethality (Figures 2B and 2C). These findings show that
when rnh1D rnh201D cells are subjected to a low level of replica-
tion stress, survival depends almost entirely on either PRR
pathway. This effect, although striking in the presence of HU,
can also be detected in unperturbed conditions (bottom line,
Figure 2B; see also Figures S3A and S3B). We conclude
that cells devoid of RNase H1 and H2 can use TLS and
template switch pathways to completely replicate their rNMPs-
containing genome. Consistently, deletion of RAD51, which is
required for a recombination-dependent PRR pathway (Ganga-
varapu et al., 2007), increases the sensitivity to HU of rnh1D
rnh201D cells, while loss of RAD52 is lethal in this genetic
background (Figures 2D and 2E). These phenotypes may be
influenced by defects in the additional processes that involve
homologous recombination.
DNA Polymerase z Is the TLS Polymerase Replicating
rNMPs-Containing DNA
To identify which translesion DNA polymerase allows the bypass
of rNMPs, we combined mutations in genes coding each of the
three yeast TLS polymerases, REV1, REV3/REV7 (the catalytic
and noncatalytic subunits of Pol z, respectively), and RAD30
(Pol h) in rnh1D rnh201D cells. The experiment was performed
in the absence of the MMS2-dependent template switch
pathway, so that rnh1D rnh201D cells rely only on TLS to
complete replication. The spot tests shown in Figure 3A reveal
that rnh1D rnh201D mms2D cells carrying a deletion of REV1
or direct inactivation of DNA polymerase z (rev3D rev7D) do
not survive HU treatment and are less viable even in untreated
conditions, recapitulating the total absence of TLS activities.
Deletion of RAD30 does not increase cell lethality under these
conditions; on the contrary, we reproducibly observed that
loss of Pol h confers an unexpected growth advantage when
genomic DNA contains unrepaired rNMPs (Figure 3A), consis-
tently with the phenotype observed in rnh1D rnh201D TLSD
(Figures 2B and 2C). This unpredicted observation may be
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justified envisioning a competition between noneffective pol h
and other PRR pathways.
Rev1 plays a noncatalytic role in supporting Pol z function
(Lawrence and Hinkle, 1996; Lawrence, 2002) and also has a de-
oxycytidyl transferase activity (Nelson et al., 1996) that could
insert a dCTP opposite a rNMP, allowing Pol z to extend. Fig-
ure 3B shows that, contrary to what was observed with rev1D,
inactivating the polymerase activity of Rev1 does not signifi-
cantly affect the HU sensitivity of rnh1D rnh201D mms2D. Alto-
gether, these data indicate that cells can use Pol z to replicate
rNMPs-containing templates in vivo and that Rev1 most likely
plays a noncatalytic role to promote Pol z activity.
To confirm biochemically that DNA polymerase z is capable of
bypassing rNMPs in DNA templates, we measured the rNMP
bypass efficiency of purified yeast Pol z in vitro. Labeled
substrates containing one, four, or sixteen consecutive rNMPs
(Figure 4A) were incubated with purified DNA polymerase z or
d, and bypass efficiency was calculated after quantifying the
Figure 2. Postreplication Repair Is Specifically Required to Tolerate rNMPs-Containing Chromosomes
Sensitivity to sublethal doses of HUwas assayed as described in Figure 1. Pictures were taken after 3 days of incubation. The contribution of NER (A), BER (A), the
two branches of PRR (B), and RAD51 (D) was tested. In (C), Quantification of cell survival was obtained as described in Figure 1H. The graph is representative of
three independent experiments. Error bars describe standard deviation. It is worth noting thatmms2D TLSD cells, despite being sensitive to HU in the spot tests,
do not exhibit increased cell lethality, suggesting that the HU sensitivity derives from a very slow cell-cycle progression. In (E), tetrads derived from a cross
between rnh1D rnh201D and rad52D were dissected on YPD plates. Five tetrads (1–5) are shown.The circles on the figure indicate the position of the original
rhn1D rnh201D rad52D spores. Cells derived from such microcolonies do not grow when restreaked, revealing that a rad52D mutation is synthetic lethal with
deletion of the RNH1 and RNH201 genes. TLSD comprises rev1D rev3D rev7D rad30D.
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primer extension products resulting from a single cycle of proc-
essive elongation (Figures 4B and 4D), as previously described
(Nick McElhinny et al., 2010b). Consistently with the genetic
observations (Figure 3A), the data indicate that Pol z bypasses
ribonucleotides incorporated in DNA, efficiently copying DNA
templates containing one (Figures 4B and 4D) or four rNMPs
(Figures 4C, right, and 4D). This is in contrast with Pol d which
is somewhat less efficient in copying templates containing rC
and much less efficient at copying templates containing rG, rA,
rU, or four consecutive rNMPs (Watt et al., 2011) (Figures 4C
and 4D). Pol d bypass of rA or four consecutive rNMPs was
stimulated several fold by adding PCNA to the reactions (see
asterisks in Figure 4D), but in neither case was bypass as effi-
cient as for Pol z.
We previously showed that, compared to RNase H2-profi-
cient cells, pol2-M644G rnh201D strains (Nick McElhinny
et al., 2010a) and rnh201D strains (Clark et al., 2011) have
elevated rates of 2–5 base pair deletions in repetitive sequences
and, recently, these deletions were shown to depend on topo-
isomerase 1 (Kim et al., 2011). This led to a model wherein topo-
isomerase 1 incises unrepaired rNMPs to create nicks in DNA
with 30-P and 50-O ends that must be processed to allow liga-
tion, and this processing may provide the opportunity for strand
misalignments in repetitive sequences that yield the observed
deletions. To determine if Pol z, which is relatively inaccurate
(Zhong et al., 2006), might also contribute to this deletion
mutagenesis, we measured the effect of deleting REV3 on
mutagenesis in the pol2-M644G rnh201D strain. Mutagenesis
rates were estimated by measuring frequencies of formation
of 5-FOA resistant clones, indicative of mutations leading to
uracil auxotrophy. The results (Figure 4E) reveal that deleting
REV3 does not significantly (at p = 0.05; see figure legend) affect
the overall rate of mutations to 5-FOA resistance, or the rates
for total 2–5 base pair deletions or deletions of CA from a previ-
ously observed CACA hotspot sequence in the URA3 gene. The
lack of an effect of rev3D on mutagenesis suggests that Pol z
does not contribute to topoisomerase 1-dependent mutagen-
esis resulting from unrepaired ribonucleotides incorporated
during replication by Pol2-M644G. When the rate of base
substitutions that might be explained by misincorporation of
dCTP by Rev1p was calculated, no significant difference was
observed between the pol2-M644G (from Pursell et al., 2007,
and unpublished data), pol2-644G rnh201D (from Nick McEl-
hinny et al., 2010a) and pol2-M644G rnh201D rev3D strains
(from Figures 3 and S6). This supports the notion that the
requirement for REV1 in rNMPs bypass is structural rather
dependent on its deoxycytidyltransferase activity.
RNase H-Defective Cells Exhibit Chronically Activated
PRR Pathways
The relevance of PRR in coping with rNMPs in chromosomal
DNA is evident by analyzing unperturbed mutant cells, which
lack RNase H activities. FACS analysis of cycling cells suggests
that rnh1D rnh201D cultures contain a higher fraction of S phase
cells, and further inactivation of PRR pathways leads to a very
sick phenotype (Figures 5A, S3A, and S3B). Indeed, these cells
exhibit G2-M arrest coupled to cell lethality, as seen by Phloxine
B staining of mutant colonies (Figure 5B).
Affinity-purified HIS-tagged PCNA from exponentially growing
rnh1D rnh201D cells revealed a striking increase in PCNA
ubiquitylation, compared to wild-type cells. Figure 5C shows
that both mono- and polyubiquitylated forms of PCNA are abun-
dant in cells that cannot remove rNMPs from genomic DNA.
Conversely, no significant effect is observed in PCNA sumoyla-
tion (Figure 5D). Accordingly, deletion of RAD18, coding for the
ubiquitin ligase responsible for conjugating ubiquitin to PCNA,
has a synthetic effect when combined with the loss of RNase
H: rnh1D rnh201D rad18D cells are exquisitely sensitive to
25 mM HU and exhibit cell lethality even in untreated conditions
(Figure S3C).
All these results indicate that cells lacking RNase H have
constitutively active PRR, which is crucial to tolerating the pres-
ence of rNMP-containing genomic DNA.
DISCUSSION
Yeast Cells Can Insert rNTPs into Genomic DNA
In eukaryotic cells the size of cellular dNTP pools is tightly
controlled, and altered dNTP levels are responsible for increased
mutagenesis and genome instability (Chabes and Stillman,
2007). Because the pools of rNTPs are much higher, DNA poly-
merases must be selective to correctly polymerize dNTPs during
genome replication. Recent evidence has shown that during
normal DNA replication in yeast, DNA polymerases incorporate
rNTPs into genomic DNA. The pol2-M644G mutation affecting
the steric gate of Pol ε increases rNTPs incorporation 10-fold
(Nick McElhinny et al., 2010b). Genomic DNA isolated from
rnh201D cells has a high number of alkali-sensitive sites, indi-
cating that RNase H2 is involved in removing rNMPs from DNA
(Nick McElhinny et al., 2010a).
Figure 3. Pol z Allows Cells to Cope with Unrepaired rNMPs
The sensitivity to HU was measured as described in Figure 1: the specific
contribution of each TLS polymerase (A) and the requirement of the catalytic
activity of Rev1 (B) were tested.
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Unrepaired rNMPs in genomic DNA will impact on cell-cycle
progression since, at the next round of DNA replication, replica-
tive polymerases must duplicate a RNA-containing DNA
template. It has been shown that replicative polymerases
cannot effectively replicate a template containing rNMPs (Nick
McElhinny et al., 2010a; Watt et al., 2011), and this situation
generates replication stress, detectable as a higher fraction of
cells in S phase (Nick McElhinny et al., 2010a and Figure S1C).
Combining a deletion inRNH201, coding for the catalytic subunit
of RNase H2, with a pol2-M644G mutation, we found that cells
became sensitive to low doses of replication stress inducing
agents (i.e., HU or MMS). These data suggest that the short
RNA tracts, which cannot be processed in the absence of RNase
H2, cause replication stress when the cell tries to replicate them.
Low levels of HU and MMS increase such stress leading to cell
lethality.
Since loss of RNase H2 activity from pol2-M644G mutated
cells does not cause cell lethality per se, additional pathways
repairing rNMPs-containing chromosomes must exist. In this
work we describe different mechanisms that are involved in
allowing cells to cope with the presence of rNMPs in their
genome.
RNase H1 Participates in the Removal from the Genome
of rNMPs Introduced during DNA Replication
RNase H1 has some overlapping substrates with RNase H2 and
is the preferential enzyme for processing RNA:DNA hybrids
where more than four rNMPs are present. Double mutant cells,
combining rnh1D with the deletion of any of the RNase H2
subunits, exhibit hypersensitivity to low levels of HU or MMS,
a cell-cycle delay in G2-M, and activation of the Rad53 check-
point kinase.
Strikingly, deletion of RNH1, the gene coding for RNase H1, is
synthetic lethal when combined with the pol2-M644G mutation
and RNase H2 inactivation (rnh201D), demonstrating that RNase
H1 also plays a crucial role in the repair of rNMPs incorporated
by replicative DNA polymerases. Our genetic analysis excludes
a contribution of NER in correcting rNMPs, while aminor involve-
ment of BER in repairing rNMP-containing chromosomes cannot
be completely ruled out.
The observation that cells lacking RNaseH activities are sensi-
tive to low doses of replication stress-inducing agents may have
consequences for cancer chemotherapy. In fact, many cancer
cells are characterized by elevated levels of endogenous replica-
tion stress (Negrini et al., 2010) and may be thus sensitized to
inhibitors of RNase H activity, which could selectively kill cells
experiencing replication stress.
Recently, topoisomerase 1 has been reported to be able to
process rNMPs-containing DNA and generate ssDNA breaks,
which can be easily converted to chromosome breaks. We
believe it unlikely that rnh1D rnh201D lethality in HU is due to
such chromosome fragmentation, since in our experiments the
rnh1D rnh201D double mutant and the wild-type strains exhibit
a similar level of phosphorylated histone H2A (Figure S1D), sug-
gesting the absence of double-strand breaks. Altogether, these
findings indicate that high levels of unrepaired rNMPs in the
chromosome hinder DNA synthesis blocking replication forks,
leading to replication stress.
Either One of the PRR Pathways Is Sufficient for
Tolerating rNTPs Incorporated by Replicative DNA
Polymerases, and DNA Polymerase z Is the Enzyme
Replicating rNMPs-Containing DNA
When replication-blocking lesions are present in the DNA
template, replication forks stall at the site of damage and cannot
proceed. Completion of replication is facilitated by PRR mecha-
nisms, namely error-prone translesion DNA synthesis (TLS)
and error-free template switch, a recombination-like pathway,
requiring, respectively, mono- and polyubiquitylation of PCNA.
Strikingly, exponentially growing rnh1D rnh201D cells exhibit
high levels of constitutive mono- and polyubiquitylated PCNA,
indicative of chronic PRR activation. Either TLS or template
switch can be used to complete replication over rNMPs. Indeed,
a strong synthetic effect is observed when both PRR pathways
are inactivated or when PCNA ubiquitylation is prevented in cells
lacking RNase H activities: these cells are exquisitely sensitive to
mild replication stress and are also extremely sick in untreated
conditions, indicating a novel role for PRR in tolerating RNA-
containing DNA templates (Figure 6).
How cells can replicate a chromosome containing rNMPs is
not known. Yeast cells contain three TLS polymerases, Pol h,
Pol z, and Rev1 (Friedberg et al., 1995). Our data show that, in
the absence of a functional template switch pathway, rNMPs-
containing DNA can only be replicated by the concerted
action of Rev1 and Pol z. The fact that a catalytic rev1 mutant
is capable of rescuing the phenotype imparted by a rev1Dmuta-
tion indicates that the role of Rev1 is likely to help Pol z to repli-
cate rNMPs containing templates. Indeed, untreated rnh1D
rnh201D cells lacking the template switch pathway and missing
Pol z form fewer and smaller colonies. A similar synthetic pheno-
type is observed in pol2-M644G mutant cells lacking PRR path-
ways (Figure S4). In conclusion, template switch and Pol z are
crucial to allow replication of endogenous, unrepaired rNMPs
(Figure 6), and mutations increasing the rNMPs load, such as
pol2-M644G, may saturate PRR pathways so that cell survival
relies on RNase H1 and RNase H2. The crucial role of Pol z for
replicating rNMP-containing chromosomes may be performed
either by adding a dNTP opposite the rNMP, or by elongating,
downstreamof the damaged site, a chain created by a replicative
polymerase. In vitro data confirm the genetic findings and
demonstrate that Pol z can efficiently insert a nucleotide oppo-
site the lesion, bypassing 1 or 4 rNMPs in the DNA template,
revealing a new cognate, endogenous substrate for this essen-
tial, specialized TLS polymerase.
Recombination-dependent PRR mechanisms are less under-
stood. Rad51 and Rad52 are involved in PRR (Gangavarapu
et al., 2007) and in other recombination events and, in general,
rad52D strains are more recombination defective than rad51D
cells. We found that deletion of RAD52 is synthetic lethal with
loss of RNase H1 and RNase H2, and rad51D has a synthetic
effect on HU sensitivity, supporting a role for recombination-
dependent PRR in tolerating chromosomal rNMPs. However,
defects in other recombination-dependent processes can
contribute to these effects: for example, restart of blocked repli-
cation forks can proceed through recombination mechanisms
(Heller and Marians, 2006; Petermann et al., 2010). Furthermore,
RNase H enzymes may have diverse cellular targets in addition
Molecular Cell
RNase H and PRR Protect from Chromosomal rNMPs
Molecular Cell 45, 99–110, January 13, 2012 ª2012 Elsevier Inc. 105
Published paper III
159
Figure 4. DNA Polymerase z Efficiently Bypasses rNMPs in the Template Strand
(A) Primer-template sequences. In the 65-mer substrate, ‘‘x’’ is the position of the single rNMP (rG, rC, rA, or rU) and ‘‘g’’ is the position of the 50-rG in the DNA
template. In the 45-mer substrate, the underlined lowercase nucleotides indicate the position and sequence of the rNMPs in 4- and 16-rNMP substrates,
respectively.
(B and C) Phosphorimages of products generated during bypass of a single rNMP (B) and tracts of rNMPs by Pol d and z (C). The template sequence is shown
on the left, the arrow depicts the location of full-length product, and ‘‘r’’ represents the position of the rNMPs in the template. No enzyme was added to the
unextended primer reaction (0 min).
Molecular Cell
RNase H and PRR Protect from Chromosomal rNMPs
106 Molecular Cell 45, 99–110, January 13, 2012 ª2012 Elsevier Inc.
Published paper III
160
to rNTPs incorporated in genomic DNA. Among these are
R-loops and Okazaki fragments; the accumulation of both these
structures can have lethal outcomes and is prevented by recom-
bination processes (Huertas and Aguilera, 2003; Ii and Brill,
2005).
Given the involvement of RNase H2 in the pathogenesis of
the Aicardi-Goutie`res syndrome, the data reported in this work
may help to understand the mechanisms underlying the disease.
The reported synthetic effects between RNase H mutations,
inducers of replication stress, and postreplication repair alter-
ations, may facilitate the identification of modifier genes, whose
alterations may be responsible for the phenotypic variability
observed in different AGS patients carrying identical RNase H2
mutations.
EXPERIMENTAL PROCEDURES
Yeast Strains
Strains are derivatives of W303, unless otherwise indicated in Table S1, and
were generated by standard genetic procedures (Adams et al., 1998).
YFL1449 and YFL1376 were obtained by crossing and backcrossing five times
pol2-M644G (Nick McElhinny et al., 2010a) or HISPCNA (Ulrich and Davies,
2009) with SY2080.
(D) Relative bypass efficiencies for Pols d and z. Images of reaction products shown in (B) and (C) were quantified, and relative bypass efficiencies were calculated
as described (Stone et al., 2009). The values for Pol dwith the 65-mer substrates in the absence of PCNA have been reported previously (Watt et al., 2011) and are
shown here for comparison. The asterisks indicate the relative bypass values for Pol d for reaction mixtures containing 200 nM PCNA.
(E) Mutation rates for the pol2-M644G rnh201D and pol2-M644G rnh201D rev3D strains. The total mutation rates for resistance to 5-FOA were determined as
described in Experimental Procedures. The 95% confidence intervals for the pol2-M644G rnh201D and pol2-M644G rnh201D rev3D strains were 110 to 200 and
57 to 140, respectively. For the pol2-M644G rnh201D strain, the rates for total 2–5 base pair deletions and for CA deletions at position 216–219 in URA3 are from
Clark et al. (2011). For the pol2-M644G rnh201D rev3D strain, rates for short deletions were calculated after sequencing the ura3 gene in 163 independent 5-FOA
resistant clones. Of these, 136 harbored 2–5 base pair deletions, 88 of which were CA deletions at the CACA hotspot at position 216–219 inURA3 (see spectrum
in Figure S6).
Figure 5. In the Absence of RNase H, the PRR Pathway Is Constitutively Activated and Promotes Cell Survival in an Unperturbed Cell Cycle
The role of PRRwas assessed in unperturbed rnh1D rnh201D cultures. Exponentially growing cells lacking RNase H and defective in PRRwere analyzed by FACS
(A), to monitor cell cycle distribution, and by Phloxine B staining (B), to evaluate cell lethality. PCNA was affinity purified from exponentially growing unperturbed
wild-type cells or from cells lacking RNase H activity. PCNA levels were estimated by western blotting with anti-HIS Ab. PCNA ubiquitylation was monitored by
western blotting with anti-ubiquitin Ab (C), and PCNA sumoylation was monitored by western blotting with anti-SUMO Ab (D).
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FACS Analysis
Cells were fixed in 70% ethanol and treated with RNase A and proteinase K.
DNA was stained with Sytox Green and cell-cycle distribution was estimated
by cytofluorimetric analysis with a FACScan.
SDS-PAGE and Western Blotting
To monitor protein levels and phosphorylation, TCA protein extracts were
prepared and analyzed by SDS-PAGE (Sabbioneda et al., 2007); western blots
were performed with anti-Rad53, anti-H2A, and anti-gH2AX antibodies.
To study PCNA posttranslational modifications, HIS-tagged PCNA was
pulled down from denaturing extracts as described (Ulrich and Davies,
2009), separated on 10% SDS-Urea-PAGE, and transferred to nitrocellulose
membranes. PCNA ubiquitylation and sumoylation were analyzed by western
blotting with anti-ubiquitin and anti-SUMO antibodies.
Sensitivity Assay
To assess cell survival in HU andMMS, overnight yeast cultures were diluted to
1 3 106 cfu/ml, and 10-fold serial dilutions were spotted on plates containing
HU or MMS at the indicated concentrations. Images were captured after
3 days’ incubation at 28C. To obtain quantitative data, exponentially growing
cells were arrested in G1 with 6 mg/ml a-factor. Cultures were diluted and
100 cfu were distributed on each of three independent YPD plates (mock or
25 mM HU). After 3 days’ incubation colonies were counted. The experiments
were repeated three times. The graphs show the percentage of surviving cells
with respect to the mock sample. Standard deviations were used to obtain
error bars.
Cell Lethality Assay
Overnight yeast cultures were diluted as above, and 100 cfu were plated on
YPD containing 20 mg/l Phloxine B, with or without 25 mM HU. Images were
captured after 3 days’ incubation at 28C.
Microcolony Assays
Yeast cells were grown to a concentration of 5 3 106 cells/ml and arrested
in G1 with a-factor (6 mg/ml). Diluted samples were spread on YPD plates
containing 25 mM HU, and single cells were separated using a micromanip-
ulator. Plates were then incubated at 28C and photographs were taken
after 22 hr; thirty individual cells were followed for each experiment. The
experiment was repeated four times, and a representative example is
shown.
Figure 6. RNase H and Postreplication Repair Protect Cells from rNMPs Incorporated in Chromosomal DNA
During DNA synthesis, replicative polymerases can incorporate rNTPs (red dot) in place of dNTPs (A). RNase H1 and RNase H2 are required to remove rNMPs
from newly replicated DNA (blue line) (B). If rNMPs persist until the following cell cycle, they will create problems at during the DNA synthesis step (C), since
replicative polymerases cannot efficiently elongate the nascent strand opposite rNMPs in the template strand (black line). Replication fork restart downstream of
the lesions leaves incomplete replication products for postreplication repair (D). PCNA is ubiquitylated. Either MMS2-dependent template switchmechanisms (E)
or Pol z-dependent translesion synthesis (F) allow bypass of rNMPs and completion of replication (G). Under these conditions, inactivation of PRR causes cell
lethality (H).
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Cell-Cycle Analysis
Yeast cultures were grown to a concentration of 53 106 cells/ml and arrested
in G1 with a-factor (6 mg/ml). Cells were released in YPD supplemented with
25 mM HU or 0.04% MMS or mock. Ninety minutes after, the release a-factor
(6 mg/ml) was added back to the culture to avoid re-entry in S phase, allowing
the analysis of a complete single cell cycle. Samples were collected for SDS-
PAGE and FACS analysis and processed as described above. Growth curves
were obtained by measuring cell concentration microscopically and normal-
izing each read to the initial concentration. Generation time was calculated
by interpolating the growth curves.
rNMP Bypass, Mutation Rates, and Spectra
S.cerevisiae two-subunit wild-type Pol z (Rev3 –Rev7) and three-subunit Pol
d were expressed in yeast and purified as previously described (Burgers and
Gerik, 1998; Garg et al., 2005). Oligonucleotide primer templates were
prepared as described (Nick McElhinny et al., 2010b). The polymerase was
added to initiate the reaction and aliquots were removed at 2, 4, 6, and
20 min. The DNA products were separated by electrophoresis through
an 8% denaturing polyacrylamide gel containing 25% formamide for the
65-mer and 12% denaturing polyacrylamide gel for the 45-mer substrates. A
PhosphorImager was used to visualize and quantify the DNA products. The
efficiency of insertion opposite individual template positions and the bypass
probability were calculated as previously described (Kokoska et al., 2003;
Stone et al., 2009; Watt et al., 2011). Mutation rates and spectra were deter-
mined as described (Nick McElhinny et al., 2010a); in the relevant strains,
theURA3 reporter was inserted at theAGP1 locus in orientation 2 as previously
described (Nick McElhinny et al., 2010a).
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 Figure S1, Related to Figure 1. Lack of RNase H Causes Replication 
Stress and a G2-M Delay 
(A) Exponentially growing yeast cultures were arrested in G1 phase with α-
factor. Cells were released in the presence of 25 mM HU, 0.04% MMS or 
fresh medium, and cell cycle progression was analyzed by FACS. The figure 
shows the number of cells in relation to the DNA content.  
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(B–D) The same cultures were used to verify checkpoint activation at the 
indicated time-points after the release. Total cell extracts were analyzed by 
western blotting to monitor Rad53, H2A and H2A phosphorylation, using 
specific antibodies.  
 
 
 
Figure S2, Related to Figure 1. Sensitivity to Replication Stress in RNase 
H Mutant Cells Is Unlinked from Defective Okazaki Fragments or R-
Loops Processing  
To verify the effect of mutants defective in processing of Okazaki fragments 
(A) or R-loops (B) on HU sensitivity, ten-fold serial dilutions of yeast overnight 
cultures were spotted on YPD plates containing a sublethal HU dose or mock. 
Ability to grow was analyzed after 3 days incubation.  
Published paper III
167
  
Figure S3, Related to Figure 5. PRR Pathways Play a Crucial Role in the 
Survival of RNase H-Defective Cells  
(A) Growth curves and duplication times (TD) for exponentially growing cells of 
the indicated strains were obtained by measuring cell concentrations at 
different time-points.  
(B) The shape and size of wt and mutant cells form exponentially growing 
cultures were visualized by microscopic analysis. The white bar represents 
5µm.  
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(C) To test the effect on HU sensitivity of a mutation eliminating Rad18, the 
enzyme responsible for conjugation of ubiquitin to PCNA, ten-fold serial 
dilutions of yeast overnight cultures were spotted on YPD plates containing a 
sublethal HU dose or mock. Ability to grow was analyzed after 3 days 
incubation. 
 
 
 
 
 
Figure S4, Related to Figure 5. PRR Is Crucial for Cells that Accumulate 
rNMP in Their Chromosomes 
To verify the effect of PRR dysfunction in strains where a mutated DNA 
polymerase ε incorporates elevated levels of rNMPs in genomic DNA, ten-fold 
serial dilutions of yeast overnight cultures were spotted on YPD plates 
containing a sublethal HU dose or mock. Ability to grow was analyzed after 3 
days incubation.  
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Figure S5, Related to Figures 1–3. Quantitative Survival Assays 
To obtain quantitative data on survival upon treatment with 25 mM HU of the 
yeast strains used throughout this work, survival assays were performed as 
described in the legend to Figure 1H. 
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Figure S6, Related to Figure 4. Mutational Spectrum in pol2-M644G 
rnh201∆ rev3∆ Strain   
The coding strand of the 804-base-pair URA3 open reading frame is shown. 
The sequence changes observed in independent 5-FOA resistant mutants are 
depicted in blue below coding sequence, for URA3 in orientation 2 as 
described in (Nick McElhinny, 2010a].  Letters indicate single-base 
substitutions, closed triangles indicate single-base additions, open triangles 
indicate single-base deletions and short lines below the coding sequence 
indicate 2–5-base deletions.  Solid boxes enclose perfect direct repeat 
sequences, and dashed boxes enclose imperfect direct repeat sequences.  
Among 163 total mutants sequenced, a few contained other sequences 
changes not depicted here.
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Table S1. Strains Used in This Study 
 
Strain 
name 
Genotype 
Source/ 
Reference 
SY2080 MATa ade2-1 trp1-1 leu2-3,112 his3-11,15 ura3-1 can1-100 RAD5 M. Foiani 
YFL1208 (SY2080) rnh1::HIS3 This study 
YFL1191 (SY2080) rnh201::KanMX6 This study 
YFL1193 (SY2080) rnh202::KanMX6 This study 
YFL1196 (SY2080) rnh203::KanMX6 This study 
YFL1213 (SY2080) rnh1::HIS3 rnh201::KanMX6 This study 
YFL1216 (SY2080) rnh1::HIS3 rnh202::KanMX6 This study 
YFL1218 (SY2080) rnh1::HIS3 rnh203::KanMX6 This study 
YMIC5A3 
MATa ade2-1 trp1-1 leu2-3,112 his3-11,15 ura3-1 can1-100 rad5-535 
mec1-1 sml1 
Sabbioneda, 2007 
YFL1449 (SY2080) pol2M644G This study 
YFL1474 (SY2080) pol2M644G rnh201::KanMX6 This study 
YMG1146 (SY2080) mms2::HPH This study 
YMG1082 (SY2080) rad30::KanMX6 rev1::KanMX6 rev3::TRP1 rev7::HIS3 Giannattasio, 2010 
YMG1149 
(SY2080) rad30::KanMX6 rev1::KanMX6 rev3::TRP1 rev7::HIS3 
mms2::HPH 
This study 
YFL1265 (SY2080) rnh1::HIS3 rnh201::KanMX6 mms2::HPH This study 
YFL1271 
(SY2080) rad30::KanMX6 rev1::KanMX6 rev3::TRP1 rev7::HIS3 
rnh1::HIS3 rnh201::KanMX6 
This study 
YFL1294 
(SY2080) rad30::KanMX6 rev1::KanMX6 rev3::TRP1 rev7::HIS3 
rnh1::HIS3 rnh201::KanMX6 mms2::HPH 
This study 
YFL1331 (SY2080) rev1::KanMX6 rnh1::HIS3 rnh201::KanMX6 mms2::HPH This study 
YFL1330 
(SY2080) rev3::TRP1 rev7::HIS3 rnh1::HIS3 rnh201::KanMX6 
mms2::HPH 
This study 
YFL1341 (SY2080) rad30::KanMX6 rnh1::HIS3 rnh201::KanMX6 mms2::HPH This study 
YFL1574 
(SY2080) rev1::KanMX6 rnh1::HIS3 rnh201::KanMX6 mms2::HPH 
ura3:REV1:URA3 
This study 
YFL1575 
(SY2080) rev1::KanMX6 rnh1::HIS3 rnh201::KanMX6 mms2::HPH  
ura3:rev1-D467A-D468A:URA3 
This study 
YFL1376 (SY2080) leu2::
6xHIS
POL30:LEU2  This study 
YFL1377 (SY2080) leu2::
6xHIS
POL30:LEU2 rnh1::HIS3 rnh201::KanMX6 This study 
YMG649 (SY2080) rad27::KanMX6 This study 
YNOV59 (SY2080) hpr1::HIS3 This study 
YNOV61 (SY2080) rnh1::HIS3 rnh201::KanMX6 hpr1::HIS3 This study 
YFL1671 (SY2080) rnh201::KanMX6 mms2::HPH rev3::TRP1 This study 
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YFL1687 (SY2080) rnh201::KanMX6 mms2::HPH rev3::TRP1 pol2-M644G This study 
YFL1580 (SY2080) rad18::KanMX6 This study 
YFL1629 (SY2080) rad18::KanMX6 rnh1::HIS3 rnh201::KanMX6 This study 
(∆|(-2) |-7B-
YUNI300) 
MATa CAN1 his7-2 leu2::kanMX ura3-∆ trp1-289 ade2-1 
lys2-∆GG2899-2900 
Nick McElhinny, 2010a 
SNM77 (∆|(-2) |-7B-YUNI300) URA3-OR2 pol2-M644G Nick McElhinny, 2010a 
SNM127 (∆|(-2) |-7B-YUNI300) URA3-OR2 pol2-M644G rnh201::HPH Nick McElhinny, 2010a 
JES184 
(∆|(-2) |-7B-YUNI300) URA3-OR2 pol2-M644G rnh201::HPH  
rev3::LEU2 
This study 
YFL1541 (SY2080) rad14::NATr This study 
YFL1545 (SY2080) rad14::NATr rnh1::HIS3 rnh201::KanMX6 This study 
YFL1511 (SY2080) apn1::HPH This study 
YFL1537 (SY2080) apn1::HPH apn2::TRP1 This study 
YFL1531 (SY2080) apn1::HPH apn2::TRP1 rnh1::HIS3 rnh201::KanMX6 This study 
YNOV162 (SY2080) rad51::HPH This study 
YFL1451 (SY2080) pol2-M644G rnh1::HIS3 This study 
YFL1677 (SY2080) rad51::HPH rnh1::HIS3 rnh201::KanMX6 This study 
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Abstract
A better understanding of the mechanisms through which eukaryotic cells
maintain the integrity of the genome is of capital importance, since failure
of these mechanisms leads to genome instability, which is known to be a
driving force in tumorigenesis. We took advantage of the Synthetic Genetic
Array (SGA) technology to develop a new approach aimed at identifying
genome stability genes in Saccharomyces cerevisiae: the screening is based
on the sensitivity to overexpression of DDC2 – a DNA damage checkpoint
gene – as a readout for the genome instability phenotype in the deletion
mutant collection. Among the genes not previously implicated in genome
integrity maintenance, we identified the transcription factor VID22. We
show that vid22 mutants exhibit both spontaneous genome instability and
increased sensitivity to genotoxic agents. The observation that Vid22-
deficient cells have a defect in G1/S transition, accompanied and likely
caused by decreased expression of G1 cyclin and replication genes, suggests
that the various phenotypes observed in vid22 mutants may arise from
deregulation of DNA replication in the absence of the Vid22 transcription
factor. Taken together, our findings described VID22 as a new player in
preserving genome integrity.
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Introduction
DNA molecules are characterized by intrinsic instability [1] and are also
subjected to the action of a series of endogenous and exogenous genotoxic
agents [2]. Given the importance of faithfully duplicating and transferring
the genetic material at each cell division, eukaryotic cells possess a num-
ber of evolutionary conserved mechanisms which preserve genome integrity
by handling problems or errors arising during DNA replication, repairing
DNA lesions, monitoring chromosome segregation and ensuring proper co-
ordination of all these processes with cell cycle progression [3, 4, 5]. If
any of these DNA integrity pathways fail, cells undergo a condition known
as “genomic instability”, characterized by the presence of many genetic
alterations, ranging from point mutations, insertions/deletions of a few
nucleotides, or expansion/contraction of repeated sequences, to gross chro-
mosomal rearrangements and aneuploidy [6]. In recent years, compelling
experimental evidence indicates that genomic instability acts as a driv-
ing force during tumorigenesis [7, 8, 9]. Therefore, the knowledge of the
mechanisms preserving genome integrity is of basic importance to better
understand the carcinogenic process.
Despite the increasing amount of data obtained in the field of genome
stability maintenance, the picture is still far from being complete. To
identify new genes involved in the maintenance of genome integrity, we
developed a screen based on the overproduction of the Ddc2 checkpoint
protein, which sensitizes yeast cells to spontaneous or induced DNA dam-
age. Ddc2 (ATRIP in human) is a binding partner and regulator of the
apical DNA damage checkpoint kinase Mec1 (human ATR) [10, 11, 12]. In
response to DNA damage, Ddc2 binds to RPA-covered ssDNA and recruits
Mec1 to the lesion, thus enabling its activation [13]. Furthermore, Ddc2
mediates the interaction between Mec1 and its activating protein Dpb11
[14]. It was shown that yeast cells overexpressing DDC2 are very sensi-
tive to DNA damage, as a consequence of checkpoint hyperactivation and
permanent cell cycle arrest [15]. Therefore, mutant strains with increased
genomic instability are expected to be sensitive to high levels of Ddc2, due
to elevated levels of endogenous DNA damage.
Among the recently developed genetic technologies that can be used in
the Saccharomyces cerevisiae model system, one of the most informative in
terms of unraveling the biological function of a given gene is the Synthetic
Genetic Array (SGA). This automated approach allows to uncover genetic
interactions on a genome-wide scale by individually combining a given mu-
tation with the deletions of all non-essential yeast genes [16]. We adapted
the SGA technology to systematically overexpress the DDC2 gene under a
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galactose-inducible promoter in the collection of yeast viable deletion mu-
tants, screening for strains whose growth is impaired in these conditions.
This approach allowed the identification of deletion mutants experienc-
ing genome instability on the basis of accumulation of spontaneous DNA
damage. We found many genes involved in peroxisome dynamics, mito-
chondrial metabolism, chromatin remodeling and protein sorting, as well
as genes implicated in DNA damage or oxidative stress response, cell cy-
cle progression, control of transcription, ribosome biogenesis, regulation of
proteasome assembly and functioning, cytoskeleton organization cell wall
integrity and aminoacid biosynthesis, together with previously uncharac-
terized genes. In particular we indentified VID22, and explored its role in
genome integrity maintenance: a vid22 mutant exhibits genome instability
phenotypes and sensitivity to DNA-damaging agents. Moreover, it has a
defect in G1/S transition and in S-phase progression. We demonstrated
that Vid22 regulates expression of the G1 cyclin genes, as well as of some
key replication genes. It is possible that decreased cyclin levels in a vid22
mutant may alter CDK1 activity and/or specificity, leading to defects in
S-phase initiation and progression. We propose that altered CDK1 regula-
tion, possibly connected to reduced pre-RC and pre-IC formation are the
key factors explaining the genome instability occurring in the absence of
Vid22.
Our work identified numerous genes and pathways responsible for main-
taining genome stability and characterized a previously unknown contri-
bution of VID22 in preserving the integrity of the genome. These results
and further characterization of the roles of the identified genes may shed
new light on the events leading to genome instability, thus contributing to
a better knowledge of the carcinogenic process.
Results
A genome-wide screen to identify new genes affecting genome sta-
bility. S. cerevisiae Ddc2 is the binding partner and activator of the DNA
damage checkpoint apical kinase Mec1 (homolog of human ATR) [10]. It
was shown that DDC2 overexpression, despite having no detectable effect
on unperturbed cells, causes hyperactivation of the checkpoint response
after DNA damage, resulting in prolonged cell cycle arrest and cell death
[15]. After verifying (Fig. S1-A) that DDC2 overexpression increases sen-
sitivity to low doses of DNA damaging agents, we speculated that it might
also sensitize yeast cells to endogenous DNA damage. We confirmed this
observation by testing the viability in conditions of DDC2 overexpression
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of some yeast strains deleted for genes coding for well known players in
genome integrity maintenance, such as RAD18 [17], RAD27 [18], MRE11
[18] and SLX8 [19]. These mutated strains accumulate spontaneous DNA
damage and, as expected, their growth is severely compromised by high
levels of Ddc2 (Fig. S1-B,C).
This observation urged us to develop a new screen to identify genes
and pathways involved in genome integrity maintenance, based on the
sensitivity to DDC2 overexpression. By exploiting the Synthetic Genetic
Array (SGA) automated approach [16], we overexpressed DDC2 under a
galactose-inducible promoter on a multicopy plasmid in the yeast haploid
deletion collection and scored for those mutants whose fitness was reduced
on galactose medium compared to the control experiment with the empty
vector (Fig. 1A). We chose a multicopy plasmid instead of a centromeric
plasmid to produce higher levels of Ddc2, thus increasing the sensitivity
of the screen in strains with moderate levels of DNA damage (compare for
instance the behavior of rad18D strain in figures S1-B and S1-C).
We found about 300 genes involved in different cellular pathways, namely
DNA damage response, oxidative stress response, cell cycle progression,
chromatin remodeling, regulation of transcription, mitochondria and per-
oxisomes metabolism, protein sorting, autophagy, proteasome function, ri-
bosome biogenesis, aminoacid biosynthesis, meiosis, cytoskeleton, cell wall
integrity (Fig. 1B). Importantly, about 20% of the ORFs identified are
still uncharacterized. Unespectedly, our screen also identified some strains
which show increased fitness after Ddc2 overexpression, but this class of
genes needs further investigation.
Vid22 is important for maintenance of genome stability. Among
the genes identified, our attention was captured by VID22, a gene that,
despite its identification in another genome instability screen [20], was
never characterized as a genome integrity gene. First, we confirmed by
spot test that a vid22 mutant is sensitive to DDC2 overexpression (Fig.
1C). We then decided to examine Vid22 localization, since conflicting data
have been reported in literature: in fact, Brown et al. described Vid22
as a plasma membrane protein [21], while Huh et al. localized Vid22 in
the nucleus [22], a finding which is more compatible with a role in genome
stability control. We assessed by immunofluorescence the localization of an
HA-tagged version of Vid22 in exponentially growing cells, and we observed
a clear colocalization of anti-HA antibody signal with DAPI (Fig. S2):
therefore, in agreement with Huh et al. [22], Vid22 is a nuclear protein.
Next we scored for phenotypes directly linked to genome instability.
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On the basis of previous observations in strains experiencing spontaneous
DNA damage [23, 24, 19], we expected that the DNA damage checkpoint
should be to a certain extent active in a vid22 mutant, even in the absence
of any genotoxic insult. We thus examined by western blot the phospho-
rylation state of the Rad53 checkpoint effector kinase (homolog of human
Chk2), which is a marker of checkpoint activation, in an unperturbed cell
cycle in wild-type and vid22D strains (Fig 2A). In a wt yeast strain par-
tial Rad53 phosphorylation is observed 60’ after release from the a-factor
block, which is likely the consequence of few cells in the population expe-
riencing some problems during DNA replication. Conversely, in a vid22D
strain, Rad53 is partially phosphorylated during the whole cell cycle (for
analysis of S-phase progression by flow cytometry see Fig. 4A). It is worth
noting, however, that this phosphorylation is clearly distinguishable from
full Rad53 phosphorylation observed when checkpoint cascade is fully acti-
vated as a consequence of genotoxic treatment (compare the western blots
in figures 2A and S4). We interpret this finding by assuming that the
checkpoint response is chronically alerted in a vid22 mutant because these
cells undergo continuous endogenous DNA damage as a consequence of
some kind of genome instability. Consistently, in the vid22D strain we
also observed increased levels of phosphorylated histone H2A (gH2A) es-
pecially at 60’ and 90’ time-points after release from the G1 block, which
persist to a lesser extent throughout the cell cycle (Fig 2A). Mec1- and
Tel1- dependent phosphorylation of H2A is one of the first events occur-
ring in response to different types of DNA damage, and this modification
has a key role in DNA damage repair and full activation of the checkpoint
cascade [25, 26, 27, 28]. Intrestingly, these elevated gH2A levels are most
evident at time-points corresponding to the end of S-phase, suggesting that
in the absence of VID22 yeast cells may encounter some problems during
DNA replication.
To examine more directly the VID22 role in preserving genome in-
tegrity, we performed some classical genome instability assays. First, we
examined forward mutation rates at the CAN1 locus and found that vid22
cells have a modest, but statistically significant, increase in spontaneous
mutation rate (∼1.5 fold higher than the wt, Fig. 2B). Next, we assessed
genome stability at the rDNA locus, which is one of the most fragile re-
gions of the genome [29]. We tested the recombination rates by measuring
spontaneous loss of the ADE2 marker integrated into the rDNA array: in-
deed, we observed a ∼3 fold higher rate in the vid22 mutant compared to
the wt (Fig. 2C). Altogether these data strongly support the notion that
VID22 is involved in genome integrity maintenance.
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Genetic interactions and DNA damage sensitivity of a vid22D
mutant. In the attempt to gain further insights in the role of VID22 in
genome integrity, we decided to take advantage of the data available on
the genetic interactions in S. cerevisiae ([30] and Charlie Boone unpub-
lished data). Through a GO-enrichment analysis – which identifies the
biological characteristics (Gene Ontology terms) over-represented in a par-
ticular subset of genes, compared to what would be expected by chance
[31, 32] – we found that VID22 negatively interacts with many genes in-
volved in recombination / resolution of replication intermediates, as well
as chromatin remodeling, cell cycle checkpoint, cytoskeleton organization,
mitochondrial maintenance and distribution, and Golgi vesicle transport
(Fig. S3-A). Among the positive interactors we observed an enrichment
for chromatin remodeling factors mainly involved in chromatin silencing,
the RNA splicing machinery, genes responsible for the formation of RNA
polymerase II transcriptional preinitiation complex, DNA repair genes,
and some protein complexes, namely cohesins, septing ring components
and protein phosphatase type 2A (PP2A) complex members (Fig. S3-B).
We also tested the viability of a vid22D strain in response to a variety of
genotoxic agents. Interestingly, this strain is sensitive to the double-strand
breaks (DSBs) inducing agent Bleomicin, to chemicals perturbing replica-
tion fork progression, such as the DNA alkylating agent methyl metane-
sulphonate (MMS) and the ribonucleotide reductase (RNR) inhibitor hy-
droxyurea (HU), and to hydrogen peroxide (H2O2) which is a source of
oxidative stress (Fig. 3). Strikingly, the same mutant is not sensitive to
UV damage up to a dose of 90 J/m2 nor to the anticancer agent camp-
tothecin (CPT) which triggers the formation of genotoxic topoisomerase-
DNA adducts.
In order to rule out the possibility that the DNA damage sensitivity
observed in the absence of VID22 is due to defective checkpoint activation,
we monitored Rad53 phosphorylation after the genotoxic treatments listed
above. vid22D mutant cells exhibit normal checkpoint activation after
Bleomicin (Fig. S5-A,B), HU (Fig. S5-C) or MMS (Fig. S5-D) treatments.
We also examined the switch-off of the checkpoint response after release
from HU: no difference was found in a vid22D mutant compared to wt
(Fig. S5-E). Altogether, these observations indicate that vid22D cells are
sensitive only to certain types of genotoxic insults.
Vid22 is involved in the control of G1/S transition. Among the
mechanisms preserving genome integrity, those ensuring proper cell cycle
progression, and especially timely and correct DNA replication, are partic-
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ularly important [33, 6]. After the observation that spontaneous checkpoint
activation in the absence of VID22 is especially evident in S-phase (Fig
2A), we decided to monitor cell cycle progression of the vid22D strain by
flow cytometry upon release from an a-factor block (Fig. 4A). Intrigu-
ingly, while wt cells enter and progress through S-phase synchronously, a
certain fraction of vid22D cells, corresponding to ∼15% of the total popu-
lation, fail to enter S-phase, as shown by a peak corresponding to 1C DNA
content which persists until the rest of the cell population exits form mi-
tosis and starts a new cell cycle. This G1-arrested subpopulation is made
up of unbudded cells (data not shown). Note that this phenotype is not
due to a defective recovery from the a-factor block, because the same 1C
peak persists when exponentially growing cells are treated for 3 hours with
the microtubule-depolimerizing agent nocodazole, which arrests cells in M
phase (Fig. 4B). Moreover, a slight defect in S-phase progression is visible
at 30 to 40 min after release from a-factor in the vid22D strain (Fig. 4A).
These observations are indicative of possible defects in initiating and/or in
carrying on DNA replication.
VID22 has been described as a promoter-binding protein, and a bona
fide transcription factor [34]. To test this hypothesis and identify puta-
tive genes whose expression may be regulated by VID22, we performed an
RNA-Seq analysis in wt and vid22D cells. Notably, among the downregu-
lated genes found in the vid22D mutant we found many cyclins involved in
the control of cell cycle progression, namely CLN1, CLN2, CLB1, CLB6,
PCL1, PCL5, as well as the essential replication genes CDC6 and CDC45
(Fig. 4C). This findings support the hypothesis that a vid22D strain is de-
fective in G1/S transition and replication initiation. This scenario, beside
explaining the cell cycle defects observed in the vid22D mutant, also pro-
vides a possible mechanism for the genomic instability phenotype observed
in the absence of VID22 (see Discussion).
Discussion
Genomic instability is a hallmark of cancer [7, 9] and it has been proposed
as a key driving force in tumorigenesis [8, 35]. Taking advantage of the high
conservation of the DNA integrity pathways, multiple screens were per-
formed in S. cerevisiae which allowed the identification of key genes in the
integrity pathways [36, 37, 38, 17, 39, 40, 41, 20, 42, 43, 44, 45, 46, 47]. How-
ever, likely due to the different approaches used, the results of these screens
are only partially overlapping, and each study provides a different perspec-
tive of the genome stability network. Here we used a modified version of
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the SGA technology [16] to screen the S. cerevisiae deletion collection for
genes implicated in genome integrity maintenance, on the basis of chronic
accumulation of spontaneous DNA damage. This approach was based on
the sensitivity of cells to high levels of Ddc2, which by hyperactivating the
DNA damage checkpoint in strains experiencing endogenous DNA damage,
results in impaired growth ([15] and Fig. S1). It is worth noting that, differ-
ently from previous studies [36, 37, 38, 17, 39, 41, 20, 42, 43, 44, 45, 46, 47],
we exploited the sensitivity to Ddc2 overexpression as a readout for spon-
taneous accumulation of any kind of DNA lesion capable to activate the
DNA damage checkpoint, thus broadening the range of genomic instability
marks taken into consideration in a single screen.
Multiple pathways contribute to maintenance of genome stabil-
ity. In our screen we identified genes involved in several cellular processes
(Fig. 1B), consistent with multiple mechanisms impacting on genome sta-
bility. Beside some already known DNA damage response genes, we found
many genes involved in protecting cells from oxidative stress, in regulat-
ing peroxisome biogenesis, number and function, and implicated in mito-
chondrial metabolism. Given that mitochondria and peroxisomes are key
players in reactive oxigen species (ROS) metabolism [48, 49], the gene cat-
egory “safeguarding against oxidative stress” accounts for about 15% of
the total identified genes. This finding supports the notion that endoge-
nous accumulation of oxidative damage is a serious challenge to genome
integrity [50, 38, 51]. Interestingly, previous screens for genes impacting
on genome stability identified only few genes related to oxidative stress
[36, 37, 38, 17, 39, 40, 41, 20, 42, 43, 44, 45, 46, 47], likely because of the
different experimental approach we used in the screening.
Other representative genes identified in the screen belong to the fol-
lowing pathways: chromatin remodeling, modulation of transcription, cell
cycle control, regulation of cytoskeleton dynamics, proteasome assembly
and function and autophagy. Most of these pathways have been previously
implicated in genome integrity maintenance. Other pathways were more
unexpected, such as protein sorting (mainly vesicular trafficking to vacuole
or Golgi), ribosome biogenesis, aminoacid biosynthesis or cell wall integrity
and composition. As predicted, none of the genes directly implicated in
DNA damage checkpoint activation were identified in our analysis: in fact,
mutations in these genes are expected to be insensitive to DDC2 overex-
pression, despite accumulation of DNA damage. It is worth noting that
about 20% of the genes identified in the screen are still uncharacterized,
leaving the way open for future studies.
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Surprisingly, our analysis also yielded some strains whose growth was
improved when DDC2 was overexpressed. This observation needs fur-
ther investigation, but may suggest that in some conditions a hyperactive
checkpoint can enhance cell viability. Alternatively, it is possible that Ddc2
might have cellular roles other than Mec1 activation. Lastly, we must rec-
ognize that some known genome stability genes were not identified in our
screen: it is possible that in some strains high levels of genome instability
can favour the occurrence of mutations suppressing the original phenotype,
which will be likely selected due to growth advantage.
VID22 is a new player in genome stability. Among the genes iden-
tified, we were intrigued by VID22 (YLR373C ), which was not expected to
have a role in genome stability maintenance, due to its annotation as “Gly-
cosylated integral membrane protein localized to the plasma membrane”
which “plays a role in fructose-1,6-bisphosphatase (FBPase) degradation;
involved in FBPase transport from the cytosol to Vid (vacuole import and
degradation) vesicles” (Saccharomyces Genome Database). In the exist-
ing literature two lines of evidence link VID22 to genome integrity. First,
VID22 was simultaneously identified in two screens for genome stability
genes based on marker inactivation in haploid or diploid yeast cells [20].
Second, Bellaoui et al. found VID22 among the negative genetic interac-
tors of MUS81 and MMS4, whose products form a protein complex with
endonuclease activity involved in the resolution of recombination interme-
diates [52]. In both papers VID22 was only mentioned without any further
investigations or additional comments.
Despite its annotation as a“plasma membrane protein”(Saccharomyces
Genome Database), published data [22] and our observations (Fig. S2)
demonstrate that Vid22 is a nuclear protein, consistent with a role in
genome stability maintenance. Moreover, Vid22 and its paralog Env11
(encoded by YGR071C ) were found in a complex with the transcription
factor and telomere silencing regulator Tbf1 [53], and it was shown that
Vid22 directly binds some gene promoters [34].
Direct observation of genome instability hallmarks in a vid22D strain al-
lows us to conclusively include VID22 among the genes required for genome
integrity maintenance. First, partial Rad53 phosphorylation and increased
gH2A levels (Fig. 2A) are indicative of chronic accumulation of DNA dam-
age. This assumption is also corroborated by a higher spontaneous muta-
tion rate at the CAN1 locus (Fig. 2B), and a greater recombination rate at
the rDNA locus in vid22D cells (Fig. 2C). Moreover, the absence of Vid22
makes yeast cells sensitive to a number of genotoxic agents (Fig. 3). Inter-
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estingly, these defects are at least partially independent from Vid22’s role
in the Vid22-Env11-Tbf1 complex, since an env11D mutant was not found
sensitive to any genotoxic agent examined, and did not display hallmarks
of genomic instability (data not shown). However, we cannot exclude that
a Vid22-Tbf1 subcomplex might play a role in genome integrity mainte-
nance, since Tbf1 is an essential gene and therefore damage sensitivity
cannot be tested in a tbf1D mutant.
We ruled out the possibility that these phenotypes are caused by a de-
fect in checkpoint activation after endogenous or exogenous DNA damage
(Fig. S5). In fact, vid22D cells were expected to be checkpoint-proficient,
due to the observation of a chronically alerted checkpoint in an unper-
turbed cell cycle (Fig. 2A) and to the sensitivity to high levels of Ddc2
(Fig. 1C), which should not occur in a checkpoint-deficient strain. We
also excluded that these phenotypes could be attributable to a defect in
checkpoint inactivation (Fig. S5-E).
Various indirect lines of evidence suggest that genomic instability in the
absence of Vid22 may be related to defects in S-phase: i) the spontaneous
accumulation of gH2A in a vid22D strain is detectable more clearly at time-
points at the end of S-phase (Fig. 2A and Fig. 4A); ii) a partial defect
in S-phase progression in a vid22D strain is detectable by FACS and it
is accompanied by the appearent inability to enter S-phase of a vid22D
subpopulation (Fig. 4A,B); iii) moreover, genome-wide genetic interaction
data suggest that deletion of VID22 is detrimental in cells deprived of genes
involved in resolution of replication and recombination intermediates (fig.
S3).
A proposed mechanism for the development of genome instability
in the absence if VID22. Transcriptional profiling of a vid22D strain
indicates that deletion of VID22 leads to downregulation of a subset of
cyclin genes involved in the control of G1/S transition and S-phase pro-
gression, namely CLN1, CLN2 and CLB6 (Fig. 4C). The G1 cyclins Cln1
and Cln2 interact with yeast CDK1 (Cdc28) to induce transcription of the
G1/S regulon [54, 55, 56], thus promoting G1/S transition [57]. Instead,
Clb6 activates CDK1 to promote replication origin firing and initiation of
DNA synthesis [58, 57]. Interestingly, two other factors necessary for repli-
cation initiation were found downregulated in a vid22D mutant: CDC6
and CDC45 (Fig. 4C). Cdc6 is a key factor for pre-replicative complex
(pre-RC) assembly at origins of replication [59], while Cdc45 is required
for pre-initiation complex (pre-IC) formation [60, 61], DNA polymerase a
recruiting and subsequent triggering of replication initiation [62, 57].
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Recent work showed that the G1/S transition is governed by a pos-
itive feedback loop involving Cln1 and Cln2 [63], which ensures proper
expression of the ∼200 genes of the G1/S regulon (among which CLN1
and CLN2 genes themselves are included). Interestingly, in a cln1D cln2D
mutant the positive feedback is disrupted, resulting in inefficient expression
of the G1/S regulon and stochastic cell cycle arrest at an unbudded stage
[63]. The deletion of VID22 seems to partially mimic this phenotype, as in
a vid22D mutant downregulation of G1 cyclin genes and sporadic failure
to enter S-phase is observed. We propose that in the absence of VID22
CDK activity required for G1/S transition is downregulated, resulting in
defective G1/S transition and impaired replication origin firing. This sug-
gestion is reinforced by the finding that CDC6 and CDC45, two genes
encoding for key replication initiation factors, are also downregulated in a
vid22D strain. We speculate that, similarly to what was observed in cln1D
cln2D cells, these defects may stochastically lead to a complete failure of
G1/S transition in a subpopulation of a vid22D mutant. We wish to point
out that our transcriptional analysis was carried out in a cellular popula-
tion and it is therefore the result of an average behaviour. However, the
trascriptional defect observed in the absence of VID22 may be particu-
larly relevant in some cells; single-cell analysis similar to that described in
Skotheim et al. [63] could shed some light on this point.
Multiple lines of evidence point at deregulation of G1/S transition, at
the level of both CDK/cyclin complexes activity and replication origin fir-
ing, as an important source of genome instability in yeast and mammalian
cells [64, 65, 66, 67]: i) CDK inhibition in human cells results in accu-
mulation of hallmarks of spontaneous DNA damage [68, 69]; ii) reduced
replication origin firing due to CLN2 overexpression [70], SIC1 deletion
[71], CDC6 mutation [72] or CDC45 and other replication factors deple-
tion [73] results in genome rearrangements; iii) finaly, it was suggested
that the human fragile site FRA3B is linked to a paucity of replication
initiation events [74]. These observations suggest the model in Figure 5.
Deregulation of G1/S transition, due to attenuated expression of G1 cyclins
and key replication factors in the absence of VID22, when not leading to
unbudded cell cycle arrest, is accompanied by defects in replication origin
firing, which may result in perturbed replication and genomic instabil-
ity. This view might also explain the synthetic lethality/sickness between
vid22D and deletion of genes involved in the resolution of recombination
structures during replication (Fig. S3).
Further experiments can be performed in the future to test this model,
in particular direct assessment of origin firing efficiency in the absence of
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VID22 and detection of the proposed aberrant recombination structures.
Moreover, ChIP analysis at the promoters of genes whose expression was
found altered in a vid22D mutant will help to define which genes are di-
rectly regulated by Vid22. Finally, the observation of a genomic instability
phenotype in cln1D cln2D cells might further reinforce our mechanistic ex-
planation for the genomic instability occurring in vid22D cells.
Altoghether, our analysis provided new information on pathways con-
tributing to genome integrity maintenance, unraveling a new role for S.
cerevisiae VID22 in ensuring proper G1/S transition, indispensable to
guarantee faithful transmission of an intact genome at each round of repli-
cation.
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Materials & methods
Strains and plasmids
Unless differently stated, the strains used in this work are RAD5 deriva-
tives of W303 [MATa ade2-1 trp1-1 can1-100 leu2-3,12 his3-11,15 ura3 ].
All the strains used in this study are listed in Table 1. Plasmid pNOV1.4
was produced by inserting the NATR marker in multicopy vector pRS426,
to allow the first selection steps of the SGA procedure. Plasmid pFL82.4
was obtained by cloning DDC2 open reading frame under the GAL1 pro-
moter in plasmid pNOV1.4.
DDC2 overexpression screen
The screen was performed adapting the SGA technology described in [16].
Briefly, a query strain previously transformed with the DDC2-overexpressing
plasmid was crossed to an ordered array of all the viable yeast deletion
strains. Diploid cells were transferred on a sporulation-inducing medium,
after which the spores were selected for the simultaneous presence of the
gene deletion and the plasmid. The mutants were then transferred on a
galactose-containing medium to induce DDC2 overexpression, and colony
size was analyzed as a measure of the mutants’ fitness, as described in
[75]. The whole procedure was performed in parallel with a control query
containing the same vector devoid of the GAL-DDC2 gene.
FACS analysis
Cells were fixed in 70% ethanol and treated with RNase A and proteinase
K. DNA was stained with Sytox Green and cell-cycle distribution was
estimated by cytofluorimetric analysis with a FACScan.
SDS-PAGE and western blotting
TCA protein extracts were separated by SDS-PAGE in 10% (to monitor
Rad53) or 15% (to detect H2A) acrylamide gels. Western blotting was
performed with anti-Rad53, anti-gH2A and anti-H2A antibodies.
DNA damage sensitivity assays
To assess cell survival after genotoxic treatment, overnight yeast cultures
were diluted to an OD of 0.06, and 10-fold serial dilutions were spotted
on YPD plates containing Bleomicin, HU, MMS or CPT at the indicated
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concentrations. To assess cell survival after H2O2 treatment, overnight
yeast cultures were diluted to OD 0.06, and treated with the indicated
doses of H2O2 for 30’, after which 10-fold serial dilutions were spotted on
YPD plates. To assess cell survival after UV irradiation, overnight yeast
cultures were diluted to OD 0.06, and 10-fold serial dilutions were spotted
on YPD plates, which were irradiated with the indicated UV doses. Images
were captured after 3 days’ incubation at 28°C.
Genome instability assays
Measurements of the CanR spontaneous mutation rate. Forward
mutation to canavanine resistance was determined by fluctuation tests
using the median method [76]. Single colonies were inoculated in 5 ml
YPD and grown up to saturation (∼2 days at 28°C). A 100-ml drop of an
appropriate dilution was plated onto canavanine-containing medium (1–2
Ö 107cells/plate) to identify forward mutations in CAN1 and an appro-
priate dilution was plated onto SD medium to count viable cell number
(∼100 cells/plate). Colonies appearing after 5 days of growth at 28°C
were counted. The number of CanR colonies per 107viable cells among 9
parallel cultures was calculated and the median value from each set of 9
cultures was used to determine the spontaneous mutation rate of a given
strain by the method of the median [77].
Measurements of the rDNA recombination rate. The loss of an
ADE2 marker integrated into the rDNA array was used to measure re-
combination, as described in [78]. Cells were grown overnight and then
plated onto solid YPD added with 12.5 mg/ml adenine. Colonies were
grown 3 days at 28°C, and then transferred at 4°C for 3 days prior to
analysis. The number of half-red/half-white colonies was determined; each
was assumed to represent a marker loss event during the first cell division
after plating. The number of half-sectored colonies divided by the total
number of colonies (excluding entirely red colonies) was reported as the
rate of marker loss. About 10000-15000 colonies were examined for each
strain in each experiment.
RNA-seq
Total RNA from ∼108 exponentially growing cells was extracted with
RiboPure-Yeast Kit (Ambion) and treated for 30 min at 37°C with RNAse
free DNase I (Ambion). Quality control on RNA samples were performed
with the following kits: Agilent RNA 6000 Nano Kit (Agilent) and Qubit
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RNA Assay Kits (Invitrogen), according to the manufacturer’s instruc-
tions. Equimolar pools of 5 independent RNA extractions were used for
the Illumina library preparation (an overall amount of 8 mg RNA). Poly(A)
RNA purification, cDNA synthesis and Illumina library preparation were
performed with the TruSeq RNA Sample Prep Kit v2 - Set A (Illumina),
according to the manufacturer’s instructions. The library was controlled
with the following kits: Agilent DNA 1000 Kit (Agilent) and Qubit ds-
DNA HS Assay Kits (Invitrogen). Clusters were generated in triplicate
with the Illumina cBot Cluster Generation System, using the TruSeq SR
Cluster Kit v2–cBot–GA (Illumina); equimolar amounts of the different
libraries were pulled together (at a final concentration of 8pM for each
library) and the pool was loaded on 3 lanes of the flowcell. The libraries
were then sequenced on a Genome Analizer IIx (Illumina) with the TruSeq
SBS Kit v5 GA (36-cycle) (Illumina), performing 36 sequencing cycles.
Sequence reads were mapped on the yeast genome (version April 2011
S288c assembly) using Bowtie [79], allowing up to two substitutions, and
keeping for further analyses only reads mapping at unique positions of the
genome. Sequence reads were assigned to ORF annotations of the SGD
database (version August 2011). Read mapping on overlapping ORFs were
discarded from further analysis. For all the annotated ORFs, differential
transcript abundance was estimated by performing a t-test between aver-
age and standard deviation of the normalized read counts assigned to the
gene in the three replicates of each mutant versus average and standard
deviation of the wild type. P-values returned from the t-test were modified
to accomodate for multiple testing by using a Bonferroni correction. Fold
ratios were obtained from average read counts computed as above.
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Figure legends
Figure 1. A new screen for genome stability genes based on
DDC2 overexpression.
A Overview of the screen procedure using the SGA technology. See the
Results and Material and Methods sections for details.
B Overview of the classes of genes identified in the screen. The assignment
of identified genes to functional categories is manually curated, based
on the descriptions found in Saccharomyces Genome Database.
C Ten-fold serial dilutions of strains YNOV920 (wt, vector), YNOV921
(wt, GAL-DDC2 ), YNOV922 (vid22D, vector) and YNOV923 (vid22D,
GAL-DDC2 ) were were spotted on YPGal/Raff medium to induce
DDC2 overexpression and on YPD as a control. Pictures were taken
after 3 days of incubation at 28°C.
Figure 2. Yeast cells deleted for VID22 experience spontaneous
genome instability.
A A vid22D strain shows spontaneous Rad53 phosphorylation and persis-
tent levels of gH2A. Exponentially growing cultures of strains SY2080
(wt) and YNOV108 (vid22D) were synchronized in G1 phase with
5 mg/ml a-factor and then released in fresh medium. Samples were
taken every 30’. The phosphorylation status of Rad53 and histone
H2A was analyzed by SDS-page and western blotting with antibod-
ies anti-Rad53 and anti-gH2A respectively; total levels of H2A were
monitored with anti-H2A antibodies.
B Spontaneous mutation rate in wt (BY4741) and vid22D (DMA3420)
cells. Forward mutation rate at the CAN1 locus rate was determined
in three fluctuation tests of nine independent colonies each for each
strain. The average and standard deviation of the three fluctuation
tests is plotted.
C Spontaneous recombination rates at the rDNA array in wt (W303R)
and vid22D (YNOV352) cells. All the strains carry an ADE2 marker
integrated into the rDNA array. Recombination rates were calculated
by assessing the loss of the ADE2 marker in the first generation after
plating (half sector assay). The average and standard deviation of
the three independent experiments is plotted.
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Figure 3. Yeast cells deleted for VID22 are sensitive to DNA
damage.
Ten-fold serial dilutions of strains SY2080 (wt) and YNOV108 (vid22D)
were spotted on YPD, Bleomicin, HU, MMS and H2O2 plates at the in-
dicated concentrations. Pictures were taken after 3 days of incubation at
28°C.
Figure 4. VID22 is implicated in the control of G1/S transition.
A Cell cycle progression of wt (SY2080) and vid22D (YNOV108) strains.
Cells were were synchronized in G1 phase with 5 mg/ml a-factor and
then released in fresh medium. Samples were taken every 5’ and
analyzed by flow cytometry. The blue arrow shows the 1C peak
which persists in the vid22D mutant; the red arrow shows the delay
in S-phase progression of the vid22D mutant. To better visualize the
S-phase defect of the vid22D mutant, overlay of the DNA content
profiles of the two strains at the crucial timepoints are also shown.
B Cell cycle profile after nocodazole arrest. Exponentially growing cul-
tures of strains SY2080 (wt) and YNOV108 (vid22D) were arrested
in M phase with 4 mg/ml nocodazole for 3h and analyzed by flow
cytometry.
C List of genes involved in G1/S transition and replication initiation which
were found downregulated in a vid22D strain.
Figure 5. A proposed model for the mechanism leading to genome
instability in the absence of VID22.
A In a wt strain, Vid22 ensures (directly or indirectly) proper expression of
genes promoting G1/S transition. A positive feedback loop regulates
the expression of CLN1 and CLN2 genes, which in turn are respon-
sible for timely and robust expression of the so-called G1/S regulon,
among which are many genes governing replication initiation. In par-
ticular, this ensures proper levels of Cdc45, a key component of the
pre-initiation complex (pre-IC). Vid22 is also required for the ade-
quate expression of CDC6, encoding for another key factor involved in
replication origin licencing. Finally, efficient G1/S regulon expression
provides enough CDK1/Clb6 complex, which controls replication ori-
gin firing by phosphorylating key replication factors. Altoghether,
these mechanisms ensure timely and efficient G1/S transition.
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B In a vid22D strain, G1/S regulon expression is incoherent and insuf-
ficient. The positive feedback involving G1 cyclins is likely abro-
gated; PCL1, which could partially compensate for Cln1 and Cln2
reduced levels, is poorly expressed; lower amounts of Cdc6 and Cdc45
are available for pre-replicative complex (pre-RC) and pre-initiation
complex (pre-IC) formation; moreover, defective expression of CLB6
gene results in reduced activity of CDK1/Clb6 complex. Depending
on the stochastic cell-to-cell variability, these defects may result in
absolute impairment of origin firing and subsequent unbudded arrest
at the G1/S transition (bottom left), or in perturbed and insufficient
origin firing, leading to genomic instability (bottom right).
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Tables
Table 1. Strains used in this study
Strain name Relevant genotype Source
YNOV42 MATa can1D::MFA1pr-HIS3
mfa1D::MFa1pr-LEU2 lyp1D leu2D0 his3D1
ura3D0 met15D0 LYS2+pFL82.4 [GAL-DDC2 ]
This study
YNOV46 MATa can1D::MFA1pr-HIS3
mfa1D::MFa1pr-LEU2 lyp1D leu2D0 his3D1
ura3D0 met15D0 LYS2+pNOV1.4 [vector]
This study
BY4741 MATa his3D1 leu2D0 met15D0 ura3D0 Euroscarf
YNOV920 BY4741 pRS426 [vector] This study
YNOV921 BY4741 pFL60.1 [GAL-DDC2 ] This study
YNOV922 BY4741 vid22D::KANMX6 pRS426 [vector] This study
YNOV923 BY4741 vid22D::KANMX6 pFL60.1
[GAL-DDC2 ]
This study
SY2080 MATa wt M. Foiani
YNOV108 MATa vid22D::KANMX6 This study
DMA3420 BY4741 vid22D::KANMX6 This study
W303R MATa RDN1::ADE2 L. Guarente
YNOV352 MATa RDN1::ADE2 vid22D::KANMX6 This study
Manuscript in preparation
203
Figure 1
A
B
C
YPGal/RaffYPD
vector
GAL-DDC2
vector
GAL-DDC2
wt
vid22Δ
KANXXX
KAN
XXX
KANXXX
KAN XXX
KANXXX
KANXXX
KAN
KAN
KAN
KAN
1
2
3
4
legenda
XXX
KAN
2μ plasmid-GAL-DDC2
deletion xxx::KAN
wt XXX gene
MATa cell
MATα cell
Query
strain
Deletion
collection
galactose
transcription
regulation
peroxisomes
chromatin
remodeling
DNA damage response
ribosome
biogenesis proteasome
oxidative stress
protein
sorting
cell wall
aminoacid
biosynthesis
cell cycle
cytoskeleton
mitochondria
autophagy
meiosis
unknown
others
Manuscript in preparation
204
Figure 2
A
B C
wt vid22Δ
Rad53
γH2A
H2A
30’ 60’ 90’ 120’0’ 30’ 60’ 90’ 120’0’
0.00
1.00
2.00
3.00
4.00
5.00
6.00
M
u
ta
ti
o
n
ra
te
 x
1
0
7
CAN1 forward mutation rate
Time after
G1 release
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
4.50
re
c
o
m
b
in
a
ti
o
n
ra
te
 X
 1
0
3
recombination rates
at rDNA locus
Manuscript in preparation
205
Figure 3
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ORF Gene SGD description
YMR199W CLN1
G1 cyclin involved in regulation of the cell cycle; activates Cdc28p kinase to promote 
the G1 to S phase transition
YPL256C CLN2
G1 cyclin involved in regulation of the cell cycle; activates Cdc28p kinase to promote 
the G1 to S phase transition
YNL289W PCL1
Cyclin, interacts with cyclin-dependent kinase Pho85p; member of the Pcl1,2-like 
subfamily, involved in the regulation of polarized growth and morphogenesis and 
progression through the cell cycle
YGR109C CLB6
B-type cyclin involved in DNA replication during S phase; activates Cdc28p to promote 
initiation of DNA synthesis
YJL194W CDC6
Essential ATP-binding protein required for DNA replication, component of the pre-
replicative complex (pre-RC)
YLR103C CDC45
DNA replication initiation factor; recruited to MCM pre-RC complexes at replication 
origins; promotes release of MCM from Mcm10p, recruits elongation machinery
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Supporting information
Supplementary figures
Figure S1. Overexpression of DDC2 increases sensitivity to ex-
ogenous or endogenous DNA damage.
A Ten-fold serial dilutions of strains YNOV46 (wt, vector) and YNOV42
(wt, GAL-DDC2 ), were were spotted on YPGal/Raff medium to
induce DDC2 overexpression and on YPD as a control. The plates
were either mock or UV irradiated (50 J/m2). Pictures were taken
after 4 days of incubation at 28°C.
B rad18D, rad27D, mre11D and slx8D strains were transformed with cen-
tromeric plasmid pFL57.1 (GAL-DDC2 ) or pRS314 (vector) and cell
viability after of DDC2 overexpression was tested as described in Fig.
1C.
C rad18D, mre11D and slx8D strains were transformed with multicopy
plasmid pFL58.1 (GAL-DDC2 ) or pRS424 (vector) and cell viability
after of DDC2 overexpression was tested as described in Fig. 1C.
Figure S2. Vid22 protein localizes in the nucleus.
Immunolocalization of Vid22-3HA in exponentially growing cells: Vid22-
3HA was detected with an anti-HA antibody, while DAPI staining marks
the nucleus.
Figure S3. Overview of the genetic interactions of VID22.
Negative (A) and positive (B) genetic interactions of VID22 obtained
from genome wide SGA experiments ([30] and Charlie Boone, unpublished
data) are shown. Colors and labels display the results of GO-enrichment
analysis.
Figure S4. Yeast cells deleted for VID22 are not sensitive to UV
or camptothecin.
A Ten-fold serial dilutions of strains SY2080 (wt) and YNOV108 (vid22D)
were spotted on YPD and mock or UV-irradiated at the indicated
doses. Pictures were taken after 3 days of incubation at 28°C.
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B Ten-fold serial dilutions of strains SY2080 (wt) and YNOV108 (vid22D)
were spotted on YPD/DMSO or CPT plates at the indicated con-
centrations. Pictures were taken after 3 days of incubation at 28°C.
Figure S5. Yeast cells deleted for VID22 are not defective in
DNA damage checkpoint activation and switch-off.
A Exponentially growing cultures of strains SY2080 (wt) and YNOV108
(vid22D) were arrested in G1 phase with 10 mg/ml a-factor and then
50 mg/ml Bleomicin was added to the cultures. Checkpoint activation
was monitored at the indicated timepoints by SDS-page and western
blotting with antibodies anti-Rad53.
B Exponentially growing cultures of strains SY2080 (wt) and YNOV108
(vid22D) were arrested in M phase with 20 mg/ml nocodazole; Bleomicin
treatment and checkpoint activation was analyzed as described in
Fig. S5-A.
C Exponentially growing cultures of strains SY2080 (wt) and YNOV108
(vid22D) were synchronized in G1 phase with 5 mg/ml a-factor and
then released in 25 mM HU. Checkpoint activation at the indicated
timepoints was monitored as described in Fig. S5-A.
D Exponentially growing cultures of strains SY2080 (wt) and YNOV108
(vid22D) were synchronized in G1 phase with 5 mg/ml a-factor and
then released in 0,02% MMS. Checkpoint activation at the indicated
timepoints was monitored as described in Fig. S5-A.
E Exponentially growing cultures of strains SY2080 (wt) and YNOV108
(vid22D) were synchronized in G1 phase with 5 mg/ml a-factor and
then treated with 200 mM HU for 1h, after which they were released
in fresh medium. Checkpoint activation status was monitored as
described in Fig. S5-A.
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Supplementary materials & methods
Supplementary strains and plasmids
Supplementary strains are listed in Table S1.
Plasmid pFL57.2 and pFL58.2 were obtained by cloning DDC2 open
reading frame under the GAL1 promoter in centromeric vector pRS314
and multicopy vector pRS324, respectively.
In situ immunofluorescence of yeast cells
1 ml cells were fixed 15’ at room temperature with fixation buffer (3.7%
formaldehyde, 0.1 M K-phosphate pH 6.4, 0.5 mM MgCl2); samples were
washed three times with wash buffer (0.1 M K-phosphate pH 6.4, 0.5 mM
MgCl2) and one time with spheroplasting solution (1.4 M sorbitol, 0.1 M
K-phosphate pH 6.4, 0.5 mM MgCl2), after which they were resuspended in
200 ml of the same buffer. Spheroplasts were prepared using 5 ml of 1 mg/ml
zymolyase at 37°C, monitoring spheroplastization by microscopic observa-
tion, and then washed one time with spheroplasting solution. Spheroplasts
were used to prepare a multi-well glass slide for immunofluorescence. For
immunodetection, slides were incubated o/n at 4°C with anti-HA primary
antibody, and then 2 hours at room temperature with secondary antibody.
DNA was stained with DAPI.
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Table S1. Supplementary strains
Strain name Relevant genotype Source
YFL747 MATa pRS314 [vector] This study
YFL741 MATa pFL57.2 [GAL-DDC2 ] This study
YFL749 MATa rad18D::KANMX6 pRS314 [vector] This study
YFL743 MATa rad18D::KANMX6 pFL57.2 [GAL-DDC2 ] This study
YFL750 MATa rad27D::KANMX6 pRS314 [vector] This study
YFL744 MATa rad27D::KANMX6 pFL57.2 [GAL-DDC2 ] This study
YFL751 MATa mre11D::KANMX6 pRS314 [vector] This study
YFL745 MATa mre11D::KANMX6 pFL57.2 [GAL-DDC2 ] This study
YFL752 MATa slx8D::KANMX6 pRS314 [vector] This study
YFL746 MATa slx8D::KANMX6 pFL57.2 [GAL-DDC2 ] This study
YNOV375 MATa pRS424 [vector] This study
YFL783 MATa pFL58.2 [GAL-DDC2 ] This study
YNOV359 MATa rad18D::KANMX6 pRS424 [vector] This study
YFL785 MATa rad18D::KANMX6 pFL58.2 [GAL-DDC2 ] This study
YNOV361 MATa mre11D::KANMX6 pRS424 [vector] This study
YFL787 MATa mre11D::KANMX6 pFL58.2 [GAL-DDC2 ] This study
YNOV362 MATa slx8D::KANMX6 pRS424 [vector] This study
YFL788 MATa slx8D::KANMX6 pFL58.2 [GAL-DDC2 ] This study
YNOV120 MATa VID22-3HA::HIS3MX6 This study
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Supplementary data
Supplementary figure 1
Yeast strains deleted for genes known to be involved in genome
stability display a chronic Rad53 psopshorylation.
Protein extracts were prepared from exponentially growing cultures of the
indicated strains and the phosphorylation status of Rad53 was analyzed
by SDS-page and western blotting with antibodies anti-Rad53.
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Supplementary data
Supplementary figure 2
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Supplementary data
Supplementary figure 3
Overview of the negative trigenic genetic interactions involving
yeast RNase H1 and RNase H2.
The SGA technology was used to identify the genetic interactors of a rnh1D
rnh201D query strain, both in unperturbed conditions and with 10mM
or 25 mM HU treatment. A summary of the biological functions of the
interactions overall identified is shown.
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